CARBAMAZEPINE," Tablet: 100mg, 200mg, 300 mg, 400mg; oral ; 
solution: each 5ml of oral solution containing 100mg of carbamazepine","Treatment of tonic-clonic, mixed and complex partial seizures
(not used in absence seizures and myoclonic seizure), management of pain in
trigeminal neuralgia or diabetic neuropathy, acute mania.","Bone marrow suppression, administration
of MAO-I within last 14 days, jaundice, hepatitis. Use cautiously in cardiac
or hepatic disease, renal failure, skin reactions, history of blood disorders,
glaucoma, pregnancy (esp. 1st trimester: risk of fetal carbamazepine
syndrome). ","As anticonvulsants: PO (adults) 200mg BD (tab) or 100mg q (suspension),
increase by 200mg/day for 7 days until therapeutic levels are achieved
(range 600-1200mg/day in divided doses q 6-8 hours; not to exceed 1 gm/
day in 12-15 year olds.; As antineuralgic: 100mg BD or 50mg qid (suspension); increase by up to
200mg/day until pain is relieved, then maintenance dose of 200-1200mg/
day in divided doses (usual range: 400-800mg/day); PO (children 6-12
years): 100mg BD or 50mg qid (suspension), increase by 100mg weekly
until therapeutic levels are obtained (400-800mg/day, not to exceed 1gm/
day); PO (children <6 years): 10-20mg/kg/day in 2-3 divided doses; may be
increased at weekly intervals until optimal response and therapeutic levels
are achieved. Usual maintenance dose is 250-350mg/day (not to exceed 35
mg/kg/day)",": Ataxia, drowsiness, CHF, renal damage, blurring of vision,
agranulocytosis, migraine (headache), increased ADH secretion (dilutional
hyponatremia), exfoliative dermatitis/hypersensitivity reaction, decreased
platelet, increased risk of lupus, nausea, emesis.","Concurrent use of MAO-I may result in
hyperpyrexia, hypertension, seizures and death, induces hepatic enzymes.
Regular dosage promotes its own metabolism and that of other drugs
metabolized in liver, including phenobarbital, ethosuximide, phenytoin, oral
contraceptives"
CLOBAZAM,": Tablet: 10 mg
","Adjunct in epilepsy, anxiety"," Hypersensitivity. Do not stop the drug
abruptly","Epilepsy: 20 to 30 mg daily (max. 60mg daily); child >3yrs:
not more than half adult dose; Anxiety: 20 to 30 mg daily in divided doses
or as a single dose at bed time, increased in severe anxiety (in hospitalized
patients) to a maximum of 60mg daily in divided doses; elderly 10-20 mg
daily","Somnolence, sedation, pyrexia, URTI",": CNS depressants (effect may be potentiated)
Patient information: Tablets should be swallowed whole; do not crush, break
or chew"
CLONAZEPAM,"Tablets: 0.25mg, 0.5mg, 1mg","Status epilepticus, all types of epilepsy, anxiety disorder
"," Hypersensitivity, severe liver diseases,
respiratory depression and acute pulmonary insufficiency. Pregnancy
category C, breast feeding mothers. Do not stop the drug abruptly","Seizures: 1.5 mg divided into 3 doses, raise by 0.5 mg every 3 days until
desired effect is reached; divide into 3 even doses or else give largest dose
at bedtime;  Panic: 1 mg/day; start at 0.25 mg divided into 2 doses, raise to 1 mg after 3
days; dose either twice daily or once at bedtime; maximum dose generally
4 mg/day","Suicidal thoughts, dizziness, drowsiness, ataxia, muscle
hypotonia, restlessness, salivary or bronchial hypertension in infants and
small children, sexual dysfunction, dependence.
","With verapamil, diltiazem: risk of AV block.
Patient information: Notify if mouth sores, sore throat, fever, swelling of
hands or feet, irregular heartbeat, chest pain, signs of angioedema. Avoid
prolong use beyond prescription."
DIAZEPAM,"Injection: 5mg/ml, Tablets: 2mg, 5mg"," Adjunct in the management of anxiety disorder, anxiety relief
prior to cardioversion, preoperative sedation, conscious sedation (provides
light anaesthesia and anterograde amnesia), treatment of status epilepticus/
uncontrolled seizures, as a skeletal muscle relaxants, management of
symptoms of alcohol withdrawal.","Acute alcohol intoxication, myasthenia
gravis, acute narrow angle glaucoma and sleep apnea, children <6 months.
Severe renal impairment, compromised liver function, history of suicidal
tendency or drug dependence and acute alcoholism, debilitated patients
with low albumin, COPD and sleep apnea. Facilities for mechanical
ventilation should always be at hand and patients should remain under close
observation for at least 1 hr. Danger of apnea and hypotension are reduced
if injections are administered slowly","IV inj. 10-20 mg at the rate of 0.5ml (2.5 mg) per 30 sec;
repeat if necessary after 30-60 min; may be followed by IV infusion to max.
3mg/kg over 24 hrs. Children: 200-300 μg/kg","Apnea, hypotension, thrombophlebitis, dizziness and
drowsiness, lethargy, depression, headache, muscle weakness, ataxia"," Concomitant use of benzodiazepine with
opioids and/or other CNS depressants may result in profound and potentially
fatal respiratory depression."
GABAPENTIN,Capsule: 300mg,"Adjunct treatment of partial seizures, with and without
secondary generalization; bipolar affective disorder (BPAD), post-herpetic
neuralgia, neuropathic pain
","Increased blood CPK levels and
rhabdomyolysis. Safety not established in children <3yrs and pregnant
women. ","Epilepsy: 300mg on day 1, then 300mg twice daily on day
2, then 300mg 3 times daily on day 3, then increased according to response
in steps of 300 mg daily (in 3 divided doses) to a maximum 2.4 gm daily; child
(6-12 yrs) 10 mg/kg on day 1, then 20mg/kg on day 2, then 25-35mg/kg daily,
maintenance 900 mg daily.","Ataxia, dizziness, drowsiness, fatigue, somnolence, diplopia,
nystagmus, tremor, suicidal thoughts.
","Antacids may decrease the absorption of
gabapentin, increased risk of CNS depression with other CNS depressants.
Patient information: Not to drive until they have gained experience to assess
whether therapy will impair their ability to drive. Do not discontinue abruptly
(may increase seizure frequency); gradually taper over a minimum of 1 week."
LACOSAMIDE,"Tablets: 50 mg, 100 mg, 150 mg, 200 mg;
injectable solution: 200 mg/20 ml; Oral solution: 10 mg/ml
"," As monotherapy or adjunctive treatment of focal seizures with
or without secondary generalization","Second- or third-degree AV block.
Conduction problems, in elderly, severe cardiac disease; Caution in renal and
hepatic impairment.","Monotherapy: 100 mg PO/IV 12hrly initially, then, based on response and
tolerability, increase dose at weekly intervals by 50 mg PO/IV BID; up to
a recommended dose of 150-200 mg BID (300-400 mg/day); Alternate
loading dose schedule: 200 mg PO/IV as a single loading dose, followed
12 hr later by 100 mg PO/IV BID; then increase dose at weekly intervals by
50 mg BID; up to a recommended dose of 150-200 mg BID (300-400 mg/
day). In patients already taking an antiepileptic drug (AED), maintain at
recommended maintenance dose of 150-200 mg PO BID for at least 3 days
before initiating withdrawal of the previous AED.",": Abnormal gait, tremor, impaired coordination, nystagmus,blurred vision, cognitive disorder, depression, dizziness, drowsiness, fatigue,
headache, agitation. Nausea, vomiting, constipation, flatulence, pruritus.
Cardiac arrhythmias and conduction defects.
",
LAMOTRIGINE,"Tablets: 25mg, 50mg, 100mg","Partial, secondarily generalized tonic clonic seizures, LennoxGastaut syndrome, bipolar affective disorder
","Hypersensitivity, lactation. Pregnancy
Category C, cardiac/renal/hepatic disease, severe depression, blood
dyscrasias, children <16yr","Monotherapy: 25mg daily initially for 14 days, increased to 50mg daily for
further 14 days, then increased by 50-100 mg daily every 7-14 days; usual
maintenance as monotherapy, 100-200 mg daily in 1-2 divided doses;
• Adjunct therapy with valproate: initially 25 mg every other day for 14 days,
then 25 mg daily for further 14 days, thereafter increased by 25-50mg daily
every 7-14days; usual maintenance 100-200mg daily in 1-2 divided doses.
• Adjunct therapy with carbamazepine: for the first 2 weeks administer 50
mg/day; at week 3 increase to 100 mg/day in 2 doses; every 1–2 weeks can
increase by 100 mg/ day; usual maintenance dose 300–500 mg/ day in 2
doses.","Dizziness, ataxia, blurred or double vision, nausea,
vomiting, rash, Stevens-Johnson syndrome.
Patient information: Medicine to be taken with food if gastrointestinal upset
occurs. Do not discontinue the drug abruptly. Discontinue the drug and
consult your doctor at first sign of rashes.",
LEVETIRACETAM," Tablet: 250 mg, 500 mg, 750 mg, 1 g; Granules:
250 mg, 500 mg, 1 g; Oral solution: 100 g/ml; Solution for infusion: 100 mg/
ml","Monotherapy of focal seizures with or without secondary
generalization, adjunctive therapy of focal seizures with or without secondary
generalization, adjunctive therapy of myoclonic seizures and tonic-clonic
seizures",": Avoid in breastfeeding mothers. Dose
should be monitored carefully during pregnancy and after birth, and
adjustments made on a clinical basis. It is recommended that the fetal
growth should be monitored. Cautions in hepatic and renal impairment, dose
adjustment required. Monitor renal function regularly",,"Abdominal pain, anorexia, nausea, vomiting, dyspepsia,
diarrhea. Headache, malaise, agitation, anxiety, insomnia, ataxia, convulsion,
dizziness, drowsiness, depression. Alopecia, amnesia, diplopia, blurred
vision, leucopenia, thrombocytopenia, myalgia, paraesthesia, eczema,
pruritus, psychosis, suicidal ideation",
OXCARBAZEPINE,"Tablet: 150mg, 300mg",: Monotherapy or adjunctive therapy of partial seizures,"Hypersensitivity, lactation. Renal
impairment, may be teratogenic, children<4 years. Monitor patients for
notable changes in behavior that might be associated with suicidal thoughts
or depression. Discontinue if dermatological reactions occur. Monitor
especially in patients at risk of hyponatremia",": Initially 300 mg BD, increased according to response in
steps up to 600mg daily at weekly intervals; Usual dose range: 0.6-2.4 g
daily in divided doses; Child over 6 years: 8-10mg/kg daily in 2 divided doses
increased according to response in steps up to 10 mg/kg daily at weekly
intervals."," Suicidal thoughts, dizziness, diplopia, headache, nausea,
vomiting, nystagmus, somnolence, ataxia, abnormal gait, tremor, abdominal
pain, fatigue, vertigo, vision abnormalities. Potentially fatal skin reactions
may occur. E.g. Steven Johnson Syndrome
","May render oral contraceptives ineffective
due to metabolic enzyme induction. Increased CNS depression with CNS
depressants"
PHENOBARBITAL,"Tablets: 30mg , 60mg; Injection 200mg","As anti-convulsant in tonic-clonic (grand mal), partial and
febrile seizures in children (except absence seizures). Pre-operative sedative
and other situations in which sedation may be required. Hypnotic (shortterm)",": Hypersensitivity, porphyria, severe hepatic
impairment, COPD, dyspnea, pregnancy and lactation. Use cautiously in
hepatic and renal dysfunction; history of suicide or drug abuse. Chronic use
in pregnancy results in drug dependency in the infant; may result in fetal
malformations and coagulation defects. May require regular monitoring of
the drug levels in plasma. Commercial injection is highly alkaline and may
cause tissue necrosis if given SC or if it extravasates (if it happens treat
with inj. 0.5% procaine); may render OCPs ineffective. Monitor respiratory
function when given parenterally or at high dose. Be aware of risk of fall
among elderly and children.","Status epilepticus (adults and children >1 mo): 15-18 mg/kg in single or
divided doses, max. loading dose = 20mg/kg;
• Maintenance anticonvulsant: IV, PO (adults and children >12 yrs): 1-3mg/
kg/day as a single dose or 2 divided doses; IV, PO (children 5-12 yrs): 4-6
mg/kg/day in 1-2 divided doses; IV, PO (children 1-5yr): 6-8 mg/kg/day in 1-2
divided doses; IV, PO (infants): 5-6 mg/kg/day in 1-2 divided doses; IV, PO
(neonates): 3-4 mg/kg/day, once daily, may need to increase up to 5mg/kg","Ataxia, dizziness, drowsiness, dysarthria, nystagmus,
irritability, vertigo, impairment in cognitive function (especially in children);
IV: respiratory depression, laryngospasm, hypotension. Hypersensitivity
reactions including angioedema, serum sickness."," Induces hepatic microsomal enzyme system
leading to increase in its own metabolism as well as that of other drugs such
as carbamazepine, warfarin, OCPs and corticosteroids thereby decreasing
their plasma concentrations"
FENTANYL,0.05 mg/ml,"Induction and maintenance of anesthesia, analgesia (preoperative and post-operative)","Hypersensitivity, myasthenia gravis,
within 2 hours of MAOI use. Pregnancy, breast feeding, geriatric patients,
increased ICP, seizure disorders, cardiac dysrhythmias, severe respiratory
disorders. Do not use fentanyl within 2 weeks of use of MAOIs","• IV for spontaneous respiration: Adult: 50-100 μg then 50 μg as required;
children: 3-5 μg/kg, then 1 μg as required;
• For assisted ventilation: Adult: 0.3-3.5 mg then 100-200 μg as required;
children:15 μg/kg, then 1-3 μg as required","confusion, delirium or sometimes paradoxical excitation,
post-operative depression and drowsiness, bradycardia, arrest, hypotension
or HTN, arrhythmias, respiratory depression, arrest, laryngospasm, blurred
vision, double vision, miosis, nausea, vomiting, constipation, biliary spasm,
urinary retention, rash, diaphoresis, muscle rigidity","With MAOI, may produce unpredictable,
potentially fatal reactions. CYP3A4 inhibitors increase plasma levels leading
to increased risk of CNS and respiratory depression.
"
PANCURONIUM,Solution: 2 mg/ml in 2 ml ampoule,"Neuromuscular blockade (long duration) during surgery/
intubation/ intensive care","Avoid in neuromuscular disease,
hypersensitive to drug &/or bromides. For use ventilator support is mandatory.
Hepatic impairment: Possibly slower onset, higher dose requirement, and
prolonged recovery time. Renal impairment: prolonged duration of block. If
CrCl 10-50 mL/min then administer 50% normal dose, if CrCl <10 mL/min
then avoid use. Pregnancy (C)","• Neuromuscular blockade (long duration) during surgery and intubation:
intravenous injection, adult: Initially 100 mcg/kg, then 20 mcg/kg as
required
• Neuromuscular blockade (long duration) during intensive care: intravenous
injection, adult: Initially 100 mcg/kg, initial dose is optional, then 60 mcg/
kg every 60–90 minutes. Doses at extremes of body-weight: To avoid
excessive dosage in obese patients, dose should be calculated on the basis
of ideal bodyweight"," Acute myopathy (after prolonged use in intensive care),
hypertension, tachycardia","With or following an opioid, sedative or
anesthetic agent- additive/synergistic effects"
ROCURONIUM BROMIDE ,Solution: 10 mg/ml,"Neuromuscular blockade (intermediate duration) during
surgery/ intubation/ intensive care
","Avoid in neuromuscular disease,
hypersensitive to drug &/or bromides. For use ventilator support is
mandatory. Hepatic impairment: reduce dose. Renal impairment: reduce
maintenance dose; prolonged paralysis. Pregnancy (C)","• Neuromuscular blockade (intermediate duration) during surgery and
intubation: intravenous injection, adult: Initially 600 mcg/kg; intravenous
injection maintenance 150 mcg/kg, OR intravenous infusion, adult:
maintenance 300–600 mcg/kg/hour, adjusted according to response.
Intravenous injection, elderly: Initially 600 mcg/kg, maintenance 75–100
mcg /kg, OR maintenance (intravenous infusion) up to 400 mcg/kg/hour,
adjusted according to response.
• Neuromuscular blockade (intermediate duration) during intensive care:
intravenous injection, adult: Initially 600 mcg/kg, initial dose is optional;
intravenous infusion maintenance 300–600 mcg/kg/hour for first hour,
then by intravenous infusion, adjusted according to response.
• To avoid excessive dosage in obese patients, dose should be calculated on
the basis of ideal bodyweight.","Anaphylactoid reactions, acute myopathy (after prolonged
use in intensive care), bronchospasm, hypotension, skin flushing, tachycardia","With or following an opioid, sedative or
anesthetic agent- additive/synergistic effects"
NEOSTIGMINE,"Tablet: 15 mg. Solution for injection: 2.5 mg/ml
ampoules, 10 mg/ml in 50mg/5ml vials","Treatment of myasthenia gravis, reversal of non-depolarising
(competitive) neuromuscular blockade","Renal impairment: reduce dose. Pregnancy
and breast feeding: use with caution","• Treatment of myasthenia gravis: oral, adult: Initially 15-30 mg, dose repeated
at suitable intervals throughout the day, total daily dose 75–300 mg,
maximum dose: 180 mg daily. Subcutaneous injection or by intramuscular
injection, adult: 1-2.5 mg, dose repeated at suitable intervals throughout
the day (usual total daily dose 5–20 mg)
• Reversal of non-depolarising (competitive) neuromuscular blockade:
intravenous injection, adult: 2.5 mg (max. per dose 5 mg), repeated if
necessary after or with glycopyrronium or atropine, to be given over 1
minute","Anaphylactoid reactions, acute myopathy (after
prolongeduse in intensive care), bronchospasm, hypotension, skin flushing,
tachycardia"," With or following an opioid, sedative or
anesthetic agent- additive/synergistic effects"
ALLOPURINOL,"Tablets: 100 mg, 300 mg","Primary hyperuricemia of gout, secondary hyperuricemia due to
haematological malignancies or anti-neoplastic therapy; especially useful for
high uric acid levels and recurrent renal stones.","Known hypersensitivity. Caution use in
pregnancy, breast feeding, hepatic and renal impairment, elderly and children.
Liberal fluid intake is advocated during treatment. Pregnancy category C.
Risk of hypersensitivity may increase with concomitant administration of
thiazides. ","• Adults: 300 mg/ day after meal, gradually increased at weekly intervals to
maximum of 800 mg/day, maintenance dose: 200- 300 mg in mild case,
400-600 mg in moderate to severe case
• Children: use only if benefit outweighs risk 150-300 mg/day once daily","Nausea, vomiting, diarrhoea, gastric irritation,
maculopapular rash, rarely exfoliative dermatitis and Steven’s Johnson
syndrome, arthralgia, myalgia, fever, malaise, aplastic anaemia, alopecia,
acute hepatic failure, intestinal nephritis.","Risk of hypersensitivity increased with aspirin,
azathioprine, benazepril, captopril, dienogest/estradiol valerate, enalapril,
ethinylestradiol, levonorgestrel intrauterine/oral, medroxyprogesterone,
theophylline, valproic acid, warfarin. During concomitant treatment, reduce
dosages of azathioprine and mercaptopurine to 25-33% of usual.
Patient information: Maintain fluid intake necessary to yield urine output of
at least 2 L/day in adults."
COLCHICINE,Tablet: 0.5 mg,"Treatment of acute gout, prophylaxis of recurrent acute attacks,
during initiation of allopurinol therapy."," Known hypersensitivity, previous failed
response, blood disorders, GI disturbance, renal diseases, elderly, cardiac
disease, pregnancy (C), lactation.","• Acute: 1 mg initially followed by 0.25-0.5 mg 2-3 hourly until attack is
controlled/ diarrhoea starts (max. dose 4 mg)
• Prophylaxis: 0.5 mg/day, short-term prophylaxis during initial allopurinol
(0.5 mg BD)"," GI disturbance, bloody diarrhoea, abdominal cramps, toxic
doses cause kidney damage, intestinal bleeding, CNS depression, respiratory
failure, muscular paralysis, chronic therapy cause agranulocytosis, myopathy
and hair loss","Clarithromycin, darunavir, itraconazole,
ritonavir, telithromycin aspirin, atorvastatin, carbamazepine.
Patient information: Take medicine with meal. Do a routine blood test in
between medication. Report if bloody diarrhoea occurs"
FEBUXOSTAT,"Tablet: 40 mg, 80 mg.", Chronic gout.,"Co-administration with theophylline,
pregnancy (C), azathioprine, mercaptopurine, congestive heart failure,
ischemic heart disorders, transplant recipients, monotherapy in acute gouty
arthritis. ","Initially: oral - 40 mg/day; maintenance: 40-80 mg/
day (increased if serum uric acid>6 mg/ml after 2 weeks, use prophylactic
colchicine or NSAID for at least 3 months after starting febuxostat to avoid
precipitating acute attack)."," Elevated liver function tests, GI disturbances, headache,
oedema, rash, other uncommon like arthralgia, atrial fibrillation, bronchitis.
","Azathioprine, mercaptopurine, theophylline
(increases their level so contraindicated).
Patient information: Lab and/or medical tests (such as uric acid blood levels,
liver function tests) may be done while you are taking this medication."
PROBENECID,Tablet: 500 mg,"Chronic gout, secondary hyperuricemia due to drugs or
diseases, prolong penicillin action in subacute bacterial endocarditis (SABE)
and gonorrhoea"," Peptic ulcer, hypersensitivity, history of
renal calculi, renal impairment, may precipitate an acute gouty attack, used
concomitantly with NSAID or colchicine, pregnancy (B), lactation. ","Gout: 250 mg BD x 1 week followed by 500 mg BD
 Gonorrhoea: 1 g oral with 2 g cefotaxime IM BD",": Gastric irritation, hypersensitivity, overdose: - seizures and
respiratory failure",
SULPHINPYRAZONE,Tablet: 100 mg and 200 mg,"Chronic gout, secondary hyperuricemia due to drugs or
diseases, prolong penicillin action in subacute bacterial endocarditis (SABE)
and gonorrhoea"," Peptic ulcer, hypersensitivity, history of
renal calculi, renal impairment, may precipitate an acute gouty attack, used
concomitantly with NSAID or colchicine, pregnancy (B), lactation. "," 100-200 mg/day taken with food initially; increased to
600-800 mg/day over 2-3 weeks. Continue till serum acid concentration is
normal then reduce dose for maintenance","Acute renal failure, GI bleeding and ulceration, elevated
liver enzymes, jaundice, hypersensitivity.",
HYDROXYCHOLOROQUINE SULFATE (HCQs,Tablet: 200 mg,"Early and mild acute rheumatoid arthritis, dermatologic
conditions caused or aggravated by sunlight.","Hypersensitivity to 4-aminoquinoline
derivatives, retinal or visual field changes 4-aminoquinoline compounds,
long term therapy in children, pregnancy (C). Acute porphyria, elderly,
G6PD deficiency, neurological disorders (especially in history of epilepsy),
may aggravate myasthenia gravis, psoriasis, shouldn’t be used for psoriatic
arthritis, discontinue if ocular toxicity suspected, retinal changes may
progress even after cessation of therapy", Oral- 400mg once daily 4-6 weeks; maintenance dose200mg oral daily,"GI disturbances, headache, pruritus, rashes, skin reactions,
convulsions, discoloration of skin hair, nails and mucous membranes, ECG
changes, ototoxicity, retinal damage and keratopathy.", Avoid concurrent use of hepatotoxic drugs
LEFLUNOMIDE,"Tablet: 10 mg, 20mg","Active rheumatoid arthritis, active psoriatic arthritis","Active serious infection, severe
hypoproteinaemia, liver disease, hepatitis B or C seropositive, severe
immunodeficiencies, hypersensitivity to leflunomide, concomitant live virus
vaccine, pregnancy (X), lactation. Avoid in significant anaemia, old age","• Moderate to severe active rheumatoid arthritis and active psoriatic
arthritis: adult- 10-20mg once a day.
• Refractory polyarticular juvenile idiopathic arthritis: up to 10 mg once a day","Abdominal pain, diarrhoea, nausea, vomiting, hepatotoxicity,
rashes, dry skin, alopecia, pruritic, oral mucosal disorders, dizziness,
headache, hypertension, paraesthesia, leukopenia, thrombocytopenia,
tenosynovitis, malignant weight loss.","Hepatotoxic drugs, other DMARDS.
Patient information: Avoid pregnancy for 3 years if on leflunomide or
detoxification/drug wash out with cholestyramine advised."
METHOTREXATE,"Tablet: 2.5 mg, 5 mg , 7.5 mg, 10 mg and 15 mg;
Injection: 25 mg/ml","Rheumatoid arthritis, choriocarcinoma, acute leukaemia in
children, psoriasis, organ transplantation, juvenile idiopathic arthritis, active
scleroderma, musculoskeletal predominant SLE.
","Pregnancy (X), alcoholism, alcoholic liver
disease, immunodeficiency, pre-existing blood dyscrasias, hypersensitivity.
Elderly patient monitors closely for signs of hepatic, renal and bone marrow
toxicity (taking with folic acid 1 mg/day significantly reduces toxicity).
Pregnancy (X): Use folic acid 5 mg once a week preceding methotrexate.","• Severe active RA in adult resistant to 1st line treatment: adult -15 mg/week
to 25 mg/week (increases by 5 mg every 4 to 6weeks);
• Paediatrics: 5-7.5 mg/week to 15mg/week, increases by 2.5mg every 4 to 6
weeks"," Bone marrow toxicity causing pancytopenia, desquamation
and bleeding in GIT (mucositis). On long term use pneumonitis, pulmonary
fibrosis and hepatic cirrhosis.",
PENICILLAMINE,"Tablet: 250 mg; Capsule: 125 mg, 250 mg","Wilson’s disease, autoimmune hepatitis, cystinuria, chronic lead
and arsenic poisoning.","Lupus erythematosus, simultaneous
with gold therapy. Neurologic involvement in Wilson’s disease, hematologic
disorders, pregnancy category D","• Wilson’s disease: 1.5-2 g/day in divided doses, maintenance dose: 0.75-1g/
day for 1 year (max. 2g/day);
• Autoimmune hepatitis: 500mg/day in divided doses, increased slowly over
3 months to maintenance of 1.25g/day;
• cystinuria :1g/day individual doses",": Anorexia, nausea, taste loss, SLE and myasthenia gravis
may be precipitated, proteinuria and kidney damage, thrombocytopenia","Ferrous fumarate, ferrous gluconate, MgSO4
sodium bicarbonate."
SULFASALAZINE,Tablet: 500 mg,"Rheumatoid arthritis, inflammatory bowel disease, ankylosing
spondylitis, juvenile chronic arthritis","Porphyria, sulfer allergy. Caution in
bronchial asthma, blood dyscrasias, pregnancy category B (D if used for
prolonged periods or near term), increased risk of neural tube defects and
neonatal jaundice. ","• Rheumatoid arthritis: oral- 2-3 g/day (enteric coated)
• Crohn’s disease: 3-6 g/day"," Anorexia, nausea/vomiting, GI distress, headache,
reversible oligospermia, haemolytic anaemia, rash and pruritus.",
TOFACUTINIB,"Tablet: 5 mg, 11 mg extended release","Moderate to severe active RA with inadequate response to
methotrexate, psoriatic arthritis, refractory JIA and refractory seropositive
arthritis","Diverticulitis, lymphocytes <500/mm3
,
neutrophil <500/ mm3
 and Hb <8.0 g/dl. Pregnancy category C. ",5 mg twice a day or 11 mg once daily.,Infections,"Do not exceed 5 mg/day in renal and hepatic
impairment and when using with CYP3A4 inhibitors like fluconazole,
erythromycin and omeprazole. Do not give live vaccines. May produce
toxicity when coadministered with CYP3A4 inhibitors."
ACELECOFENAC,"Tablet: 100 mg, 200 mg (SR)","Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis,
analgesic, fibromyalgia","Active gastro-intestinal bleeding, active
gastro-intestinal ulceration, history of gastrointestinal bleeding related to
previous NSAID therapy, history of gastro-intestinal perforation related to
previous NSAID therapy, history of recurrent gastro-intestinal haemorrhage",100 mg twice daily (child- not recommended),"Allergy and cross-sensitivity, exacerbation of symptoms
of asthma, angioedema, raised blood pressure, colitis, pancreatitis, hearing
disturbance, tinnitus, vertigo.","Oral anticoagulants, lithium oral hypoglycaemic
agents, phenytoin, methotrexate, digoxin, aminoglycosides.
"
ASPIRIN,"Tablets: 50 mg, 75 mg and 300 mg; Dispersible
tablets: 350 mg. ","Mild to moderate pain and fever, rheumatic fever. ","Haemophilia, previous or active peptic
ulcer, children and adolescents under 16 years, breast-feeding, gout, heart
disease, high blood pressure, congestive heart failure, erosive gastritis,
peptic ulcer, impaired renal and hepatic function, asthma, third trimester of
pregnancy. ","• Mild to moderate pain and pyrexia: 300-900 mg every 4-6 hours when
necessary, maximum 4 g daily; child and adolescent: not recommended.","Dyspepsia, epigastric distress, gastrointestinal bleeding,
mucosal lesions (erosive gastritis, gastric ulcer), tinnitus and hearing loss by
high dose aspirin, prolongation of bleeding time, hypersensitivity reactions
with skin rashes and asthma.","• Acetazolamide: Increased risk of toxicity with high-dose aspirin
• Antacids (Aluminum hydroxide, Magnesium hydroxide): Excretion of
acetylsalicylic acid increased by alkaline urine
• Dexamethasone: Increased risk of gastrointestinal bleeding and ulceration.
• Enalapril: Antagonism of hypotensive effect, risk of renal impairment when
acetylsalicylic acid given in doses of over 300mg daily.
• Heparin: Enhanced anticoagulant effect.
• Hydrocortisone: Increased risk of gastrointestinal bleeding and ulceration
• Ibuprofen: Avoid concomitant use (increased adverse effects); antiplatelet
effect of acetylsalicylic acid possibly reduced
• Methotrexate: Reduced excretion of methotrexate
• Metoclopramide: Enhanced effect of acetylsalicylic acid (increased rate of
absorption)
• Phenytoin: Enhancement of effect of phenytoin
• Prednisolone: Increased risk of gastrointestinal bleeding and ulceration
• Spironolactone: Antagonism of diuretic effect
• Valproate: Enhancement of effect of valproate
• Warfarin: Increased risk of bleeding due to antiplatelet effect
Patient information: Avoid alcohol ingestion, GI bleeding may occur. Report
symptoms of hepatotoxicity, renal toxicity, visual changes, ototoxicity,
allergic reactions, bleeding (long-term therapy)"
DICLOFENAC,"• Diclofenac sodium: Tablet: 50 mg and 100 mg; Injection: 25 mg/ml; Gel: 3%
• Diclofenac potassium: Tablet: 25 mg, 50 mg","Rheumatic disease, osteoarthritis, juvenile arthritis, acute gout,
post-operative pain, dysmenorrhea.","Active gastro-intestinal bleeding or
ulceration, cerebrovascular disease, history of gastro-intestinal bleeding or
perforation related to previous NSAID therapy, ischemic heart disease, heart
failure, peripheral arterial disease, third trimester of pregnancy, onset of
labour (delayed and duration may be increased), history of hypersensitivity
reactions to aspirin or other NSAIDS, breast-feeding, renal or cardiac or
hepatic impairment ","• Adult: oral-75-150 mg daily in 2-3 divided doses preferably after food, by
deep IM into the gluteal muscle;
• Acute exacerbations and postoperative pain: 75 mg once daily (twice daily
in severe cases) for maximum of 2 days;
• Ureteric colic: oral- 75 mg then a further 75 mg after 30 minutes if necessary
by IV-75 mg repeated after 4-6 hours for maximum 2 days.
• Maximum total dose by any route 150 mg.
• In child (1 year or over) for juvenile arthritis (oral): 1-3 mg/kg daily in divided
doses.","Hypersensitivity reactions like rashes, angioedema,
bronchospasm, dizziness, headache, drowsiness, fluid retention (precipitating
congestive heart failure) and raised blood pressure, gastro-intestinal
discomfort like nausea, vomiting, diarrhoea, gastro-intestinal ulceration
and bleeding, haematuria, hearing disturbances like tinnitus and vertigo,
insomnia, nervousness, renal failure (especially in patients with pre-existing
renal impairment), NSAIDs induced headache. ","Increase- Hyperkalaemia with potassiumsparing diuretics, increase- anticoagulant effect-anticoagulants, NSAIDs,
platelet inhibitors, salicylates, thrombolytics, SSRIs, increase-toxicityphenytoin, lithium, cyclosporine, methotrexate, digoxin, increases- GI side
effects-aspirin, other NSAIDs, bisphosphonates, corticosteroids; decreaseantihypertensive effect-beta-blockers, diuretics, ACE inhibitors, decreaseeffect of diuretic.
Patient information: To take with food, milk or antacids to avoid GI upset.
To avoid aspirin, alcoholic beverages, NSAIDs, or other over the counter
drugs medications unless approved by prescriber. Do not lie down for 15-
30min after taking medication. Monitor weight and report gain greater then
1kg/24hrs."
FLURBIPROFEN,"Tablets (coated): 50 mg, 100 mg and 200 mg.","Rheumatic disease, other musculoskeletal disorders"," Breast-feeding, renal or cardiac or hepatic
impairment; Lab test (Hgb, LFT, KFT, audiometry and eye test) should be
under taken regularly. Monitor for GI bleeding.","Oral- 150 -200 mg daily in divided doses, increased in
acute conditions to 300 mg daily.
• Dysmenorrhea: initially 100 mg then 50-100 mg every 4-6 hours, maximum
300 mg daily.","Similar to ibuprofen but more gastro-intestinal adverse
effects than ibuprofen.",
IBUPROFEN,"Tablet: 200 mg, 400 mg; Oral liquid: 100mg/5ml.","Rheumatoid arthritis, osteoarthritis, primary dysmenorrhea,
dental pain, musculoskeletal disorders, fever, migraine.","Pregnancy (D) 3rd trimester,
hypersensitivity to this product, NSAIDs, asthma, severe renal and hepatic
disease. Pregnancy(C) 1st and 2nd trimester, breastfeeding, children, geriatric
patients, bleeding disorders, GI disorders, cardiac disorders.","Adult- initially 1.2-1.8 g daily in 3-4 divided doses preferably
after food, increased if necessary to maximum of 2.4 g daily, maintenance
dose of 0.6-1.2 g daily may be adequate; child - 20-30 mg/kg daily in divided
doses (juvenile arthritis up to 40 mg/kg daily), not recommended for children
under 5 kg.","Gastrointestinal irritation, bleeding, hypersensitivity
reactions like rash, angioedema, bronchospasm, pruritic, photosensitivity
and photophobia, tinnitus, dizziness, headache, fluid retention, vertigo.
",
INDOMETHACIN,"Capsules: 25 mg, 50 mg, 75 mg; Modified-release
capsules: 75 mg; Suppositories: 100 mg.","Rheumatic disease and other musculoskeletal disorders, acute
gout, dysmenorrhea, closure of ductus arteriosus.","Active gastro-intestinal bleeding, active
gastro-intestinal ulceration , history of gastrointestinal bleeding related to
previous NSAID therapy, history of gastro-intestinal perforation related to
previous NSAID therapy, history of recurrent gastro-intestinal hemorrhage
(two or more distinct episodes), history of recurrent gastro-intestinal
ulceration (two or more distinct episodes), severe heart failure, pregnancy(D)
3rd trimester, neonates, aortic coarctation, salicylate/NSAID hypersensitivity,
lactating mother. Heart failure, allergic disorders, cardiac impairment,
cerebrovascular disease, coagulation defects, connective tissue disorders","• Pain and moderate to severe inflammation in rheumatic disease and other
musculoskeletal disorders: oral using immediate-release medicines- 50-200
mg daily in divided doses; by rectum-100 mg twice daily if required, dose
to be administered at night and in the morning, combined oral and rectal
treatment, maximum total daily dose 150-200 mg
• Oral using modified-release medicines-75 mg 1-2 times a day.
• Acute gout: oral using immediate-release medicines- 150-200 mg daily in
divided doses;
• Oral using modified-release medicine-75 mg 1-2 times a day.
• Dysmenorrhea: oral using immediate-release medicines- up to 75 mg daily;
• Oral using modified-release medicines- 75 mg daily.","General side-effects: See under diclofenac, specific sideeffects: with oral use- nausea; with rectal use- suppositories may cause
occasional bleeding and rectal irritation",
MEFENAMIC ACID,"Tablet: 500 mg, capsule 250 mg; Oral
suspension: 50 mg/5ml","Rheumatoid arthritis, osteoarthritis, postoperative pain, pain
during dysmenorrhea/ menorrhagia.","Active gastro-intestinal bleeding and
ulceration, history of recurrent gastro-intestinal bleeding or ulceration,
inflammatory bowel disease, severe heart failure, lactating mother, allergic
disorder, acute porphyria, cardiac impairment, cerebrovascular disease,
coagulation defect, connective tissue disorder, Chron’s disease, ulcerative
colitis, uncontrolled hypertension, pregnancy category C and D.","Pain and inflammation in rheumatoid arthritis and
osteoarthritis/postoperative pain/mild to moderate pain/acute pain
including dysmenorrhea/menorrhagia: 500 mg 3 times a day.","Diarrhea (withdraw treatment), rashes (withdraw
treatment), stomatitis, fatigue, paresthesia, aplastic anemia, glucose
intolerance, thrombocytopenia.",
NAPROXEN,"Tablet: 500 mg, 750 mg, 250 mg (SR)","Rheumatic disease, musculoskeletal disorders, dysmenorrhea,
acute gout.","Active gastro-intestinal bleeding and
ulceration, history of recurrent gastro-intestinal bleeding or ulceration,
inflammatory bowel disease, severe heart failure, pregnancy category C and
D. Uncontrolled hypertension, allergic disorders, cardiac impairment, Chron’s
disease, ulcerative colitis, breastfeeding, children <2-year, geriatric patients.","• Pain and inflammation in rheumatic disease: 0.5-1 g daily in 1-2 divided
doses.
• Pain and inflammation in musculoskeletal disorders / dysmenorrhea:
initially 500 mg, then 250 mg every 6-8 hours as required, maximum dose
after the first day 1.25 g daily.
• Acute gout: initially 750 mg then 250 mg every 8 hours until attack has
passed.","Diarrhea (withdraw treatment), rashes (withdraw
treatment), stomatitis, fatigue, paresthesia, aplastic anemia, glucose
intolerance, thrombocytopenia.",
PARACETAMOL," Pediatric oral solution: 150 mg/ml in a suitable
flavored vehicle; Oral suspension: 125mg/5ml, tablet 500 mg; Injection: 150
mg/ml; Rectal suppositories: 120, 325, 650 mg; Infusion: 1000mg/100ml.","Mild to moderate pain or fever, arthralgia, dental pain,
dysmenorrhea, headache, myalgia, osteoarthritis."," Hypersensitivity, pregnancy B and C,
breastfeeding, geriatric patients, anemia, renal/hepatic disease, chronic
alcoholism. May cause hepatic toxicity at doses 0.4 g/day with chronic use,","• Mild to moderate pain /pyrexia: adult-oral-0.5–1 g every 4-6 hours,
maximum 4 g per day, by IV - adult (body-weight 10–50 kg): 15 mg/kg every
4–6 hours, dose to be administered over 15 minutes, maximum 60 mg/kg
per day, adult (body-weight 50 kg and above): 1 g every 4-6 hours, dose to
be administered over 15 minutes, maximum 4 g per day, by rectum-adult0.5-1 g every 4–6 hours, maximum 4 g per day.
• Mild to moderate pain in patients with risk factors for hepatotoxicity: by
IV- adult (body-weight 50 kg and above): 1 g every 4-6 hours, dose to be
administered over 15 minutes, maximum 3 g per day.
• Pain/ pyrexia with discomfort: oral-children -10-15 mg/kg/dose every 4-6
hours and do not exceed more than 5 doses.","General side-effects: See under diclofenac, specific sideeffects: with oral use- nausea; with rectal use- suppositories may cause
occasional bleeding and rectal irritation",
PIROXICAM,"Orodispersible tablet: 20 mg; Capsule: 10 mg,
20 mg; Gel: 0.5%","Rheumatoid arthritis, juvenile rheumatoid arthritis,
osteoarthritis, ankylosing spondylitis, musculoskeletal conditions.","Inflammatory bowel disease. Increase risk
of asthma, cardiac disease, CHF, hepatic and renal impairment, HTN. For
topical preparations apply with gentle massage only. Piroxicam orodispersible
tablets can be taken by placing on the tongue and allowing to dissolve or by
swallowing.","• Rheumatoid arthritis/Osteoarthritis/Ankylosing spondylitis: Up to 20 mg
once daily.
• Pain relief in musculoskeletal conditions / treatment in knee or hand
osteoarthritis (adjunct)to the skin: apply 3-4 times a day, 0.5% gel to be
applied, review treatment after 4 weeks.","Indigestion, upper respiratory infection, headache,
diarrhea, nausea, abdominal pain, edema, anemia, dizziness. With topical
use-photosensitivity, rash (discontinue use if develops).
",
CELECOXIB,"Capsules: 50, 100, 200 and 400 mg
","Acute pain and primary dysmenorrhoea, ankylosing spondylitis,
osteoarthritis, rheumatoid arthritis","Aspirin allergy, chronic hepatitis,
perioperative pain resulting from coronary artery bypass graft surgery.
Congestive heart failure, hypertension, asthma, bleeding disorder,
bronchospasm, duodenal/gastric/peptic ulcer, renal impairment, pregnancy
category C and D, lactation. Increased risk of adverse cardiovascular events
and skin reactions, risk of gastro-intestinal bleeding, ulceration, perforation.","• Acute pain and primary dysmenorrhoea: initially 400 mg oral then 200 mg
as required;
• Ankylosing spondylitis: 200 mg/day up to 400 mg/day;
• Osteoarthritis: 200 mg/day,
• Rheumatoid arthritis: 100-200mg/day.","Headache, hypertension, fever, dyspepsia, flatulence,
peripheral oedema, pharyngitis.",
ETORICOXIB,"Tablets: 30 mg, 60 mg, 90 mg and 120 mg","Ankylosing spondylitis, osteoarthritis, rheumatoid arthritis,
acute gout.","Hypersensitivity, active GI ulceration or
bleeding, inflammatory bowel disease, heart failure, ischaemic heart disease,
peripheral arterial disease, cerebrovascular disease, uncontrolled HTN,
history of bronchospasm, acute rhinitis, nasal polyps, children, lactation.
Renal and hepatic impairment. ","• Osteoarthritis: 30 mg once daily increased to 60 mg once daily; 
• Rheumatoid arthritis & ankylosing spondylitis: 90 mg once daily; 
• Acute gout: 120 mg once daily, max duration- 8 days.","Stevens-Johnson syndrome, exfoliative dermatitis and
toxic epidermal necrolysis, upper GI ulceration, perforation and bleeding,
alveolar osteitis, oedema/fluid retention, dizziness, headache, palpitations,
arrhythmia, HTN, asthenia/fatigue, flu-like disease, bronchospasm,
ecchymosis, increased ALT and AST.",
DIACEREIN,Tablet: 50 mg,Osteoarthritis.,"Pregnancy category B, lactation,
hypersensitivity to anthraquinone derivatives. Hepatic and renal impairment.
Monitor CBC, LFT and urinalysis every 6 month.",Oral -50mg twice daily,"Diarrhea, pain abdomen, nausea, vomiting, intense yellow
coloring of urine",
ALENDRONATE,"Tablet: 5 mg, 10 mg, 35 mg, 40 mg, 70 mg"," Osteoporosis, Paget’s disease","Hypersensitivity, hypocalcaemia,
oesophageal stricture or achalasia. If allergy to bisphosphonate oesophageal
narrowing/blockage, low blood Ca2+ level, serum kidney problem. Pregnancy,
breastfeed, taking herbal preparation, dietary supplements."," 5-10 mg OD, 35-70 mg weekly","Heart burn, gastric erosion, retrosternal pain, flatulence,
headache, body ache, fall in serum Ca2+level.
",
ETIDRONATE,"Tablet: 200 mg, 400 mg","Paget’s disease, total hip replacement, spinal cord injury,
prevention of PTH-induced bone resorption, myositis ossificans.","Osteomalacia, hypersensitivity,
oesophagus stricture and achalasia, Enterocolitis, renal impairment, GI
irritation, esophagitis, oesophageal ulcer and erosion.","• Paget’s disease: oral- 5-10 mg/kg qday not to exceed 6 months;
• Total hip replacement: oral- 20 mg/kg qday one month pre- and three
months post-surgery (4 months total).","Convulsion, fever, hypocalcaemia, hypomagnesemia,
hypophosphatemia, bone pain, abnormal renal function.",
IBANDRONATE,"Tablet: 150 mg; Prefilled syringe: 1 mg/ml
","Treatment and prevention osteoporosis in postmenopausal
women.","Hypersensitivity, uncorrected
hypocalcaemia, oesophageal achalasia and stricture, pregnancy, lactation,
esophagitis, dysphagia, oesophageal ulcer, renal impairment. Adequate
intake of calcium and vitamin D is recommended","Oral: 150 mg every month or 3 mg IV every 3 months
administered over 15-30 seconds.","URI, back pain, dyspepsia, bronchitis, asthenia, diarrhoea,
dizziness, myalgia tooth disorder, UTI.",
PAMIDRONATE,"Powder: 30 mg; Injection: 3 mg/ml, 6 mg/ml,
9 mg/ml","Prevention of androgen deprivation induced osteoporosis,
hypercalcemia of malignancy, Paget’s disease, osteolytic bone metastasis of
breast cancer, multiple myeloma","Pregnancy category D, lactation,
hypersensitivity. Renal impairment, electrolyte abnormalities,
myelosuppression.","• Hypercalcemia of malignancy: 90 mg single dose IV infusion over 2-24
hours;
• Paget’s disease: 30 mg IV infusion over 4 hours qday for 3 consecutive days;
• Osteolytic bone metastases of breast cancer and multiple myeloma: 90 mg
IV infusion over 4 hours qmonth.
","Anaemia, UTI, hypokalaemia, hypophosphatemia,
hypocalcaemia, hypomagnesemia, seizure, HTN, osteonecrosis",
RISEDRONATE,"Tablet: 5 mg, 30 mg, 35 mg, 150mg; Delayed
release tablet: 35 mg"," Postmenopausal osteoporosis, glucocorticoid-induced
osteoporosis, Paget’s disease, osteoporosis in men, osteogenesis imperfecta
(orphan).","Hypersensitivity, angioedema, generalized
rash, bullous skin reactions, Stevens-Johnson syndrome, toxic epidermal
necrolysis, hypocalcemia, esophagus stricture and achalasia, dysphagia,
esophagitis, esophageal or gastric ulcer, osteonecrosis of the jaw.","• Postmenopausal osteoporosis: oral -5 mg once daily or 35 mg once weekly
or 150 mg once monthly;
• Glucocorticoid-induced osteoporosis: oral- 5 mg/day;
• Paget’s disease: oral- 30 mg/day for 2 months.","Arthralgia, diarrhea, headache, nausea, constipation, rash,
abdominal pain, hypertension, dyspepsia, flulike syndrome, depression, chest
pain, dizziness, pharyngitis, rhinitis, prostatic hyperplasia, hypocalcemia,
dyspnea, gastritis, nephrolithiasis, hypophosphatemia, arrhythmia.
",
BACLOFEN,"Tablet: 10 mg, 20 mg; Oral solution: 1 mg/ml.","Pain of muscle spasm in palliative care, hiccup due to gastric
distension in palliative care, chronic severe spasticity resulting from disorders
such as multiple sclerosis or traumatic partial section of spinal cord, severe
chronic spasticity unresponsive to oral anti-spastic drugs.","Active peptic ulceration, pregnancy
category C, breastfeeding, geriatric patients, peptic ulcer disease, renal/
hepatic disease, stroke, seizure disorder, diabetes mellitus.","• Pain of muscle spasm in palliative care: oral- 5–10 mg three times a day;
• Hiccup due to gastric distension in palliative care: oral- 5 mg twice daily;
• Chronic severe spasticity resulting from disorders such as multiple sclerosis
or traumatic partial section of spinal cord: oral- initially 5 mg 3 times a
day gradually increased, maintenance up to 60 mg daily in divided doses,
review treatment if no benefit within 6 weeks of achieving maximum dose,
maximum 100 mg per day;
• Severe chronic spasticity unresponsive to oral anti-spastic drugs (or where
side-effects of oral therapy unacceptable) or as alternative to ablative
neurosurgical procedures (specialist use only): intrathecal injection- test
dose 25–50 micrograms to be given over at least 1 minute via catheter or
lumbar puncture then increased in steps of 25 micrograms (max. per dose
100 micrograms) not given more often than every 24 hours to determine
appropriate dose then dose titration phase most often using infusion
pump (implanted into chest wall or abdominal wall tissues) to establish
maintenance dose (ranging from 12 micrograms to 2 mg daily for spasticity
of spinal origin or 22 micrograms to 1.4 mg daily for spasticity of cerebral
origin) retaining some spasticity to avoid sensation of paralysis","Agitation, anxiety, ataxia, cardiovascular depression,
confusion, depression, dizziness, drowsiness, dry mouth, euphoria,
gastrointestinal disturbances, hallucinations, headache, hyperhidrosis,
hypotension, insomnia myalgia, nightmares, rash respiratory depression,
sedation, seizure, tremor, urinary disturbances, visual disorders.",
TIZANIDINE,"Tablet: 2 mg, 4 mg","Spasticity associated with multiple sclerosis or spinal cord
injury or disease","Pregnancy category C, breastfeeding,
elderly, children, geriatric patients, hypotension, renal/hepatic disease.
Monitor liver function monthly for first four months and in those who
develop unexplained nausea, anorexia or fatigue","Spasticity associated with multiple sclerosis or spinal cord
injury or disease: Initially 2 mg for 1 dose, then increased in steps of 2 mg/24
hours every 3–4 days in divided doses, adjusted according to response, usual
dose up to 24 mg daily in 3–4 divided doses, maximum 36 mg per day.","Somnolence, dizziness, speech disorder, dyskinesia,
nervousness, hallucination, psychosis, hypotension, bradycardia, dry mouth,
vomiting, increased ALT, abnormal LFTs, constipation, blurred vision, urinary
frequency, pharyngitis, rhinitis, tremor, rash, muscle weakness.",
BECLOMETHASONE,"Aerosol inhaler: 50 µg, 100 µg and 200 µg per
metered dose","Prophylaxis of bronchial asthma, prophylaxis and treatment of
allergic rhinitis","It may cause oral candidiasis. Also see
under respiratory system",,"Bronchospasm and wheezing, rash, Candida infections in
mouth or throat",
CORTISONE ACETATE,Tablet: 5 mg and 25 mg,,,,"Oral, for replacement therapy, 25-37.5 mg in divided dose.",
DEXAMETHASONE,Tablet: 0.5 mg; Injection: 4 mg/ml,,Should be protected from light,"• Physiological replacement (oral): Adult: 0.03-0.15 mg/kg/day in 2-4 divided
doses; (parenteral)- 0.03-0.15 mg/kg/day IV or IM in 2-4 divided doses;
• As anti-inflammatory (oral): adult: 0.75-9mg/day in 2-4 divided doses,
children: 0.8-0.3 mg/ day in 2-4 divided doses; (parenteral)- adult: 0.75-
9 mg IM/IV in 2-4 divided doses, children: 0.8-0.3 mg/ day IM/IV in 2-4
divided doses;
• Adrenal crisis: 4-10 mg/day as single dose, repeat if required;
• Bacterial meningitis: children (>2 months): 0.6 mg/kg/day in 4 divided
doses on the first 4 days of treatment;
• Cerebral edema: 10 mg IV followed by 4 mg 6 hourly till condition improves","Oral, for replacement therapy, 25-37.5 mg in divided dose.",
FLUDROCORTISONE ACETATE,Tablet: 100 µg,: Mineralocorticoid replacement in adrenocortical insufficiency,,"Adrenocortical insufficiency: adult 50-300 µg daily; child
5 micrograms/kg daily",,
METHYLPREDNISOLONE,"Tablet: 4 mg, 8 mg and 16 mg; Injection: 250
mg/vial"," Cushingoid side effects more likely with
doses above 7.5 mg daily; should be protected from light",,"Oral: 2-40 mg daily; IM injection or slow IV injection or
infusion: initially 100-500 mg",,
INSULIN ASPART,Injectable solution: 100 units/ml,Diabetes mellitus,"Can be given during pregnancy and
breastfeeding. Should be taken before meal or immediately after meal","By SC injection, immediately before meals or when
necessary shortly after meals, according to requirements; By IV injection or
infusion according to requirements",,
ACARBOSE,Tablet: 50 mg,Type 2 diabetes mellitus,"<18 years age, pregnancy, breast-feeding,
hepatic impairment and severe renal impairment. 
","Initially 50 mg/day, increased to 50 mg 3 times daily then
increased if necessary after 6-8 weeks to 100 mg 3 times daily; maximum 200
mg 3 times daily","Abdominal pain, flatulence, diarrhoea, jaundice","Used with caution with insulin and
sulphonylureas (enhance hypoglycaemia)"
METFORMIN,"Tablet: 500 mg, 850 mg, 1000 mg","Type 2 diabetes mellitus, gestational diabetes, polycystic
ovarian syndrome","Renal impairment, hepatic impairment,
recent myocardial infarction, pregnancy, chronic alcoholics, ketoacidosis,
general anaesthesia. Suspend metformin on the morning of surgery and
restart when baseline returns to normal","Adult and child over 10 years, initially 500 mg with
breakfast for at least 1 week then 500 mg every 12 hours with or after food
for at least 1 week, maximum 2 g daily in divided doses","Anorexia, nausea, vomiting, diarrhoea, metallic taste,
abdominal discomfort, vitamin B12 deficiency, and hepatitis and lactic
acidosis (rarely)",
SITAGLIPTIN,"Tablets: 25 mg, 50 mg and 100 mg",Type 2 diabetes mellitus,"Hypersensitivity. Pregnancy Category B
",Oral: 100 mg/day,"Hypoglycemia, acute pancreatitis, acute kidney injury,
bundle branch block, exfoliative dermatitis. May develop arthralgia, bullous
pemphigoid, pancreatitis, hypersensitivity reactions.",
REPAGLINIDE,"Tablet: 500 µg, 1 mg and 2 mg",Type 2 diabetes mellitus,"Avoid during ketoacidosis, pregnancy,
breast-feeding, severe hepatic impairment. Myocardial infarction, infection,
coma, during surgery, renal impairment; child and adolescent under 18 years
not recommended. Substitute by insulin during peri-operative period and
during intercurrent illness such as MI, coma, infection; use cautiously in renal
impairment and liver impairment;","Initially 500 µg within 30 minutes before main meals,
adjusted according to response at intervals of 1-2 weeks","Hypoglycaemia, diarrhoea, constipation, abdominal pain,
nausea, vomiting, pruritus, urticaria, vasculitis, visual disturbances",
CHLORPROPAMIDE,Tablet: 250 mg,Type 2 diabetes mellitus,"Patients with ketoacidosis, diabetic coma,
severe infection, severe impairment of kidney or liver function. Safety of drug
during pregnancy and breast-feeding has not been established","Initially 250 mg/day, adjusted according to response,
maximum 500 mg daily taken with breakfast or meal","Hypoglycaemia, nausea, vomiting, diarrhoea and disulfiram
like reaction with alcohol. The antidiuretic action may result in the symptoms
and signs of water intoxication (mental confusion, decreased sodium
concentration, dizziness etc.)",
GLIBENCLAMIDE, Tablet: 2.5 mg and 5 mg,Type 2 diabetes mellitus,"Patients with ketoacidosis, diabetic coma,
severe infection, severe impairment of kidney or liver function. Safety of drug
during pregnancy and breast-feeding has not been established","Initially 5 mg/day (elderly patient 2.5 mg), adjusted
according to response; maximum 15 mg daily; taken with breakfast or meal","Hypoglycaemia, nausea, vomiting, photosensitivity,
hyponatremia, diarrhoea, constipation, weight gain. Neonatal hypoglycaemia
when used by pregnant mother during first trimester.",
GLICLAZIDE,Tablet: 80 mg,Type 2 diabetes mellitus,Acute porphyria," Initially 40-80 mg daily, adjusted according to response;
up to 160 mg as a single dose with breakfast or meal; higher doses divided;
maximum 320 mg daily.","Hypoglycaemia, nausea, vomiting, photosensitivity,
hyponatremia, diarrhoea, constipation, weight gain. Neonatal hypoglycaemia
when used by pregnant mother during first trimester.",
GLIMEPERIDE,"Tablet: 1 mg, 2 mg, 3 mg and 4 mg",Type 2 diabetes mellitus.,"Porphyria (but comparatively safer than
other sulphonylureas); hepatic impairment; ketoacidosis","Initially 1 mg daily, max up to 4 mg daily","Hypoglycaemia, nausea, vomiting, photosensitivity,
hyponatremia, diarrhoea, constipation, weight gain. Neonatal hypoglycaemia
when used by pregnant mother during first trimester.",
GLIPIZIDE,Tablet: 5 mg,Type 2 diabetes mellitus,Acute porphyrias. ,"Initially 2.5-5 mg daily, adjusted according to response;
maximum 20 mg daily, up to 15 mg may be given as a single dose before
breakfast or meal; higher doses divided. To be ingested 30 min before
breakfast because food decreases its absorption.","Dizziness, drowsiness, hyponatremia, hepatic impairment,
renal impairment",
PIOGLITAZONE,Tablet: 15 mg and 30 mg ,Type 2 diabetes mellitus.,"Avoid during ketoacidosis, pregnancy,
breast-feeding, hepatic impairment, cardiac failure, previous or active
bladder cancer, uninvestigated macroscopic hematuria. Substitute insulin
during peri-operative period; Risk of bladder cancer so patient should be
asked to immediately report if hematuria or any urinary symptoms occur",": Initially 15-30 mg/day, increased to 45 mg/day according
to response","Anemia, arthralgia, dizziness, gastro-intestinal
disturbances, hematuria, headache, peripheral edema, weight gain,
impotence, hypoaesthesia",
LEVOTHYROXINE (L-THYROXINE),Tablet: 100 µg,"Cretinism, adult hypothyroidism, myxoedema coma, non toxic
goitre, papillary carcinoma of thyroid after surgery","Angina pectoris and other cardiovascular
disorders, diabetes milletus, hypertension; pregnancy, breast-feeding.
Should be protected from light.","Initially up to 50-100 µg/day (preferably before morning
meal or breakfast), 25-50 µg in elderly patients or those with cardiac disease,
increased by 50 µg at intervals of at least 3-4 weeks; neonate (up to 1
month)- 5-10 µg/kg/day; child (over 1 month)- initially 5 µg/kg, adjusted in
steps of 25 µg every 2-4 weeks until mild toxic symptoms appear then reduce
dose slightly","Palpitation, tachycardia, diarrhoea, cardiac arrhythmias,
tremor, weight loss, sweating, insomnia, angina pain and increased appetite. ",
CARBIMAZOLE,Tablet: 5 mg,"Hyperthyroidism, first episode in patient <40 years, control
thyrotoxicosis in both Grave’s disease and toxic nodular goitre, preoperatively to make euthyroid state, along with radioactive iodine (given after
5 to 7 days and withdrawn till response develops), thyroid storm","Hypersensitivity, pregnancy, breastfeeding, liver disorders","15-40 mg daily in divided doses, until patient becomes
euthyroid (usually 4-8 weeks), then reduced to a maintenance dose of 5-15
mg for 12-18 months","Major side effects- hepatitis, SLE like syndrome. Most
serious-agranulocytosis but reversible; hypothyroidism and goitre may occur
due to over treatment but is reversible once stopped. GI Intolerance, skin
rashes, urticaria, joint pain, loss of hair, loss of taste, fever",
PROPYLTHIOURACIL,Tablet: 50mg,,"200-400 mg daily and maintained on this dose until
the patient becomes euthyroid, the dose may then be gradually reduced to
maintenance of 50 to 150 mg daily","May cause thrombocytopenia, aplastic anaemia,
hypoprothrombinaemia and bleeding. Also see under carbimazole.",,
SODIUM ALDRONATE,"Tablet: 5 mg, 10 mg, 35 mg and 70 mg","Prevention and treatment of post-menopausal osteoporosis,
osteoporosis in men, prevention and treatment of corticosteroid-induced
osteoporosis","Avoid in pregnancy, breast-feeding,
stricture or achalasia of oesophagus. Use caution in patients with history of
ulcers, active gastro-intestinal bleeding, renal impairment, gastritis","• Prevention of post-menopausal osteoporosis: 5 mg daily; Treatment of
post-menopausal osteoporosis and osteoporosis in men, 10 mg daily or (in
post-menopausal osteoporosis) 70 mg once weekly
• Prevention and treatment of corticosteroid-induced osteoporosis: 5
mg daily (post-menopausal woman not receiving hormone replacement
therapy, 10 mg daily)","Oesophageal reactions (oesophagitis, oesophageal ulcers,
oesophageal stricture and oesophageal erosions), dyspepsia, abdominal pain
and distension, regurgitation, diarrhoea or constipation, melaena, headache,
peptic ulceration, severe skin reactions including Stevens-Johnson syndrome",
ORLISTAT,Capsule: 120 mg,"Obesity management (Body mass index >30 kg/m2
 or >27 kg/m2
in the presence of other risk factors- hypertension, diabetes, dyslipidaemia)","Avoid during pregnancy (category
X), chronic malabsorption syndrome, cholestasis, hepatotoxicity, renal
impairment, dysglycaemia. Fat soluble vitamin supplementation ≥2hrs before
or after administering orlistat","Obesity management: 120 mg 3 times daily with each
main meal containing fat (during or up to 1 hour after the meal), omit dose if
meal is occasionally missed or contains no fat.","Oily rectal leakage, abdominal distress/pain, flatulence
with discharge, bowel urgency, steatorrhea, oily evacuation, frequent bowel
movements, nausea, faecal incontinence, infectious diarrhoea, rectal pain,
gingival disease, cholelithiasis, pancreatitis, acute renal failure, calcium
oxalate nephrolithiasis",
NIMESULIDE,"Tablets: Adult:100mg , Children: 5mg/kg of bodyweight","Acute pain,Osteoarthritic pain,Dysmenorrhea primary",,,"Acid or sour stomach
Dizziness
Diarrhoea
Blood clotting problems
Stomach pain and cramps
Skin infection",
PHENYTOIN,"Capsule: 100mg ; Oral suspension: 100mg/5ml;
Tablet: 100mg","All forms of epilepsy (except absence seizures, myoclonic
seizure and drug induced), trigeminal neuralgia.","Hypersensitivity, alcohol intolerance,
myoclonic seizure. It has a wide pharmacokinetic variability; needs
therapeutic drug level monitoring. Monitor closely for notable changes in
behavior that could indicate the emergence or worsening of suicidal thoughts
or behavior or depression. Tell patients about hypersensitivity syndrome.
Monitor for gingival hypertrophy.","By mouth, initially 3-4 mg/kg daily or 150-300mg daily (as
a single dose or 2 divided doses) increased gradually as necessary (plasma
monitoring); usual dose 200-500 mg daily; child 4-8 mg/kg daily (1 or 2
doses); By slow IV injection (with blood pressure and ECG monitoring) for
status epilepticus, 15mg/kg at a rate not exceeding 50mg per minute, as a
loading dose. Maintenance doses of about 100mg should be given thereafter
at intervals of every 6-8 hours, monitored by measurement of plasma
concentration; rate and dose reduced according to weight. Child: 15mg/kg as
a loading dose. Not recommended by IM injection.","Suicidal thoughts, agranulocytosis, aplastic anemia,
Stevens-Johnson syndrome; gingival hyperplasia, acne, hirsutism and skin
rash at therapeutic level; nystagmus, ataxia, diplopia, sedation, nausea and
vomiting occur at high plasma leve",
TOPIRAMATE,"Tablets: 25 mg, 50 mg, 100 mg, 200 mg;
Capsules: 15 mg, 25 mg, 50 mg.","Monotherapy of generalized tonic-clonic seizures or focal
seizures with or without secondary generalization, adjunctive treatment of
generalized tonic-clonic seizures or focal seizures with or without secondary
generalization, adjunctive treatment for seizures associated with LennoxGastaut syndrome, migraine prophylaxis, substance dependence.","Acute porphyrias. Risk of metabolic
acidosis, risk of nephrolithiasis; ensure adequate hydration",,"CNS symptoms: anxiety, agitation, cognitive impairment,
depression, drowsiness, dizziness, sleep disturbance, visual disturbances,
seizures, GI distress, arthralgia, myalgia, pruritus, paraesthesia, speech
disorder, etc.",
VALPROIC ACID,Tablet: 200mg,"All forms of epilepsy, bipolar affective disorder","Hypersensitivity, hepatic impairment.
Pregnancy Category D. Hepatic function tests should be performed before
treatment and every 2 months for the first six months.
","By mouth-initially, 600 mg daily in divided doses,
preferably after food, increasing by 200 mg/day at 3 days intervals to a
maximum of 2.5 g daily in divided doses, usual maintenance 1-2 g daily (20-
30 mg/kg daily); Child up to 20 kg (about 4 years), initially 20 mg/kg daily in
divided doses, may be increased provided plasma concentration monitored;
over 20 kg, initially 400 mg daily in divided doses increased gradually to 20-
30 mg/kg daily; maximum 35 mg/kg daily. By IV injection (over 3-5 minutes)
or by IV infusion, continuation of valproate treatment when oral therapy not
possible, same as current dose by oral route. Initiation of valproate therapy
when oral valproate not possible by IV injection (over 3-5 minutes), 400- 800
mg (up to 10 mg/kg) followed by IV infusion up to maximum 2.5 g daily; Child,
usually 20-30 mg/kg daily","Suicidal thoughts, agitation, dizziness, headache, insomnia,
sedation, confusion, visual disturbance, tremor, nausea and gastric irritation,
weight gain, increased appetite, thrombocytopenia, transient hair loss,
oedema, drug induced hepatitis, sedation and drowsiness",
AMANTADINE,Capsule: 100mg,"Parkinsonism, post-herpetic neuralgia","Hypersensitivity, breast-feeding,
pregnancy, children. In patients with cardiac, hepatic and renal disease and
history of seizures. Watch patient for confusion, mottling of skin, bowel
pattern before or during treatment.","100mg daily increased after 1 week to 100mg twice daily,
max. 400mg daily in divided doses.","Restlessness, depression, irritability, insomnia, excitement,
agitation and confusion, livedo reticularis, peripheral edema and postural
hypotension.",
BENZTROPINE,Tablet: 2mg,"Parkinsonism, EPS associated with neuroleptic drugs, acute
dystonic reactions, hypersalivation
","Children <3yrs, hypersensitivity, closed
angle glaucoma, dementia, tardive dyskinesia. Pregnancy (category C) and
breast-feeding; renal and hepatic diseases; hypo/hypertension, tachycardia,
dysrhythmia; myasthenia gravis; GI/GU obstruction, peptic ulcer, megacolon,
prostrate hypertrophy. ","Parkinsonism: 0.5-1 mg at bed time, increased by 0.5 mg
q5-6 days titrated to patient’s response, max. 6mg/day","Anxiety, restlessness, irritability, hallucinations, confusion,
delirium, palpitation, tachycardia. Dry mouth, constipation, paralytic ileus,
hyperthermia, heat stroke, numbness of fingers.",
BROMOCRIPTINE,"Tablets: 1.25 mg, 2.5 mg","Parkinsonism, hyperprolactinemia; galactorrhoea,
amenorrhoea, infertility in women; gynecomastia, impotence and sterility in
men; acromegaly, breast engorgement.","Hypersensitivity to ergot alkaloids, breast
carcinoma, severe ischemic heart disease, uncontrolled HTN, pregnancy and
lactation, children. In patients with hepatic, renal and cardiovascular disease;
history of psychosis, peptic ulcer, DM. Ability to drive may be impaired. May
result in failure of OCPs. Disulfiram reaction with alcohol.","Parkinsonism: 1-1.25 mg OD at bed time in the 1st week,
2-2.5 mg at bed time in the 2nd week, gradually increasing to 2.5mg twice daily
and thrice daily weekly as required up to usual maintenance dose of 7.5-30
mg/day","Headache, nausea, vomiting, fatigue, postural hypotension,
confusion, leg cramps, loss of appetite, nasal stuffiness.
Patient information: Raise slowly from lying and sitting position. Do not
discontinue drug abruptly. Take medicine with food to reduce GI upset.
Hormonal contraception may fail (use other methods).",
ENTACAPONE,Tablet: 200 mg,"Adjunct in Parkinson’s disease with ‘end-of-dose’ motor
fluctuations","History of neuroleptic malignant syndrome,
history of non-traumatic rhabdomyolysis, phaeochromocytoma, hepatic
failure; avoid in pregnancy (no information available), avoid in breastfeeding
women (present in milk in animal studies).","under expert supervision, oral, adult: 200 mg, along with
each dose of levodopa with dopa-decarboxylase inhibitor; maximum 2 g/day","Abdominal pain, nausea, vomiting, constipation/diarrhoea,
confusion, dizziness, insomnia, hallucinations, abnormal dreams, dyskinesia,
dystonia, sweating, dry mouth, fatigue, ischaemic heart disease.
",
LEVODOPA AND CARBIDOPA,"Tablet: 10mg+100mg, 25mg+250mg",Parkinsonism,"Acute angle closure glaucoma, psychotic
illness, malignant melanoma, pregnancy and lactation. Caution should be
taken in patients with hepatic and renal impairment, MI, cerebrovascular
accidents and psychiatric disorders; history of peptic ulcer, glaucoma and
gout. Monitor skin lesion changes as levodopa may activate malignant
melanoma. Observe for S/E including mental status and BP changes.","100mg levodopa+25mg carbidopa 3 times daily ½ hrs
before meal. 100mg levodopa + 10mg carbidopa 3-5 times daily. Start with 1
tablet 3 times a day and increase by 1 tab/day every 1-2 days, maximum up
to 8tabs/day. 200mg levodopa + 50mg carbidopa (controlled release form)
once or twice daily.","Acute effect: Nausea, anorexia, vomiting, postural
hypotension, altered taste sensation, cardiac arrhythmia, angina, psychosis.
After prolonged therapy: dyskinesia, abnormal movements, behavioral effects
like delusion, nightmares, hallucinations.",
OXPHENADRINE HYDROCHLORIDE,Tablet: 50 mg,,"Narrow angle glaucoma, pyloric/duodenal
obstruction, BPH, stenosing peptic ulcer, cardiospasm (megaesophagus),
paralytic ileus, ulcerative colitis, toxic megacolon, achalasia; Myasthenia
gravis, obstructive uropathy. Use cautiously in patients with diarrhea, partial
obstructive uropathy, open angle glaucoma, hepatic/renal impairment,
cardiac conduction disorder, thyrotoxicosis, history of drug abuse or acute
alcoholism. May be taken with food to avoid stomach upset","150mg daily in divided doses, gradually increased;
maximum 400mg daily","Drowsiness, anticholinergic effects (dry mouth,
constipation, urinary retention, increased intraocular pressure, palpitation,
tachycardia), CNS stimulation (restlessness, agitation, insomnia, mental
confusion). Injectable form contains sulfites and precipitates anaphylactic
reactions in sensitive or asthmatic individuals",
PRAMIPEXOLE,"Tablets: 0.125 mg, 0.25 mg, 0.5 mg, 1 mg
","Parkinson’s disease, used alone or as an adjunct; restless leg
syndrome.","Severe cardiovascular disease. Avoid in
breast feeding, may suppress lactation. Psychotic disorders, risk of visual
disorders (ophthalmological testing recommended). In pregnancy, use only
if potential benefit outweighs risk. Caution in patients with renal impairment.",,"Nausea, vomiting, anorexia, weight changes, constipation;
Headache, confusion, dizziness, drowsiness, sleep disturbances, sudden
onset of sleep, dyskinesia, hallucinations, restlessness, visual disturbances;
Hypotension, postural hypotension, peripheral oedema; Impulse control
disorders: pathological gambling, binge eating, hypersexuality",
RASAGILINE,Tablet: 1 mg,"Parkinson’s disease, used alone or as adjunct for ’end-of-dose’
fluctuations","Avoid in moderate to severe hepatic
impairment. Pregnancy, breast feeding, mild hepatic impairment. Avoid
abrupt withdrawal","Oral, adult: 1 mg daily","Anorexia, weight loss, dyspepsia, flatulence, constipation,
headache, vertigo, abnormal dreams, hallucinations, depression, angina",
ROPINIROLE,"Tablets: 250 microgram, 500 microgram, 1 mg,
2 mg, 4 g, 5 mg, 8 mg","Parkinson’s disease, either used alone or as adjunct","Breast feeding: may suppress lactation.
In elderly, in patients with major psychotic disorders, severe cardiovascular
diseases (risk of hypotension, monitor blood pressure). Avoid in pregnancy
unless potential benefit outweighs risk (toxicity in animal studies). Avoid
in patients with renal impairment, hepatic impairment. Monitor patient for
impulsive behavior. ",,"Abdominal pain, dyspepsia, nausea, vomiting, constipation,
fatigue, gastro-oesophageal reflux, hypotension, peripheral oedema,
syncope, dizziness, drowsiness, sudden onset sleep, nervousness, dyskinesia,
confusion, hallucinations. Impulse control disorders: pathological gambling,
binge eating, hypersexuality.",
SELEGILINE HYDROCHLORIDE,"Tablets: 5 mg, 10 mg; oral lyophilisates: 1.25 mg","Parkinson’s disease, used alone or as adjunct ","Active duodenal or gastric ulceration, avoid
in postural hypotension (when used in combination with levodopa). Avoid in
patients with angina, arrhythmias, acute porphyrias, duodenal ulceration,
gastric ulceration, history of hepatic dysfunction, patients predisposed to
confusion and psychosis, uncontrolled hypertension. Avoid in pregnancy
and lactation. Caution in patients with renal and hepatic impairment. Oral
lyophilisates should be placed on the tongue and allowed to dissolve. ","Immediate-release tablets, adult: Initially 5 mg once daily
for 2–4 weeks, then increased if tolerated to 10 mg daily, dose to be taken
in the morning. Oral lyophilisate, adult: 1.25 mg once daily, dose to be taken
before breakfast. Dose equivalence and conversion: 1.25 mg oral lyophilisate
is equivalent to 10 mg tablet (dosage form interchangeable)","Arthralgia, myalgia, movement disorders, tremor, impaired
balance; Bradycardia, hypotension, hypertension, angina, palpitations;
Headache, confusion, depression, dizziness, fatigue, sweating, anxiety;
Nausea, constipation, diarrhea, dry mouth, mouth ulcers, stomatitis; Hair
loss, nasal congestion, psychosis, sleeping disorders.",
TRIHEXYPHENIDYL HYDROCHLORIDE (BENZHEXOL),Tablet: 2mg,"Drug induced parkinsonism; modest improvement in tremor and
rigidity but no effect on bradykinesia","Hypersensitivity, angle-closure glaucoma.
Caution in patient with conditions in which anti-cholinergic effects are
undesirable. Not recommended in children. Monitor fluid intake and urine
output ratio: retention commonly causes decreased urine output, distention.","1 mg daily, gradually increased, usual maintenance dose
5-15mg daily in 3-4 divided doses","Drowsiness, confusion, atropine like effects (dry mouth,
constipation, impaired vision and urinary retention)
Patient information: Take plenty of fluids and bulk forming food. Monitor
urine output. ",
ALUMINIUM HYDROXIDE,"Oral suspension: Aluminium hydroxide 250 mg/5 ml and Magnesium hydroxide 250 mg/5 ml; Tablets/Gel: may contain simethicone, and some contain algenic acid",Ulcer and non ulcer dyspepsia; gastro-oesophageal reflux.,"Hypophosphatemia, undiagnosed GI or rectal bleeding, appendicitis, porphyria, renal impairment (aluminium may accumulate), constipation, hepatic impairment, dehydration.",Tablets: 1-2 tablets chewed 4 times a day and at bed time or as required; Suspension: 5-10 ml 4 times daily between meals and at bedtime; Children (6-12 years): up to 5 ml 3 times daily,"Constipation, haemorrhoids, fissures, faecal impaction","Decreases absorption of digoxin, azithromycin, ciprofloxacin, norfloxacin, rifampicin, tetracycline, isoniazid Patient information: Take with water to decrease constipation"
MAGNESIUM HYDROXIDE,"Oral suspension: Aluminium hydroxide 250 mg/5 ml and Magnesium hydroxide 250 mg/5 ml; Tablets/Gel: may contain simethicone, and some contain algenic acid","Ulcer and non ulcer dyspepsia, gastro-oesophageal reflux","Severe renal impairment, renal impairment, hepatic impairment.","250-500 mg, per oral 3-4 times a day","Diarrhoea in renal impairment, respiratory depression, hypotension, loss of tendon reflexes, cardiac arrest",Decrease absorption of other drugs Patient information: Do not take this medicine within 2 hours of taking other medicines (especially flouroquinolones); causes diarrhoea
ATROPINE SULPHATE,Injection: 0.6 mg/ml,"Gastrointestinal spasm, renal colic, anesthetic premedication, OP poisoning","Avoid in case of angle closure glaucoma, hypersensitivity, tachycardia secondary to cardiac insufficiency or thyrotoxicosis. Use in pregnancy only when potential benefits justify possible risk to fetus.",,"Premedication: intravenous injection, 200-600 micrograms immediately before induction of anesthesia and in incremental doses of 100 micrograms for the treatment of bradycardia; intramuscular injection, 300-600 micrograms 30-60 minutes before induction; child 20 micrograms/kg; For control of muscarinic side effects of neostigmine: in reversal of competitive neuromuscular block, by intravenous injection, 0.6-1.2 mg; Bradycardia: particularly complicated by hypotension after myocardial infarction, intravenous injection of 300 micrograms, increasing to 1 mg if necessary; Antidote to organophosphorous poisoning: by intramuscular or intravenous injection, 1 to 2 mg, repeated in 20-30 minutes as soon as cyanosis has cleared","Anticholinergic effect is more pronounced with tricyclic antidepressants, amantidine, antiparkinsonism agents; decreases the absorption of ketoconazole, levodopa; antacids decrease the effect of atropine Patient information: Do not perform strenuous activity in high temperatures, heat stroke may occur; do not perform tasks requiring motor co-ordination and alertness (e.g. driving)"
DROTAVERINE,"Tablet: 10 mg, 40 mg and 80 mg; Injection: 20 mg/ml","Gastrointestinal colicky pain, renal colic, 1st stage of labour (dilation of cervical opening)","Paralytic ileus (or about to undergo surgery), gall bladder disease, diabetes, depression, ulcerative colitis, heart disease, liver disease, kidney disease",40-80 mg 3 times per day,"Nausea, vomiting, fainting, dry mouth",
FLAVOXATE HYDROCHLORIDE,Tablet: 100 mg and 200 mg,"Increased urinary frequency and incontinence, bladder spasms due to catheterization, urgency, dysuria","Obstructive uropathy, ileus, GI obstruction, GI bleeding, glaucoma",200 mg 3 times daily,"Same as in hyoscine, fatigue, vertigo",Can be taken without regard to food Patient information: Do not perform tasks requiring motor co-ordination/alertness (e.g. driving)
HYOSCINE BUTYL BROMIDE,Tablet: 10 mg and 20 mg; Injection: 20 mg/ml,"Symptomatic GI and pain to urinary spasm, irritable bowel syndrome, excessive respiratory secretion, bowel colic","Pregnancy, geriatric patient, hyperthyroidism, dysarrhythmias, ulcerative colitis, hypertension, renal disease, hepatic disease, urinary retention",10 mg 3 times a day; 4 to 20 mg 4 times a day,"Headache, confusion, dizziness, hallucination, palpitation, tachycardia, blurred vision, tachycardia, blurred vision, photophobia, cycloplegia, dry mouth, constipation, paralytic ileus",
MEBEVERINE HYDROCHLORIDE,Tablet: 135 mg; Suspension: 50 mg/5ml,"Irritable bowel syndrome, other spasmodic conditions",Paralytic ileus. To be taken 20 minutes before meal,135-150 mg 3 times a day to be taken 20 minutes before meal,"Allergic reaction, angioedema, urticaria, rash",
CIMETIDINE,Tablets: 200 mg and 400 mg; Injection: 100 mg/ml,"Benign duodenal and gastric ulcer, reflux oesophagitis, Zollinger–Ellison syndrome, GERD, stress ulcer","Hypersensitivity, pregnancy, impaired renal function, children<12 years. Sexual dysfunction in male (loss of libido, impotence, gynaecomastia)","Benign ulcer (oral): 400 mg twice daily followed by 800 mg once at night for 4 weeks, maintainence 400 mg at night; Child: 25-30 mg/kg; Infant: 20 mg/kg in divided doses; Injection(IM): 200 mg every 4-6 hrs, Injection(IM): 200 mg slowly over 2 minutes; IV infusion: 400 mg in 100 ml of normal saline over ½-1 hours, 50-100 mg/hour over 24 hrs for continuous infection","Headache, dizziness, myalgia, nausea, skin rash and diarrhoea or constipation, gynaecomastia, microsomal enzyme inhibition and hepatotoxicity are higher","Decreases absorption of sucralfate, decreased absorption by ketoconazole, itraconazole"
ESOMEPRAZOLE,Tablets: 20 mg and 40 mg; Injection: 40 ml/vial,"Benign gastric and duodenal ulcer, NSAID associated duodenal or gastric ulcer, duodenal or benign gastric ulcer associated with Helicobacter pylori, reflux oesophagitis, Zollinger–Ellison syndrome, stress ulcer","Hypersensitivity reaction, breast-feeding, patients with liver disease","Duodenal ulcer associated with H. pylori: 20 mg twice daily; NSAID associated GU: 20mg once daily for 4-8 weeks; for prophylaxis with increase rate of gastroduodenal complication who require continued NSAID treatment 20 mg daily GERD: 40 mg once daily for 4 weeks, continued for further 4 weeks if not fully healed or symptom persist, maintenance 20 mg daily","Nausea, vomiting, diarrhoea, abdominal colic, skin rash, headache and dizziness","Inhibits hepatic metabolism of diazepam, phenytoin, flurazepam, digoxin etc; increases the bleeding tendency with warfarin Patient information: Avoid alcohol, salicylates, NSAIDs; avoid excessive amounts of caffeine; report onset of black tarry stools, diarrhoea, abdominal pain"
FAMOTIDINE,Tablets: 20 mg and 40mg; Injection: 10 mg/ml,"Benign duodenal and gastric ulcer, reflux oesophagitis, Zollinger–Ellison syndrome, GERD, stress ulcer","Hypersensitivity, pregnancy, impaired renal function, children<12 years. Sexual dysfunction in male (loss of libido, impotence, gynaecomastia)","Benign ulcer: Oral 40 mg at night for 4-8 weeks, maintenance dose 20 mg at night; Reflux oesophagitis: 20-40 mg twice daily for 5-12 weeks; Zollinger–Ellison syndrome: 20 mg every 6 hours","Headache, dizziness, myalgia, nausea, skin rash and diarrhoea or constipation","Decreases absorption of sucralfate, decreased absorption by ketoconazole, itraconazole Patient information: Avoid alcohol, NSAIDs, extreme hot and spicy foods"
LANSOPRAZOLE,Capsule: 15 mg and 30 mg,"Benign gastric and duodenal ulcer, NSAID associated duodenal or gastric ulcer, duodenal or benign gastric ulcer associated with Helicobacter pylori, reflux oesophagitis, Zollinger–Ellison syndrome, stress ulcer","Hypersensitivity reaction, breast-feeding, patients with liver disease","Duodenal ulcer: 30 mg daily in morning for 4 week, maintenance 15 mg daily; Benign gastric ulcer: 30 mg daily in morning for 8 week; NSAID associated duodenal or gastric ulcer: 15-30 mg once daily for 4 weeks continued for further 4 weeks if not fully healed; Reflux oesophagitis: 30 mg daily in morning for 4 weeks, continued for further 4 weeks if not fully healed; Zollinger-Ellison syndrome: initially 60 mg once daily adjusted according to response, daily dose of 120 mg or more given in two divided doses; Reflux oesophagitis refractory to other treatment: 40 mg for 8 weeks","Nausea, vomiting, diarrhoea, abdominal colic, skin rash, headache and dizziness","Inhibits hepatic metabolism of diazepam, phenytoin, flurazepam, digoxin etc; increases the bleeding tendency with warfarin Patient information: Avoid alcohol, salicylates, NSAIDs; avoid excessive amounts of caffeine; report onset of black tarry stools, diarrhoea, abdominal pain"
OMEPRAZOLE,Capsule: 10 and 20mg,"Benign gastric and duodenal ulcer, NSAID associated duodenal or gastric ulcer, duodenal or benign gastric ulcer associated with Helicobacter pylori, reflux oesophagitis, Zollinger–Ellison syndrome, stress ulcer","Hypersensitivity reaction, breast-feeding, patients with liver disease",Adult: 20 mg/day for 4-8 week,"Nausea, vomiting, diarrhoea, abdominal colic, skin rash, headache and dizziness","Inhibits hepatic metabolism of diazepam, phenytoin, flurazepam, digoxin etc; increases the bleeding tendency with warfarin Patient information: Avoid alcohol, salicylates, NSAIDs; avoid excessive amounts of caffeine; report onset of black tarry stools, diarrhoea, abdominal pain"
PANTOPRAZOLE,Tablets: 20 and 40mg; Injection: 40 mg/vial,"Benign gastric and duodenal ulcer, NSAID associated duodenal or gastric ulcer, duodenal or benign gastric ulcer associated with Helicobacter pylori, reflux oesophagitis, Zollinger–Ellison syndrome, stress ulcer","Report severe diarrhoea, black tarry stools, abdominal pain, product may have to be discontinued. Hypersensitivity reaction, breast-feeding, patients with liver disease",Duodenal ulcer: 40 mg daily in the morning for 2 weeks; Benign gastric ulcer: 40mg daily in the morning for 2 weeks,"Nausea, vomiting, diarrhoea, abdominal colic, skin rash, headache and dizziness","Inhibits hepatic metabolism of diazepam, phenytoin, flurazepam, digoxin etc; increases the bleeding tendency with warfarin Patient information: Avoid alcohol, salicylates, NSAIDs; avoid excessive amounts of caffeine; report onset of black tarry stools, diarrhoea, abdominal pain"
RABEPRAZOLE,Tablet: 10 mg and 20 mg,"Benign gastric and duodenal ulcer, NSAID associated duodenal or gastric ulcer, duodenal or benign gastric ulcer associated with Helicobacter pylori, reflux oesophagitis, Zollinger–Ellison syndrome, stress ulcer","Hypersensitivity reaction, breast-feeding, patients with liver disease, children - not recommended","Benign gastric ulcer: 20 mg daily in the morning for 6 weeks, continued for further 6 weeks if not fully healed; Duodenal ulcer: 20 mg daily in the morning for 4 week continued for further 4 week if not fully healed; GERD: 20 mg once daily for 4-8 weeks, maintenance 10-20mg daily","Nausea, vomiting, diarrhoea, abdominal colic, skin rash, headache and dizziness","Inhibits hepatic metabolism of diazepam, phenytoin, flurazepam, digoxin etc; increases the bleeding tendency with warfarin Patient information: Avoid alcohol, salicylates, NSAIDs; avoid excessive amounts of caffeine; report onset of black tarry stools, diarrhoea, abdominal pain"
RANITIDINE,Tablets: 150 mg and 300 mg; Injection: 25 mg/ml,"Benign duodenal and gastric ulcer, reflux oesophagitis, Zollinger–Ellison syndrome, GERD, stress ulcer","Hypersensitivity, pregnancy, impaired renal function, children<12 years. Sexual dysfunction in male (loss of libido, impotence, gynaecomastia)","Benign ulcer: oral 150 mg twice daily, 300 mg at night for 4-8 weeks; Chronic episodic dyspepsia: 6 weeks; NSAID induced ulcer: for 8 weeks; Reflex oesophagitis: 150 mg twice daily, 300 mg at night for 8 weeks, or if necessary 12 weeks; Gastric acid reduction (Prophylaxis of acid aspiration in obstetric): oral – 150 mg at onset of labour, then every 6 hours; Surgical procedure: IM or slow IV injection, 50 mg 45-60 minutes before induction of anaesthesia, oral 150 mg 2 hours before induction of anaesthesia, IM 50 mg every 6-8 hours IV infusion, 25 mg/hour for 2 hours, repeated every 6-8 hours.","Headache, dizziness, myalgia, nausea, skin rash and diarrhoea or constipation","Decreases absorption of sucralfate, decreased absorption by ketoconazole, itraconazole"
SUCRALFATE,Tablet: 1 g,"Benign gastric and duodenal ulceration, chronic gastritis","Pregnancy, safety and efficacy of sucralfate in children have not been established","2 g twice daily (on rising and at bed time) for 4-6 week or in resistant case 12 weeks, morning 8 g daily; Prophylaxis of NSAIDs induced ulcer (suspension) 1 g 6 times daily (maximum 8 g daily)",,"Concomitant use with cimetidine, phenytoin, tetracyclines and fluoroquinolones result in reduction in bioavailability of these drugs. It should be taken at least 2 hours after administration of other drugs Patient information: Complete full course of treatment to ensure ulcer healing, increase fluid intake, dietary bulk and exercise to prevent constipation"
CYCLIZINE,Tablets: 25 mg and 50 mg,"Prevention and treatment of nausea, vomiting and vertigo associated with motion sickness","Asthma, glaucoma, emphysema, chronic pulmonary disease. Should not be concurrently used with sedatives, tranquilizers and anticholinergic medication","Motion sickness: 50 mg 30 minutes before traveling, can be repeated in 6 hours (up to 200 mg/day), 6-12 hours, 25 mg up to 3 times/day not to exceed 75 mg/day","Drowsiness, xerostomia, headache, dermatitis, urinary retention, diplopia Patient information: Avoid hazardous activities, activities requiring alertness because dizziness may occur; avoid alcohol, other CNS depressants; take 30 minutes before travelling",
DIMENHYDRINATE,Tablet: 50 mg; Injectable: 50 mg/ml,"Prevention of motion sickness, Meniere’s disease","Hypersensitivity, pregnancy and neonates, breast-feeding, seizures, angle closure glaucoma, benign enlargement of prostate. Masks early signs of ototoxicity if given consistently with ototoxic drugs","Prevention of motion sickness: 50-100 mg 4-6 hours or 30 minutes before traveling (not to exceed 400mg/day); Meniere’s disease: 50 mg intra-muscular for acute attack, 25-50 mg 8 hourly for maintenance","Paradoxical CNS stimulation (children & occasionally in adults), CNS depression, dizziness","Eluxadoline, sodium oxalate increases effects by pharmacodynamics synergism Patient information: Avoid hazardous activities, activities requiring alertness because dizziness may occur; avoid alcohol, other CNS depressants"
DOMPERIDONE,Tablet: 10 mg; Suspension: 1 mg/ml,"Antiemetic, gastrokinetic to accelerate gastric emptying, dyspepsia, GERD (Gastro esophageal reflux disease)","Obstruction to GIT, urinary outflow, paralytic ileus, comatose condition, hepatic and cardiovascular disease, glaucoma",Acute nausea and vomiting: 10-20 mg 6-8 hours (child 0.25-0.5 mg/kg); Functional dyspepsia: 10-20 mg 3 times daily before food for maximum of 12 hours,"Galactorrhoea, gynaecomastia, decreased libido, skin rashes",Anticholinergic drugs may reduce the therapeutic effects of domperidone Patient information: Avoid grapefruit juice during therapy
METOCLOPRAMIDE,Tablet: 10 mg; Injection: 5 mg/ml,"Nausea and vomiting in GI disorders and treatment with cytotoxic or radiotherapy, GERD, gastroparesis, premedication and post operatively","Gastro intestinal obstruction, haemorrhage or perforation, 3-4 days after GI surgery, pheochromocytoma, convulsive disorders, renal and hepatic impairment, elderly, children, pregnancy and breast feeding, Parkinson’s disease, epilepsy, depression, porphyria. Assess for extra-pyradimal side effects (difficulty in speaking, loss of balance, rigidity, tremor), signs of depression","Nausea and vomiting, GERD, Gastroparesis: Adult: 10 mg 3 times daily (children 2-5 mg/kg); Premedication: 10 mg single dose; Aid to gastrointestinal procedure: 10-20 mg as single dose 5-10 minutes before examination","Extrapyramidal symptoms (children and young adult), tardive dyskinesia on prolonged use, hyperprolactinemia, drowsiness, dizziness, restlessness, headache, neuroleptic malignant syndrome, rashes, pruritus, cardiac conduction abnormalities following IV administration","Alcohol, other CNS depressants increase sedation effects. haloperidol, phenothiazines increase risk for EPS Patient information: Avoid concurrent use of alcohol and other CNS depressants"
ONDANSETRON,"Injectable: 2 mg/ml; Tablet: 4 mg, 8 mg and 24 mg; Oral solution: 4 mg/5ml","Chemotherapy induced nausea and vomiting, post operative nausea and vomiting, radiation induced nausea and vomiting, uremic pruritus, rosacea, hyperemesis gravidarum","Hypersensitivity reactions, co-administration with apomorphine, pregnancy, breastfeeding, moderate to severe liver impairment; child below 4 years of age - safety and efficacy not established","Chemotherapy induced nausea and vomiting: moderate - 8 mg started 30 minutes prior, highly emetogenic 24 mg; IV - 0.15 mg/kg over 15 minutes, 30 minutes prior to chemotherapy then 4 and 8 hours; Postoperative nausea and vomiting : 4 mg IV/IM before anaesthesia as after procedures; Radiation induced nausea and vomiting: 8 mg PO 1-2 hours before radiation, subsequent doses every 8 hours; Cholestatic pruritus: 8 mg 12 hours or 8 hours for 7 days; Uremic pruritus: 8 mg 12 hours or 8 hours for 14 days, Child below 4 years of age: Safety and efficacy not established, can be given 0.1 mg/kg IV in postoperative nausea &vomiting","Headache, constipation, hiccups, flushing, transient visual disturbances, involuntary movements, dizziness, arrhythmia, hypotension Patient information: Report to health care professional immediately if symptoms of irregular heart beat or involuntary movement of eyes, face or limbs occur",
PROCHLORPERAZINE,Injection: 12.5 mg/ml; Tablets: 5 mg and 25 mg,"Postoperative nausea and vomiting, chemotherapy induced nausea and vomiting, vertigo, psychosis","Coma, hypersensitivity. Should be protected from light",Acute attack of vomiting: 20 mg initially then 10 mg after 2 hours; Prevention of nausea and vomiting: 5-10 mg 2-3 times daily (0.25 mg/kg); Labyrinthine disorders: 5 mg 3 times daily (up to 30 mg daily in divided doses),"Muscle dystonia and other extrapyramidal side effect, dry mouth, drowsiness","Increase serotonin syndrome, neuroleptic malignant syndrome with SSRIs, SNRIs Patient information: Avoid hazardous activities, activities requiring alertness, alcohol; not to double or skip doses; avoid sun, wear sunscreen, protective clothing"
PROMETHAZINE,"Tablets: 25 mg, 50 mg and 125 mg; Syrup: 6.25 mg/ml; Suppository: 25 mg, 50 mg and 125 mg; Injection: 25 and 50 mg/ml","Nausea, vomiting, motion sickness, pre-operative and post-operative sedation, obstetric sedation","Porphyria, child under 2 years (risk of respiratory depression), pregnancy. May cause photosensitivity","Nausea and vomiting: PO/PR 12.5-25 mg 4-6 hours, IV/IM 12.5-25 mg 4-6 hours; Motion sickness: 25 mg PO/PR 30-60 minutes before travel; Pre-operative sedation: 50 mg PO/PR on night before procedure; Post-operative: 25-50 mg IV/IM combined with reduced doses of analgesics; Allergic conditions: 25 mg at bedtime or 12.5 mg (PO/PR), 25 mg may be repeated in 2 hours (IV/IM)","Sedation, blurred vision, confusion, hallucination, disorientation, extrapyramidal symptoms","May potentiate the sedative action of opiates, other CNS depressants, antihistamines and alcohol Patient information: Avoid prolonged exposure to sunlight, avoid concurrent use of alcohol or other CNS depressants"
DIPHENOXYLATE,Tablet: 2.5 mg diphenoxylate and 0.025 mg atropine,"Acute diarrhoea, chronic mild ulcerative colitis","Children <4 years, hypersensitivity, hepatorenal disease, pregnancy, obstructive jaundice, abnormal liver function, diarrhoea, pseudomembranous colitis, pregnancy, breast feeding, hepatic disease, ulcerative colitis, hypertensive crisis","Initial dose for adults is 4 tablets, followed by 2 tablets every 6 hours until diarrhoea is controlled. Maintenance dose as low as ¼th of initial dose","Blurred vision, sedation, nausea, vomiting, abdominal discomfort, dryness of mouth, urinary retention","Antimuscarinics, opioids and analgesics, avoid in those with NAD inhibitors"
LOPERAMIDE,Tablet: 2 mg,"Acute nonspecific diarrhoea, chronic diarrhoea, faecal incontinence, pain of intestinal colic","Active ulcerative colitis, antibiotic associated colitis, condition where abdominal distention develops, condition where inhibition of peristalsis should be avoided. Hypersensitivity, bloody diarrhoea, high fever, infectious diarrhoea; pseudomembranous colitis, age<2 years. Patients in whom constipation must be avoided. Avoid use as primary therapy with acute dysentery. Discontinue if no improvement seen within 48 hours in patient with acute diarrhoea, symptoms worsen or abdominal swelling or bulging develops","Acute diarrhoea: Initially 4 mg, followed by 2 mg for up to 5 days; usual dose 6 to 8 mg daily; maximum 16 mg per day; Chronic diarrhoea: Initially 4 to 8 mg daily in divided doses; subsequently adjusted accordance to response, maintenance up to 16 mg daily in 2 divided doses","Dizziness, drowsiness, fatigue, flatulence, headache, nausea","Eluxadoline and fentanyl increase chance and severity of constipation Patient information: Do not take missed doses, do not double dose"
ORAL REHYDRATION SALTS,"Sachet: 2.6 g/l sodium chloride, 2.9 g/l sodium citrate (dihydrate), 1.5 g/l potassium chloride,13.5 g/l glucose (anhydrous)",Dehydration from acute diarrhoea,Renal impairment. Should be protected from moisture,Fluid and electrolyte loss in acute diarrhoea: oral - adult 200-400 ml solution after every loose motion; infant 1-1.5 times usual feed volume; child 200 ml after every loose motion,"Vomiting (too rapid administration), hypernatremia and hyperkalaemia (overdose in renal impairment or administration of too concentrated solution) Patient information: One sachet should be used to prepare one litre of solution, discard any unused solution after 24 hours; do not boil/dilute the solution",
RIFAXIMIN,Tablet: 200 mg and 550 mg,"Traveller’s diarrhoea, hepatic encephalopathy, irritable bowel syndrome","Hypersensitivity, pregnancy category C, breast feeding. Not effective in traveller’s diarrhoea due to organism other than E. coli; discontinue if symptoms worsen or persist > 24-48 hours; hepatic impairment. Possibility of pseudomembranous colitis","Traveller’s diarrhoea: oral, 200mg TDS for 3 days; Hepatic encephalopathy (maintenance of remission): oral, 550mg BD; Irritable bowel syndrome: oral, 550 mg TDS for 14 days","Flatulence, rectal tenesmus, abdominal pain, defecation urgency, constipation, nausea, vomitting",
ZINC SULFATE,"Oral solution: 10 mg/5 ml; Tablet: 10 mg, 20 mg",Adjunct to ORS in acute diarrhoea,Acute renal failure (may accumulate),Infants<6 months: 10 mg daily for 10-14 days; Child 6 months-5 years ronic diarrhoea: 20 mg daily for 10-14 days,"Abdominal pain, dyspepsia, Nausea, Vomiting, Diarrhoea, Headache, Gastric irritation","Absorption of ciprofloxacin, levofloxacin, ofloxacin, ferrous salt and calcium salt can be reduced Patient information: Tablets may be dispersed in breast milk, in oral rehydration solution or in water on a small spoon, older children may chew tablets or swallow them with water; inform doctor if severe nausea/vomiting, abdominal pain or tarry stools seen"
ISPAGHULA HUSK,"Powder (in plastic bottles): 50 g, 100 g, 200 g, 500 g",Constipation,Useful to patient who cannot tolerate bran,"0.5-2 gm/day (3 tea spoonful) at bed time, children ½ of adult dose","Abdominal distension, flatulence Patient information: increase fluid intake, bulk forming foods in diet and mobility",
DOCUSATE SODIUM,Tablet: 100 mg; Syrup: 50 mg/ml; Drops: 25mg/drop,"Constipation, adjunct to radiological procedure (with Barium meal 400 mg)","Hypersensitivity reaction, intestinal obstruction, prolong use and children","50-300 mg per oral single or divided dose (up to 500 mg), initially large dose, gradually decrease dose, with barium meal 400 mg","Rashes, transient abdominal cramping pain",
LIQUID PARAFFIN,Emulsion: 25% v/v,Constipation,Hypersensitivity reactions,10-30 ml at night,"Lipoid pneumonia due to aspiration, interfere fat soluble vitamin absorption, Foreign body granulomatous lesion on mesenteric, liver and spleen",
BISACODYL,"Tablet: 5 mg, 10 mg; Suppository: 5 mg, 10 mg","Constipations, bowel preparation for radiology and surgery","Intestinal obstruction, pregnancy, children<4 years.","Constipation: 5-10 mg (oral) at night, 10 mg at morning suppository; Radiological procedure: 10 mg per oral at night then 10 mg suppository at morning, 1 hour before procedure; Paediatric: >6 yr, 5 mg per oral at night, <10 yrs, 5 mg suppository; Radiological procedure: 5 mg by mouth at night, 5 mg per rectal at morning","Abdominal cramp, local irritation","Increase risk of mucusoal ulceration while coadminstering with sodium sulfate, potassium sulfate or magnesium sulfate. May produce hypokalemia with deflazacort or dichlorphenamide. Patient information: Better to be taken in empty stomach, to be taken with full glass of water. Swallow tabs whole with full glass of water; do not break, crush, chew tabs. alone only with water for better absorption. Do not take with antacid with in 1 hour"
SENNA,Tablet: 7.5 mg,"Constipation, bowel preparation for radiological and surgical procedure","Avoid in children and pregnancy, intestinal obstruction. Should be avoided except when straining, increased risk of rectal bleeding in haemorrhoids","Constipation: Adult:2-4 tablets at night, Children (>6 years): ½ of adult dose; Bowel preparation: 1 mg/kg in two divided doses",Abdominal cramps,
LACTULOSE,Syrup: 10 mg/15 ml,"Constipation, hepatic encephalopathy","Hypersensitivity, intestinal obstruction, diabetic patient, pregnancy- use if benefit > risk. Take adequate water","Constipation: adult, 15 ml per oral twice daily (not more than 60ml/day) gradually titrate the dose to produce 2-3 soft stool/day; Children: <1 year, 2.5 ml twice a day titrate according to stool frequency, 1-5 years, 5 ml twice a day titrate according to stool frequency, >6-12 years – 10ml twice a day, titrate according to stool frequency; Hepatic encephalopathy: 30-45 ml (20-30 g) per oral to induce rapid detection, 30-45 ml per oral after 6-8 hours","Dehydration, hypernatremia, abdominal distension","Do not use with other laxative (hepatic encephalopathy), increase chance of GI obstruction with nifedipine Patient information: Dilute with fruit juice or water to counteract sweet taste, take in empty stomach for rapid action; may cause belching, flatulence, abdominal cramping"
MACROGOL 3350,"Powder (in satchet): 13.125 g (macrogol 3350) with 0.3507 g sodium chloride, 0.1785 g sodium bicarbonate, 46.6 mg potassium chloride","Constipation, fecal impaction","Gut obstruction, gut perforation, severe inflammatory bowel disease, known hypersensitivity, cardiovascular diseases.","Constipation: dissolve 1 sachet in 125 ml of water, to be taken 1-3 times/day as required; Fecal impaction: dissolve 1 sachet in 125 ml of water, 8 sachets to be taken within 6 hours, up to 3 days if required","Diarrhoea, dehydration, indigestion, pain abdomen, allergic reactions","Anti-epileptics (decreased effectiveness) Patient’s information: Take plenty of fluids. Reconstituted solution can be kept in fridge (2-8oC) and covered, remaining solution to be discarded after 6 hours if not consumed"
MAGNESIUM HYDROXIDE (MILK OF MAGNESIA),"Tablet: 400 mg; Suspension: 7.75%, 400 mg/5ml, 800 mg/5 ml, 1200 mg/5 ml","Constipation, acid peptic disease","Renal failure, acute abdomen, undiagnosed abdominal pain, known hypersensitivity reaction, renal insufficiency","Constipation: 30-60 ml/day per oral at bed time (400 mg/5ml); Acid peptic disease: 5-15 ml (400 mg/5ml) per oral in 4 divided doses, 2-4 tab/day chewable tables","Abdominal cramp, electrolyte imbalance, hypotension Patient information: Shake solution before use. Better to be taken in empty stomach",
MAGNESIUM SULPHATE,"Injectable: 40 mg/ml, 80 mg/ml, 50%; Infusion solution: 1 g/10 ml, 2 g/100 ml","Constipation, hypomagnesemia, eclampsia/severe preeclampsia, preterm labor, torsades de pointes","Renal impairment, abdominal pain, acute surgical abdomenorectal bleeding, heart block",Constipation: 5-10 g dissolved in 24 ml of water,"Flaccid paralysis, circulatory collapse, nausea, vomiting, electrolyte and fluid disturbance","Increases effects of neuromuscular blocker, increases hypotension-antihypertensives, decreases absorption of tetracyclines, fluoroquinolones Patient information: Not to use laxative for long time; shake suspension well before use, not to given at bedtime as laxative may interfere with sleep"
POLYETHYLENE GLYCOL 3350,"Powder (in sachet): 255 g, 527 g",Constipation,"Bowel obstruction, pregnancy category C, children","Constipation: 17 g, after reconstitution in a glass of water","Nausea, abdominal bloating, cramping and flatulence, diarrhoea and excessive stool frequency Patient’s information: Report if unusual cramps, bloating or diarrhoea occurs",
ADALIMUMAB,Injection: 40 mg/0.8 ml prefilled syringe/pen,"Crohn’s disease, ulcerative colitis, rheumatic and psoriatic arthritis, ankylosing spondylitis, plaque psoriasis",,"Crohn’s disease and ulcerative colitis: subcutaneous, initial: 160 mg (given on day 1 or split and given over 2 consecutive days), then 80 mg 2 weeks later (day 15), maintenance: 40 mg every other week beginning day 29",,
BUDESONIDE,Tablet (enteric coated): 3 mg,"Treatment of mild to moderate active Crohn’s disease,","Hypersensitivity, pregnancy cat (C), hepatic impairment","Treatment of mild to moderate active Crohn’s disease: 9 mg orally once daily for up to 8 weeks; Maintenance of clinical remission of mild to moderate Crohn’s disease: 6 mg orally once daily for maintenance of clinical remission up to 3 months (if symptom control maintained, taper doses to complete cessation)","Increased risk of infection, abdominal pain, flatulence, vomitting and other corticosteroid related systemic adverse effects",Avoid using CYP3A4 inhibitors concomitantly
HYDROCORTISONE ACETATE,Suppository: 25 mg,"Ulcerative colitis, proctitis, proctosigmoiditis","Avoid in bowel obstruction preparation, and untreated infection. Proctoscopic examination required before treatment, avoid prolonged use",Suppository 25 mg twice daily for 2 weeks – can be increased up to 25 mg 3 times daily or 50 mg twice daily,"Local pain/burning sensation, rectal bleeding, exacerbation of untreated infections",
INFLIXIMAB,Injection: 100 mg,"Crohn’s disease, ulcerative colitis","Discontinue if serious infection/sepsis, pregnancy (B). Consider premedication with antihistamines, acetaminophen, and/or corticosteroids. Increases risk of lymphoma and other malignancy in children and adolescents","Crohn disease: adult, IV: 5 mg/kg at 0, 2, and 6 weeks, followed by 5 mg/kg every 8 weeks thereafter; dose may be increased to 10 mg/kg in patients who respond but then lose their response. If no response by week 14, consider discontinuing therapy, Children ≥6 years and adolescents, IV: 5 mg/kg at 0, 2, and 6 weeks, followed by 5 mg/kg every 8 weeks thereafter; Ulcerative colitis: IV: 5 mg/kg at 0, 2, and 6 weeks, followed by 5 mg/kg every 8 weeks thereafter, children ≥6 years and adolescents, IV, 5 mg/kg at 0, 2, and 6 weeks, followed by 5 mg/kg every 8 weeks thereafter","Hypersensitivity, abdominal pain, increased serum ALT, infection, infusion related reaction","Adalimumab, etanercept (increases immunosuppressive effect of infliximab)"
MESALAZINE,Tablet: 1.2 g; Suppository: 500 mg; Enema: 5 ml,"Ulcerative colitis (acute attack, maintenance of remission). maintenance of remission of Crohn’s ileo-colitis","Hypersensitivity to salicylates, breast feeding mother, children with chickenpox or flu like symptoms, active peptic ulcer disease, severe renal failure. Empty stomach prior rectal administration of drug; instruct patient on correct method of administration","Maintenance of remission of ulcerative colitis (UC) and Crohn’s ileo-colitis: Adult 1.2-2.4 g daily in divided dosage, child 12-17 years 400-800 mg 3 times/day; Treatment of mild to moderate UC and acute attack: Adult 2.4 g daily in divided dosage, child 12-17 years 800 mg 3 times a day","Dizziness, oligospermia, abdominal pain, flatulence and headache",Preparation that lower stool pH (e.g. lactulose) may prevent release of mesalazine
SULFASALAZINE,"Tablet: 0.5 g, 1 g; Suppository: 500 mg","Ulcerative colitis, active Crohn’s disease, active rheumatoid arthritis","Avoid in cases of hypersensitivity to salicylates or sulfonamides, child under 2 years, porphyria, intestinal or urinary obstruction, severe renal impairment. Use with caution in renal, hepatic impairment, G6PD deficiency, blood related disorder, child","Ulcerative colitis: adult (oral) - 1-2 g QID in acute attack until remission maintenance dose 500 mg QID, child > 2 yrs 40 -60 mg/kg in acute attack, reducing to maintenance dose 20-30 mg/kg daily; Active Crohn’s disease: adult (oral) 1-2 g QID in acute attack until omission occurs, child >2 year 40-60 mg/kg daily in acute attack; Ulcerative colitis, Crohn’s disease: by reactive suppositories, 0.5-1 g morning & evening after bowel movement, by rectum (retention enema), 3 gm at night for at least an hour","Nausea, vomiting, exacerbation of colitis, diarrhoea, loss of appetite, fever, blood disorders, hypersensitivity, lung complications (eosinophilia, fibrosing alveolitis), periorbital edema Patient information: Take each oral dose with full glass of water to prevent crystalluria, urine, skin may be coloured yellow orange.",
OCTREOTIDE,"Injection: 0.05 mg/ml, 0.1 mg/ml, 0.2 mg/ml, 0.5 mg/ml and 1 mg/ml","Esophageal variceal bleeding, acromegaly, carcinoid tumor, VIPoma","Esophageal variceal bleeding: 50 mcg IV bolus, then 25-50 mcg/hr for 1-5 days",,,
TERLIPRESSIN,Injection: 200 mg/2 ml,Bleeding from esophageal varices,"Avoid in seizure, migraine, asthma, heart failure and renal disease. Use in pregnant women only if clearly needed","Initially 2 mg every 4-6 hours until bleeding is controlled, then 1 mg every 4-6 hour for maximum up to 48 hours","Abdominal cramps, headache, cardiac arrhythmias",
URSODEOXYCHOLIC ACID,Tablets: 150 mg; Capsules: 250 mg,"Used in dissolution of gallstones, primary biliary cirrhosis","Pregnant and lactating mothers. Avoid aluminium containing antacids during therapy, may impair absorption","Dissolution of gall stones: 8-12 mg/kg daily as a single dose at bedtime or in two divided doses, for up to 2 years; treatment is continued for 3-4 months after stones dissolve; Primary biliary cirrhosis: 10-15 mg/kg daily in 2-4 divided doses","Nausea, vomiting, diarrhoea, gallstone calcification, pruritus",
GLYCERYL TRINATRE (Nitroglycerine),"Solution (infusion): 25 mg/250 ml, 50 mg/250
ml, 100 mg/250 ml; Solution (injection): 5 mg/ ml","Prophylaxis and acute attack of angina pectoris, Hypertensive
emergencies, acute decompensated heart failure","Avoid in hypersensitivity to nitrates,
hypotension, hypovolemia, hypertrophic obstructive cardiomyopathy,
aortic stenosis, cardiac tamponade, constrictive pericarditis, mitral stenosis,
marked anemia, head trauma, cerebral hemorrhage, angle-closure glaucoma.
Use caution in severe hepatic impairment, hypothyroidism, malnutrition,
hypothermia, recent history of myocardial infarction. Renal impairment: 10-
50 ml/min: never administer. Uninterrupted infusion > 24 hours produces
tolerance.","• Angina (acute attack): Intravenous infusion, adult: initially 5–10 mcg/min.
The rate of the infusion may be increased by 10 mcg/min every 3–5 min until
symptoms are relieved, systolic arterial pressure falls to <100 mm Hg, or the
dose reaches 200 mcg/min
• Hypertensive emergencies: Intravenous infusion, adult: 5-10 mcg/min
initial dose and up to 200 mcg/min as long as hemodynamic stability is
maintained) for the first 24–48 h after the onset of infarction.
• Acute decompensated heart failure: Intravenous infusion, adult: 10–20
mcg/min, increase up to 200 mcg/min. Intravenous infusion, Children:
Initially 0.25- 0.5 mcg/kg/min to titrate to 0.5-1.0 mcg/kg/min. Maximum
dose 20 mcg/kg/min
• Start with the lowest dose. Subsequent doses and intervals of administration
should be adjusted according to the blood pressure response and duration
of action.","Throbbing headache (most frequent in early therapy),
flushing, dizziness, postural hypotension, Tachycardia, syncope, paradoxical
bradycardia","Increases the effect of beta-blockers, ACE
inhibitors, angiotensin receptor blockers, calcium channel blockers. Avoid in
concomitant/recent use of erectile dysfunction products (sildenafil, tadalafil,
vardenafil) - may cause severe hypotension and death. Avoid alcohol intake."
ISOSORBIDE DINITRATE,"Tablet (sublingual): 5 mg, 10 mg","Prophylaxis and treatment of angina, left ventricular failure.","Avoid in hypersensitivity to nitrates,
hypotension, hypovolemia, hypertrophic obstructive cardiomyopathy,
aortic stenosis, cardiac tamponade, constrictive pericarditis, mitral stenosis,
marked anemia, head trauma, cerebral hemorrhage, angle-closure glaucoma.
Use caution in severe hepatic impairment, hypothyroidism, malnutrition,
hypothermia, recent history of myocardial infarction. Renal impairment: 10-
50 ml/min: never administer. Uninterrupted infusion > 24 hours produces
tolerance. Patients taking isosorbide dinitrate for the long-term management of angina
may often develop tolerance to the antianginal effect; avoid by giving the
second of 2 daily doses of longer-acting oral preparations after an 8-hour
rather than a 12-hour interval, thus ensuring a nitrate-free interval each day.","• Angina (acute attack): Sublingual, adult: 5–10 mg repeated as required.
• Angina (prophylaxis): Oral, adult: 30-120 mg daily in divided doses.
Intravenous infusion: 2-10 mg daily, maximum dose 20 mg/hour.
• Left ventricular failure: Oral, adult 40-160 mg daily in divided doses,
maximum dose 240 mg daily in divided doses. Intravenous infusion: 2-10
mg daily, maximum dose 20 mg/hour.","Throbbing headache (most frequent in early therapy),
flushing, dizziness, postural hypotension, Tachycardia, syncope, paradoxical
bradycardia, tolerance (in long term,
uninterrupted use)",
ATENOLOL,"Tablet: 25 mg, 50 mg, 100 mg; Solution: 500
mcg/ml in 10ml vial.","Chronic stable angina, secondary prevention after myocardial
infarction, supra ventricular arrhythmia, mild CHF, hypertension, migraine
prophylaxis.","Avoid in history of asthma or bronchospasm
(if no alternative, then use with extreme caution and under specialist
supervision), uncontrolled heart failure, prinzemetal angina, bradycardia
(heart rate <50 bpm), hypotension, sick sinus syndrome, second and third
degree atrioventricular block, cardiogenic shock, metabolic acidosis, severe
peripheral arterial disease, pheochromocytoma (unless used with an alpha
blocker). Use caution in patients with first –degree atrioventricular block,
portal hypertension, renal impairment (reduce dose), diabetes mellitus (small
decrease in glucose tolerance, which can mask symptoms of hypoglycemia),
history of hypersensitivity and myasthenia gravis, obstructive airway
disease, portal hypertension, psoriasis. Pregnancy- avoid (IUGR, neonatal
hypoglycemia and bradycardia). Breast feeding: avoid. Monitor lung function
in inadequate cardiac function and bronchospasm disease. Symptoms of
hypoglycemia and thyrotoxicosis may get masked. Assess weight daily, watch
for CHF (rales/crackles, jugular vein distension, weight gain, and edema).
Abrupt withdrawal of drug may exacerbate angina symptoms or precipitate
myocardial infarction in patients with coronary artery disease.","• Hypertension: Oral, adult: 25 – 50 mg daily. Oral, child: 0.5-1.0 mg/kg/dose
in 1-2 divided doses daily. Maximum dose- 2mg/kg/day or 100 mg/day
• Angina: Oral, adult: 100 mg, maximum dose 200 mg daily 1 or 2 doses.
• Arrhythmias: Oral, adult: 50-100 mg daily. Intravenous, adult: 2.5 mg at
rate of 1 mg/min repeated at 5 min interval to a maximum of 10 mg/dose.
Intravenous infusion, adult: 150 mcg/kg every 12 hourly over 20 minutes,
repeated every 12 hours if required.
• Early intervention Myocardial infarction (within 12 hour): slow intravenous
infusion, adult: 5 mg by then oral 50 mg after 15 minutes then oral 50 mg
after 12 hours then 100 mg daily.
• Migraine prophylaxis: Oral, adult: 50–200 mg daily in divided doses","Bradycardia, gastrointestinal disturbances including
nausea, vomiting, diarrhea, constipation, abdominal cramp, fatigue, cold
hands and feet, hypertriglyceridemia.","Avoid with verapamil. Hypotensive effect
increases with diuretics, ACE inhibitors, Angiotensin II receptor antagonist,
calcium channel blocker. Atenolol may enhance bradycardia produced by
cardiac glycosides."
BISOPROLOL,"Tablet: 2.5 mg, 5 mg, 10 mg","Hypertension, angina, adjunct in heart failure","Avoid in history of asthma or bronchospasm
(if no alternative, then use with extreme caution and under specialist
supervision), uncontrolled heart failure, prinzemetal angina, bradycardia
(heart rate <50 bpm), hypotension, sick sinus syndrome, second and third
degree atrioventricular block, cardiogenic shock, metabolic acidosis, severe
peripheral arterial disease, pheochromocytoma (unless used with an alpha
blocker). Use caution in patients with first –degree atrioventricular block,
portal hypertension, renal impairment (reduce dose), diabetes mellitus (small
decrease in glucose tolerance, which can mask symptoms of hypoglycemia),
history of hypersensitivity and myasthenia gravis, obstructive airway
disease, portal hypertension, psoriasis. Pregnancy- avoid (IUGR, neonatal
hypoglycemia and bradycardia). Breast feeding: avoid. Monitor lung function
in inadequate cardiac function and bronchospasm disease. Symptoms of
hypoglycemia and thyrotoxicosis may get masked. Assess weight daily, watch
for CHF (rales/crackles, jugular vein distension, weight gain, and edema).
Abrupt withdrawal of drug may exacerbate angina symptoms or precipitate
myocardial infarction in patients with coronary artery disease.","• Hypertension and angina: Oral, adult: 5-10 mg once daily, 20 mg daily
(maximum).
• Adjunct in heart failure: Oral, adult: initially 1.25 mg once daily (in the
morning) for 1 week then, if well tolerated, increased to 2.5 mg once daily
for 1 week, then 3.75 mg once daily for 1 week, then 5 mg once daily for 4
weeks, then 7.5 mg once daily for 4 weeks, then 10 mg once daily, maximum
10 mg daily.","Bradycardia, gastrointestinal disturbances including
nausea, vomiting, diarrhea, constipation, abdominal cramp, fatigue, cold
hands and feet, hypertriglyceridemia.","Avoid with verapamil. Hypotensive effect
increases with diuretics, ACE inhibitors, Angiotensin II receptor antagonist,
calcium channel blocker. Atenolol may enhance bradycardia produced by
cardiac glycosides."
CARVEDILOL,"Tablet: 3.125 mg, 6.25 mg, 12.5 mg, 25 mg","Angina, hypertension, adjunct to diuretics/digoxin/ACE
inhibitors in heart failure","Avoid in history of asthma or bronchospasm
(if no alternative, then use with extreme caution and under specialist
supervision), uncontrolled heart failure, prinzemetal angina, bradycardia
(heart rate <50 bpm), hypotension, sick sinus syndrome, second and third
degree atrioventricular block, cardiogenic shock, metabolic acidosis, severe
peripheral arterial disease, pheochromocytoma (unless used with an alpha
blocker). Use caution in patients with first –degree atrioventricular block,
portal hypertension, renal impairment (reduce dose), diabetes mellitus (small
decrease in glucose tolerance, which can mask symptoms of hypoglycemia),
history of hypersensitivity and myasthenia gravis, obstructive airway
disease, portal hypertension, psoriasis. Pregnancy- avoid (IUGR, neonatal
hypoglycemia and bradycardia). Breast feeding: avoid. Monitor lung function
in inadequate cardiac function and bronchospasm disease. Symptoms of
hypoglycemia and thyrotoxicosis may get masked. Assess weight daily, watch
for CHF (rales/crackles, jugular vein distension, weight gain, and edema).
Abrupt withdrawal of drug may exacerbate angina symptoms or precipitate
myocardial infarction in patients with coronary artery disease. Avoid in acute
decompensated heart failure requiring intravenous inotropes. Check for
edema in feet, legs daily. Rise slowly from sitting or lying position to minimize
orthostatic hypotension","• Hypertension: Oral, adult: Initially 12.5 mg once daily for 2 days, then
increased to 25 mg once daily; increased if necessary up to 50 mg daily,
dose to be increased at intervals of at least 2 weeks and can be given as a
single dose or in divided doses daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    • Angina: Oral, adult: initially 12.5 mg once daily, increased after 2 days to 25
mg twice daily.
• Adjunct in heart failure: Oral, adult: initially 3.125 mg twice daily to 6.25
mg twice daily, then to 12.5 mg twice daily then to 25 mg twice daily. Dose
increased at intervals of at least 2 weeks","Allergic skin reactions, angina, AV block, changes in
liver enzymes, depressed mood, disturbances of micturition, influenza-
like symptoms, leucopenia, nasal stuffiness, postural hypotension,
thrombocytopenia, wheezing, headache, dizziness, bradycardia and
impotence","Conduction disturbances increases with calcium
channel blocker. Carvedilol increases the effect of antidiabetic drugs."
METOPROLOL,"Tablets: 50 mg, 100 mg; Injection: 1 mg/ml","Angina, hypertension, arrhythmias, migraine prophylaxis,
hyperthyroidism adjunct, early intervention in myocardial infarction.","Avoid in history of asthma or bronchospasm
(if no alternative, then use with extreme caution and under specialist
supervision), uncontrolled heart failure, prinzemetal angina, bradycardia
(heart rate <50 bpm), hypotension, sick sinus syndrome, second and third
degree atrioventricular block, cardiogenic shock, metabolic acidosis, severe
peripheral arterial disease, pheochromocytoma (unless used with an alpha
blocker). Use caution in patients with first –degree atrioventricular block,
portal hypertension, renal impairment (reduce dose), diabetes mellitus (small
decrease in glucose tolerance, which can mask symptoms of hypoglycemia),
history of hypersensitivity and myasthenia gravis, obstructive airway
disease, portal hypertension, psoriasis. Pregnancy- avoid (IUGR, neonatal
hypoglycemia and bradycardia). Breast feeding: avoid. Monitor lung function
in inadequate cardiac function and bronchospasm disease. Symptoms of
hypoglycemia and thyrotoxicosis may get masked. Assess weight daily, watch
for CHF (rales/crackles, jugular vein distension, weight gain, and edema).
Abrupt withdrawal of drug may exacerbate angina symptoms or precipitate
myocardial infarction in patients with coronary artery disease. Abrupt withdrawal
may cause MI, ventricular arrhythmias, myocardial ischemia; taper dose over
7-14 days.","• Angina: Oral, adult: 50- 100 mg, 2-3 times daily.
• Hypertension: Oral, adult: initially 100 mg daily, maximum dose 400 mg
daily in 1-2 doses.
• Arrhythmias: Oral, adult: 50-100 mg, 2-3 times daily, maximum dose 300
mg daily in divided doses. Intravenous, adult: up to 5 mg at rate 1-2 mg/
minute repeated after 5 minutes if necessary, total dose 10-15 mg.
• Migraine prophylaxis: Oral, adult: 100 -200 mg daily in divided doses.
• Early intervention in myocardial infarction (within 12 hours): Intravenous,
adult: 5 mg every 2 minutes to a maximum dose of 15 mg, followed after 15
minutes by oral 50 mg every 6 hours for 48 hours; maintenance oral 200 mg
daily in divided doses.
• Hyperthyroidism (adjunct): Oral, adult: 50 mg 4 times a day
• In surgery: intravenous 2-4 mg by slow injection to control arrhythmias
developing during anesthesia; 2 mg doses may be repeated, maximum dose
10 mg.
• Oral, child: 1-2 mg/kg/day in 2 divided doses daily. Maximum dose 6 mg/
kg/day up to 200 mg/day
Assess ECG directly when giving IV during initial treatment.","Bradycardia, gastrointestinal disturbances including
nausea, vomiting, diarrhea, constipation, abdominal cramp, fatigue, cold
hands and feet, hypertriglyceridemia.","Avoid with verapamil. Hypotensive effect
increases with diuretics, ACE inhibitors, Angiotensin II receptor antagonist,
calcium channel blocker. Atenolol may enhance bradycardia produced by
cardiac glycosides."
PROPRANOLOL,"Tablet: 10 mg, 20 mg, 40 mg, 80 mg. Injection:
1 mg/ml","Chronic stable angina, hypertension, secondary prevention after
acute myocardial infraction, anxiety, thyrotoxicosis, migraine prophylaxis,
pheochromocytoma (only with alpha blocker), prophylaxis of variceal
bleeding in portal hypertension, hypertrophic obstructive cardiomyopathy,
mitral valve prolapse, essential tremor, child with cyanotic spells or
hypertension or infantile hemangioma","Avoid in history of asthma or bronchospasm
(if no alternative, then use with extreme caution and under specialist
supervision), uncontrolled heart failure, prinzemetal angina, bradycardia
(heart rate <50 bpm), hypotension, sick sinus syndrome, second and third
degree atrioventricular block, cardiogenic shock, metabolic acidosis, severe
peripheral arterial disease, pheochromocytoma (unless used with an alpha
blocker). Use caution in patients with first –degree atrioventricular block,
portal hypertension, renal impairment (reduce dose), diabetes mellitus (small
decrease in glucose tolerance, which can mask symptoms of hypoglycemia),
history of hypersensitivity and myasthenia gravis, obstructive airway
disease, portal hypertension, psoriasis. Pregnancy- avoid (IUGR, neonatal
hypoglycemia and bradycardia). Breast feeding: avoid. Monitor lung function
in inadequate cardiac function and bronchospasm disease. Symptoms of
hypoglycemia and thyrotoxicosis may get masked. Assess weight daily, watch
for CHF (rales/crackles, jugular vein distension, weight gain, and edema).
Abrupt withdrawal of drug may exacerbate angina symptoms or precipitate
myocardial infarction in patients with coronary artery disease. Use caution in
inadequate cardiac function and bronchospastic disease. Reduce oral
dose in renal and hepatic impairment. Pregnancy (C) breast feeding: safety
not established. Do not discontinue abruptly; as dysrhythmia, angina,
myocardial ischemia may occur so taper over at least a few weeks. Symptoms
of hypoglycemia may get masked- monitor blood glucose.","• Hypertension: Oral, adult: initially 80 mg twice daily, increased at weekly
intervals as required; maintenance dose 160-320 mg daily. Oral, child: 1-4
mg/kg/day in 3-4 divided doses.
• Prophylaxis of variceal bleeding in portal hypertension: Oral, adult: initially
40 mg twice daily increased to 80 mg twice daily according to heart rate;
maximum dose 160 mg twice daily.
• Pheochromocytoma (only with an alpha blocker): Oral, adult: 60 mg daily
for 3 days before surgery. 30 mg daily for patients not fit for surgery
• Angina: Oral, adult: initially 40 mg 2-3 time daily; maintenance 120-240 mg
daily.
• Arrhythmias, hypertrophic obstructive cardiomyopathy, anxiety,
tachycardia and thyrotoxicosis (adjunct): Oral, adult: 10-40 mg in 3-4
divided doses daily
• Anxiety (with symptoms such as palpitation, sweating, tremor): Oral, adult:
40 mg once daily; may increase to 40 mg 3 times daily, if necessary.
• Prophylaxis after infraction: Oral, adult: 40 mg 4 times daily for 2-3 days,
then 80 mg twice daily, beginning 5-21 days after infraction.
• Essential tremor: Oral, adult: initially 40 mg 2-3 times daily; maintenance
80-160 mg daily.
• Migraine prophylaxis: Oral, adult: 80-240 daily divided doses.
• Arrhythmias and thyrotoxic crisis: Intravenous injection; 1 mg over 1 minute.
• Cyanotic spells: Child, intravenous: 0.15-0.25 mg/kg/day in 4 divided dose,
not to exceed 1 mg for infants and 3 mg for children. Oral, child: 2-4 mg/kg/
day in 4 divided doses
• Infantile hemangioma: Oral, child: 1-2 mg/kg/day in 3 divided doses","Bradycardia, gastrointestinal disturbances including
nausea, vomiting, diarrhea, constipation, abdominal cramp, fatigue, cold
hands and feet, hypertriglyceridemia. Hallucination, nightmare, sexual
dysfunction.","Avoid with verapamil. Hypotensive effect
increases with diuretics, ACE inhibitors, Angiotensin II receptor antagonist,
calcium channel blocker. Atenolol may enhance bradycardia produced by
cardiac glycosides. Hypersensitivity to
catecholamine during withdrawal"
DILTIAZEM,"Tablet: 30 mg, 60 mg",Angina pectoris,"Avoid in acute porphyria, left ventricular
failure with pulmonary congestion, second- or third-degree AV block (unless
pacemaker fitted), severe bradycardia, sick sinus syndrome. Use caution
bradycardia (avoid if severe), first degree AV block, heart failure, prolonged
PR interval, significantly impaired left ventricular function. Pregnancy: avoid.
Hepatic impairment reduce dose. Renal impairment, start with smaller dose.","• Angina: Oral, adult: Initially 60 mg 3 times a day, adjusted according to
response; maximum 360 mg/day. Elderly: Initially 60 mg twice daily,
adjusted according to response; maximum 360 mg per day
• Oral, child: 1.5-2 mg/kg/day in 3-4 divided doses (maximum dose: < 6mg/
kg/day up to 360 mg/day","Asthenia, AV block, bradycardia, dizziness, gastro-intestinal
disturbances, headache, hot flushes, hypotension, malaise, edema (notably
of ankles), palpitation, Sino-atrial block",
VERAPAMIL,"Verapamil Hydrochloride: Tablet (immediate
release): 40 mg, 80 mg, 240 mg. Solution: 2.5 mg/ml
Verapamil injection should be protected from light.","Angina pectoris, supra ventricular arrhythmias, hypertension,
migraine prophylaxis, supraventricular tachycardia in children","Hypotension, bradycardia, second- and
third-degree heart block, sick sinus syndrome; cardiogenic shock, history
of heart failure , atrial flutter or fibrillation complicating Wolff-Parkinson-
White syndrome, acute porphyria. First-degree atrioventricular block, acute
phase of myocardial infarction (avoid if bradycardia, hypotension, or left
ventricular failure present), hepatic impairment; children (specialist advice
only); Pregnancy and breastfeeding: Avoid use in neonate and young infants.
Not to discontinue abruptly, chest pain may occur.","• Angina, supraventricular arrhythmia: Oral, adult: 40-120 mg 3 times daily
• Hypertension: Oral, adult: 240-480 mg daily in 2- 3 divided doses. By
slow intravenous injection over 2 minutes (3 minutes in elderly), 5 - 10 mg
(preferably with ECG monitoring)
• Paroxysmal tachyarrhythmia: slow intravenous injection, adult: initially
5-10 mg further 5 mg after 5-10 minutes if required over 2 minutes (over 3
minutes in elderly) under ECG monitoring.
• Supraventricular tachycardia: Child, intravenous: 0.1-0.3 mg/kg/dose may
be repeated in 30 min. Maximum first dose 5 mg, and second dose 10 mg
• Supraventricular arrhythmias: slow intravenous injection, adult: 5-10 mg,
over 2 minutes (over 3 minutes in elderly) under ECG monitoring","Constipation; less commonly nausea, vomiting, flushing,
headache, dizziness, fatigue, and ankle edema; rarely allergic reactions
including pruritus, urticaria, angioedema, and erythema multiforme (Stevens-
Johnson syndrome); myalgia, arthralgia, paresthesia, erythromelalgia;
increased prolactin concentration; gynecomastia and gingival hyperplasia
on long-term treatment; hypotension, heart failure, bradycardia, heart block,
and asystole (due to negative inotropic effect) with high doses.",
ADENOSINE,Injection: 6 mg/2 ml vial,"Paroxysmal supraventricular tachycardia (including Wolff-
Parkinson-White syndrome)","Pre-existing second or third degree AV
block, asthma and sick sinus syndrome. Use cautiously in arterial fibrillation
or flutter and heart transplant.","• Rapid intravenous injection into central or large peripheral vein: 3 mg over
2 seconds with cardiac monitoring; if necessary followed by 6 mg after 1-2
minutes and then by 12 mg after a further 1-2 minutes.
• Neonate, intravenous: 0.05 mg/kg over 1-2 sec may increase dose by 0.05
mg/kg every 2 mins. Maximum dose 0.25 mg/kg
• Child, intravenous: 0.1-0.2 mg/kg (initial maximum dose 6 mg) over 1-2 sec.
May increase dose by 0.05mg/kg every 2 mins to maximum of 0.25 mg/kg
Follow each dose with normal saline flush. Assess the cardiopulmonary and
respiratory status.","Chest pain, transient facial flush, bronchospasm,
nausea and severe bradycardia, difficult or labored breathing, chest tightness","Increased risk for higher degree of heart
block: carbamazepine. Increased risk of ventricular fibrillation with digoxin,
verapamil. Increased effects with dipyridamole. Methylxanthines decrease
the activity of adenosine
Patient’s information: Patient should report facial flushing, dizziness,
sweating, palpitations, and chest pain (usually transient)."
AMIODARONE,"Tablet: 100 mg, 200 mg; Solution: 25 mg/ml, 30
mg/ml, 50 mg/ml","Paroxysmal supraventricular, nodal and ventricular tachycardia,
atrial fibrillation or flutter, ventricular arrhythmia (unresponsive to others)
and ventricular fibrillation, all atrial and ventricular tachycardia","Avoid in sinus bradycardia, SA heart block,
Iodine sensitivity, cardiogenic shock, second or third degree AV block, thyroid
dysfunctions, severe hepatic, pneumonitis, pulmonary fibrosis, hypokalemia,
CHF (with inadequate compensation). Pregnancy: risk of neonatal goiter.
Breast feeding: avoid. Clinical monitoring (baseline and every 3 to 6 months)
of serum potassium; chest X-ray, pulmonary function tests (with diffusion
capacity), liver function test and thyroid function tests is recommended.
Toxicity is reversible when managed early.","• Arrhythmias: Oral, adult: 200 mg 3 times daily for 1 week reduced to 200
mg twice daily
• Ventricular fibrillation: intravenous infusion, adult: 300 mg over at least 3
minutes.
• Drug resistant refractory cardiac arrhythmia: Oral, child: < 1 year: 600-
800 mg/1.73m2/day in 1-2 divided dose for 1-14 days. > 1 years: 10-15 mg/
kg/day in 1-2 divided doses for -14 days and/or until adequate control is
achieved, then reduce to 5 mg/kg/day. Child, intravenous: 5 mg/kg over 30
min followed by continuous infusion at the rate of 5 mcg/kg/min. Maximum
dose: 15 mcg/kg/min or 20 mg/kg/day
• Infusion should be diluted in glucose 5%, concentration should not exceed
2 mg/ml.
Marked hypotension on IV administration.","Nausea, vomiting, raised serum transaminases,
bradycardia, ventricular arrhythmia, ventricular fibrillation. Neurologic
dysfunction (dizziness, paresthesia, tremor and involuntary movements, lack
of co-ordination, abnormal gait and ataxia), thyroid dysfunction, pulmonary
toxicity (pneumonitis and fibrosis) on long term use.","Inhibits CYP450 enzymes and may increase
concentrations of Digoxin, Methotrexate, Theophylline, Procainamide.
Increase risk of myopathy with simvastatin. Increased risk of bradycardia with
beta-blockers, calcium channel blockers. Increased risk of QT prolongation
with azoles, fluoroquinolones, macrolides
Patient’s information: Do not discontinue abruptly. Use sunscreen or stay
out of sun to prevent burns, use dark glasses to prevent photophobia. Skin
discoloration is usually reversible"
DIGOXIN,"Injection: 250 mcg/ml in 2-ml ampoule; Oral liquid: 50
mcg/ml; Tablet: 62.5 mcg, 250 mcg","Supraventricular arrhythmias, particularly atrial fibrillation;
heart failure
(considered for selected patients who remain symptomatic despite treatment
with an ACE inhibitor, a diuretic, and a suitable beta-blocker)","Avoid in hypertrophic obstructive
cardiomyopathy (unless also atrial fibrillation and heart failure); Wolff-
Parkinson-White syndrome or other accessory pathway, particularly if
accompanied by atrial fibrillation; ventricular tachycardia or fibrillation;
intermittent complete heart block; second-degree atrioventricular block.
Use caution in recent myocardial infarction; sick sinus syndrome; severe
Pulmonary disease; thyroid disease; the elderly (reduce dose); renal
impairment; avoid hypokalemia; avoid rapid intravenous administration
(nausea and increased risk of arrhythmias); Pregnancy (C) Breastfeeding:
use with caution. Obtain ECG after 6 hours to assess toxicity. Monitor apical
pulse for 1 full minute before administration .Withhold dose if pulse rate is
<60 bpm in an adult, <70 bpm is a child or <90 bpm in an infant. Monitor
blood pressure periodically, monitor ECG throughout IV administration and
6 hrs. after each dose. Therapeutic drug monitoring is advised in patient
receiving digoxin. Take missed doses within 12 hrs. of scheduled dose. Do
not double the dose.
Digoxin has been associated with an increased risk of falls in the elderly, so
patient and family should be advised for monitoring.","• Atrial fibrillation: Oral, adult: initially 1–1.5 mg in divided doses over 24
hours for rapid digitalization (or 250 mcg once or twice daily if digitalization
less urgent) followed by: 62.5–500 mcg daily (higher dose may be divided),
according to renal function and heart rate response; usual maintenance
dose: 125–250 mcg daily (lower dose more appropriate in the elderly).
• Emergency control of atrial fibrillation: intravenous infusion over at least 2
hours, adult: 0.75–1 mg.
NOTE. Infusion dose may need to be reduced if digoxin or other cardiac
glycoside has been given in previous 2 weeks.","Usually only with high doses; gastrointestinal disturbances
including anorexia, nausea, vomiting, diarrhea, and abdominal pain; visual
disturbances, headache, fatigue, drowsiness, confusion, dizziness, delirium,
hallucinations, depression; all arrhythmias except for rapidly conducted
atrial arrhythmias (atrial fibrillation and atrial flutter) and except Mobitz
type II second degree heart block; rarely rash, and intestinal ischemia;
gynecomastia on long-term use; thrombocytopenia reported.","When digoxin is administered with beta
blockers and verapamil, there is increased risk of AV block and bradycardia."
DISOPYRAMIDE,"Capsules: 100 mg, 150 mg; Injection: 10 mg in
5 ml ampoule.","Atrial and ventricular arrhythmias including those resistant to
lignocaine.","Avoid in preexisting second or third degree
AV block, cardiogenic shock, heart failure (can produce severe hypotension
due to negative inotropic properties). Renal or hepatic insufficiency, third
trimester of pregnancy, glaucoma, myasthenia gravis or urinary retention.
Use caution in the elderly and children because they may be more sensitive
to its effects.","Oral (immediate release), adult: 300-800 mg daily in
divided doses. Slow intravenous injection, adult: 2 mg/kg over at least 5
minutes to a maximum of 150 mg with ECG monitoring.
Take disopyramide on a regular schedule around the clock, unless otherwise directed by your doctor. If you miss a dose of disopyramide, take it if you
remember within 4 hours. If it has been more than 4 hours since your missed
dose, skip the missed dose and go back to your regular doses schedule. Do
not take 2 doses at once.","Angle-closure glaucoma, antimuscarinic effects, AV block,
blurred vision, cholestatic jaundice, dry mouth, gastro-intestinal irritation,
hypoglycemia, hypotension, myocardial depression, psychosis, urinary
retention, ventricular tachycardia, ventricular fibrillation or torsade de
pointes (usually associated with prolongation of QRS complex or QT interval).","The effects of disopyramide can increase with
metoprolol and alcohol (minor).
Patient’s information: Do not drive, operate machinery. Do not stop the drug
suddenly."
ISOPRENALINE,Injection: 0.2 mg/ml. Tablet: 20 mg,"Torsade de pointes, bradycardia in patients with heart block,
control attacks of Stokes Adam syndrome.","Preexisting cardiac arrhythmia (especially
tachycardia).","• Intravenous injection, adult: 0.5-10 mcg/minute
• Oral, adult: initially 30 mg every 6hours, range, 90-840 mg daily (but oral
route is rarely used).","Tachycardia, hypotension, arrhythmia, tremor, sweating",
LIDOCAINE/ LIGNOCAINE,Injection: 20 mg/ml in 5 ml ampoule,"Ventricular arrhythmias (especially after myocardial infarction),
local anesthesia","Avoid in Sino atrial nodal disorder, any
grade of atrioventricular block or any other type of conduction disturbances,
severe myocardial depression, acute porphyria or hypovolemia, Wolff-
Parkinson-White syndrome, Stokes Adams syndrome. Lower dosage
in congestive heart failure and following cardiac surgery, bradycardia,
hepatic impairment, severe respiratory depression, the elderly, pregnancy
and breastfeeding, hypothermia, electrolyte imbalance (potassium and
magnesium imbalance). Monitor for ECG","• Ventricular arrhythmias: intravenous injection, adult: loading dose of 50-
100 mg (or 1-1.5 mg/kg) at a rate of 25-50 mg/minute, followed immediately
by intravenous infusion of 1-4 mg/minute, with ECG monitoring of all
patients (reduce infusion dose if required for longer than 24 hours).
• Intravenous, child: 1 mg/kg/dose slow IV, may repeat 10-15 min. Maximum
total dose: 3-5 mg/kg within first hour.
Lidocaine has a short duration of action (15-20 minutes), if the intravenous
infusion cannot be given immediately, the initial intravenous injection of 50-
100 mg can be repeated once or twice at intervals of not less than 10 minutes.","Flushing or redness, dizziness, paresthesia, itching,
drowsiness, confusion, apnea, respiratory depression, coma, seizure and
convulsions, hypotension, arrhythmia, heart block, cardiovascular collapse,
bradycardia (may lead to cardiac arrest), nystagmus (often an early sign of
lidocaine overdose).","Increased cardiac depression and toxicity with
amiodarone, phenytoin, procainamide, propranolol. Increased neuromuscular
blockade with neuromuscular blockers. Increased hypotensive effects with
MAO inhibitors, antihypertensive. Increased effects of lorazepam (additive
CNS depressants) and alprazolam effects (increase CNS side effects)"
PROCAINAMIDE,"Solution: 100 mg /ml in 10 ml ampoule; tablet:
250 mg","Severe ventricular arrhythmias (especially those resistant to
lidocaine or those appearing after myocardial infarction); atrial tachycardia,
atrial fibrillation; maintenance of sinus rhythm after cardioversion of atrial
fibrillation.","Avoid in Torsade’s de pointes, SLE, 2nd and
3rd degree heart block, heart failure, hypotension, elderly, renal impairment,
hepatic impairment, asthma, myasthenia gravis, pregnancy, breastfeeding,
electrolyte imbalance (hyperkalemia, hypokalemia, magnesium disorders).
Discontinue treatment in case of drop in leukocyte and platelet count.
Perform complete blood count twice a week for 3 months.","• Oral, adult:, up to 50 mg/kg daily in divided doses every 3-6 hours, preferably
controlled by monitoring plasma-procainamide concentration (therapeutic
concentration usually within 3-10 mcg/ml); in atrial arrhythmia, higher
doses may be required.
• Slow intravenous injection, adult: rate not exceeding 50 mg/minute, 100
mg repeated at 5 minute intervals until arrhythmia controlled; maximum 1g.
• Intravenous infusion, adult: 500-600 mg over 25-30 minutes, followed
by maintenance at rate of 2-6 mg/minute, then if necessary oral anti-
arrhythmic treatment as above, starting 3-4 hours after infusion.
When using IV, monitor continuously by ECG.","Nausea, vomiting, diarrhea, anorexia, rash, pruritus,
urticarial, flushing, fever, myocardial depression, heart failure, angioedema,
depression, dizziness, psychosis; blood disorders including leukopenia,
hemolytic anemia and agranulocytosis after prolonged treatment, SLE like
syndrome, high plasma procainamide concentration may impair cardiac
conduction.
Patient’s information: A wax matrix may appear in stools. Do not discontinue
without prescriber’s approval. Notify prescriber if lupus-like symptoms
appear, leucopenia (sore mouth, gums, and throat) or thrombocytopenia,
bleeding, bruising). Avoid driving until product effect is known",
CAPTOPRIL,"Tablet: 25 mg, 50 mg","Mild to moderate essential hypertension, adjunctive treatment
in congestive heart failure, severe hypertension resistant to other treatment,
following myocardial infraction, diabetic nephropathy in insulin dependent
diabetes.","Avoid in bilateral renal artery stenosis,
pregnancy, hyperkalemia, pre-existing cough. Use caution in severe or
symptomatic aortic stenosis. Monitor renal function before and during
treatment.","Hypertension: Oral, adult: initially 5 mg once daily, lower
initial dose if used in addition to diuretic or in renal impairment; usual
maintenance dose 20 mg once daily; maximum 40 mg once daily. Take 1-2
hours after meals.","alopecia, rash, profound hypotension (usually with first
dose, especially in patients taking high dose of diuretics on low sodium
diet, dehydration, taste impairment, leucopenia, proteinuria, persistent dry
cough, sleep disorder, dyspnea, pallor, neutropenia, Raynaud’s syndrome.","With potassium sparing diuretics hyperkalemia
may result especially in existing renal impairment. With alcohol, alpha
blocker, general anesthetic, angiotensin 2 receptor antagonist, beta blocker,
calcium channel blocker, hypotensive effect is increased.
Patient’s information: Avoid activities that require concentration, the person
may feel dizziness, fainting, and light headedness. Not to discontinue
product abruptly, if dose is missed, take as soon as remembered but do not
double the doses. Rise slowly to sitting or standing position to minimize
orthostatic hypotension"
ENALAPRIL,"Tablets: 2.5 mg, 5 mg, 10 mg","Hypertension, heart failure","Avoid in bilateral renal artery stenosis,
pregnancy, hyperkalemia, pre-existing cough. Use caution in severe or
symptomatic aortic stenosis. Monitor renal function before and during
treatment. Avoid in renal
impairment when GFR < 30 ml/1.73m2/min. use cautious in impaired liver
function and neonates. Monitor renal function.","• Hypertension: Oral, adult: 5 mg once daily, if used in addition to diuretic or
in renal impairment or in elderly patient, 2.5 mg daily initially, maintenance
dose 20 mg once daily: maximum 40 mg once daily. Oral, child: 0.1- 0.6 mg/
kg/day in 1-2 divided doses. Maximum dose 40 mg/day","Dizziness, headache, nausea, diarrhea, dry cough,
fatigue, asthenia, angioedema, urticaria, rashes, hyperkalemia, impaired
perspiration","With potassium sparing diuretics hyperkalemia
may result especially in existing renal impairment. With alcohol, alpha
blocker, general anesthetic, angiotensin 2 receptor antagonist, beta blocker,
calcium channel blocker, hypotensive effect is increased.
Patient’s information: Avoid activities that require concentration, the person
may feel dizziness, fainting, and light headedness. Not to discontinue
product abruptly, if dose is missed, take as soon as remembered but do not
double the doses. Rise slowly to sitting or standing position to minimize
orthostatic hypotension.  Patient’s information: Avoid activities requiring coordination, the drug may
cause skin rash, or angioedema. Discontinue if angioedema occurs. Patient’s information: Avoid activities requiring coordination, the drug may
cause skin rash, or angioedema. Discontinue if angioedema occurs."
LISINOPRIL,"Tablets: 2.5 mg, 5 mg, 10 mg, 20 mg","Essential and renovascular hypertension, adjunctive treatment
in congestive heart failure, following myocardial infarction in hemodynamically
stable patients, diabetic nephropathy in normotensive insulin-dependent
and hypertensive non-insulin dependent diabetes mellitus.","Avoid in pregnancy, hereditary
angioedema, breast-feeding. Avoid in bilateral renal artery stenosis,
pregnancy, hyperkalemia, pre-existing cough. Use caution in severe or
symptomatic aortic stenosis. Monitor renal function before and during
treatment.","• Hypertension: initially 10 mg daily, if used in addition to diuretic or in
patient with renal impairment, initially 2.5-5 mg daily; usual maintenance
dose 20 mg once daily( maximum 80 mg daily).
• Heart failure (adjunct): Oral, adult: initially 2.5 mg daily; usual maintenance
dose 5-20 mg daily.
• Diabetic nephropathy: Oral, adult: initially 2.5 mg daily adjusted to achieve
diastolic blood pressure below 75 mm Hg in normotensive insulin dependent
diabetes and below 90 mm Hg in hypertensive non-insulin dependent
diabetes; usual dose range 10-20 mg daily.
• Prophylaxis after myocardial infarction: Oral, adult: 5 mg within 24 hours if
systolic blood pressure over 120 mm Hg, followed by further 5 mg 24 hours
later, then 10 mg after a further 24 hours, and continuing with 10 mg once
daily for 6 weeks; if systolic blood pressure 100-120 mm Hg, initially 2.5 mg,
increasing to maintenance dose of 5 mg once daily.","Profound hypotension, hyperkalemia, rash, tachycardia,
myocardial infarction, sweating, impotence, dizziness, upper respiratory tract
infection, fatigue, diarrhea.
Patient’s information: Drink plenty of water each day while taking the
medication. Avoid potassium rich diet.",
RAMIPRIL,"Tablets/Capsules: 1.25 mg, 2.5 mg, 5 mg, 10 mg","Hypertension, congestive heart failure, prophylaxis after
myocardial infarction, prophylaxis of cardiovascular events or stroke.","Avoid in pregnancy, hereditary
angioedema, breast-feeding. Avoid in bilateral renal artery stenosis,
pregnancy, hyperkalemia, pre-existing cough. Use caution in severe or
symptomatic aortic stenosis. Monitor renal function before and during
treatment.","• Hypertension: Oral, adult: initially 1.25 mg once daily, increased at intervals
of 1-2 weeks; usual range 2.5-5 mg once daily; maximum 10 mg once daily.
• Congestive heart failure (adjunct): Oral, adult: initially 1.25 mg once daily
under close medical supervision, increased if necessary at intervals of 1-2
weeks; maximum 10 mg daily.
• Prophylaxis after myocardial infarction: Oral, adult: initially 2.5 mg twice
daily, increased after 2 days to 5 mg twice daily; maintenance 2.5-5 mg
twice daily.
• Prophylaxis of cardiovascular events or stroke: initially 2.5 mg once daily,
increased after 1 week to 5 mg once daily, then increased after a further 3
weeks to 10 mg once daily.","Dizziness, headache, nausea, diarrhea, dry cough,
fatigue, asthenia, angioedema, urticaria, rashes, hyperkalemia, impaired
perspiration",
IRBESARTAN,"Tablet: 75 mg, 150 mg","Hypertension, hypertension in patients receiving hemodialysis,
renal disease in hypertensive with type 2 diabetes mellitus","Avoid in renal artery stenosis, moderate to
severe renal impairment or liver impairment, aortic or mitral valve stenosis.","• Hypertension: Oral, adult (18–74 years): Initially 150 mg once daily,
increased if necessary to 300 mg once daily.
• Hypertension: Oral, adult (>75 years): Initially 75–150 mg once daily,
increased if necessary to 300 mg once daily.
• Hypertension in patients receiving hemodialysis: Oral, adult: Initially 75–
150 mg once daily, increased if necessary to 300 mg once daily.
• Renal disease in hypertensive type 2 diabetes mellitus: Oral, adult (18–74
years): Initially 150 mg once daily, increased if tolerated to 300 mg once
daily.
• Renal disease in hypertensive type 2 diabetes mellitus: Oral, adult (>75
years): Initially 75–150 mg once daily, increased if tolerated to 300 mg once
daily","Fatigue, musculoskeletal pain, nausea, vomiting",
LOSARTAN,"Tablet: 25 mg, 50 mg","Hypertension, congestive heart failure, diabetic nephropathy in
type 2 diabetes mellitus","Avoid in pregnancy and breast feeding,
children of 6 years or younger, CHF, renal impairment (GFR < 30 ml/
min/1.73m2, renal artery stenosis. Use caution in moderate to severe renal
impairment or liver impairment, aortic or mitral valve stenosis.","• Hypertension: Oral, adult: 50 mg (in intravascular volume depletion initially/
elderly >75 years: initially 25 mg) once daily for several weeks, then increase
up to 150 mg in weekly interval if necessary and tolerated. Oral, Child: 0.75
mg/kg/dose once daily up to 50 mg/day. Maximum dose: 1.4 mg/kg/day or
100 mg/day
• Diabetic nephropathy in DM type II: Oral, adult: initially 50 mg (elderly >75
years: 25 mg) once daily for several weeks then increase up to 100 mg in
weekly interval if necessary and tolerated.
• CHF with ACE inhibitors unsuitable or contraindicated: Oral, adult: Initially
12.5 mg once daily, increase if tolerated to up to 150 mg once daily, to be
increased daily.","Hypotension, dizziness, diarrhea, pruritus, rash, taste
disturbance, thrombocytopenia, photosensitivity","With lithium, increases lithium toxicity. With
hypertensive agents, increases antihypertensive effect. Avoid use in Aliskiren.
Patient’s information: Rise slowly to sitting or standing position to minimize
orthostatic hypotension. Avoid sunlight, salt substitutes, alcohol, over the
counter products unless approved by prescriber."
TELMISARTAN,"Tablet: 20 mg, 40 mg, 80 mg","Hypertension, prevention of cardiovascular events in patients
with established atherosclerotic cardiovascular disease or type 2 diabetes
mellitus with target-organ damage.","Avoid in bilateral renal artery stenosis, pregnancy and
breast feeding, in severe impairment or biliary obstruction.","• Hypertension: Oral, adult: Initially 20–40 mg once daily for at least 4 weeks,
increased if necessary up to 80 mg once daily
• Prevention of cardiovascular events in patients with established
atherosclerotic cardiovascular disease or type 2 diabetes mellitus with
target-organ damage: Oral, adult: 80 mg once daily
• Severe renal impairment: Oral, adult: Initial dose of 20 mg once daily.","Arthralgia, back pain, chest pain, eczema, gastro-intestinal
disturbances, influenza like symptoms, leg cramps, myalgia, pharyngitis,
sinusitis, urinary-tract infection, abnormal vision, anxiety, dry mouth,
increased sweating, tendonitis- like symptoms, vertigo","Avoid use with ACE inhibitor, aspirin, acebutolol,
aceclofenac, amiloride, atenolol, chlorthiazide, digoxin, enoxaparin,
furosemide, ibuprofen, insulin, irbesartan, ketorolac, piroxicam, potassium
chloride, spironolactone, sulfasalazine, torsemide, trimethoprim."
VALSARTAN,"Tablet: 40 mg, 80 mg, 160 mg","Hypertension, myocardial infarction with left ventricular failure
or left ventricular systolic dysfunction.","Avoid in pregnancy and breast feeding,
children of 6 years or younger, CHF, renal impairment (GFR < 30 ml/
min/1.73m2, renal artery stenosis. Use caution in moderate to severe renal
impairment or liver impairment, aortic or mitral valve stenosis. Avoid in biliary
cirrhosis, cholestasis, severe hepatic impairment, renal impairment when
eGFR <10 ml/min/ 1.73m2. Use caution in mild to moderate renal and hepatic
impairment.","• Hypertension: Oral, adult: 80 mg once daily (initially 40 mg once daily in
intravascular volume depletion); if necessary increased after at least 4
weeks to 160 mg daily.
• Myocardial infarction: Oral, adult: initially 20 mg twice daily increased over
several weeks to 160 mg twice daily if tolerated.
• Mild to moderate hepatic impairment: maximum dose of 80 mg daily.
Take medicine before meal.","Hypotension, dizziness, diarrhea, pruritus, rash, taste
disturbance, thrombocytopenia, photosensitivity",Food interferes with absorption.
LABETALOL,"Tablet: 100 mg, 200 mg; Solution: 100 mg/20ml","Hypertension, Hypertensive emergencies, hypertension
following myocardial infarction, hypertension of pregnancy","Avoid in severe liver damage. Hepatic
impairment: avoid as reported. Renal impairment: Dose reduction may be
required. Pregnancy: possibly harmful in the first trimester. If labetalol used
close to delivery, monitor infants for signs of alpha-blockade (as well as beta
blockade). Breast feeding: monitor infants for possible toxicity due to alpha-
blockade (in addition to beta-blockade. Laboratory testing needed at first
symptom of liver dysfunction and if laboratory evidence of damage (or if
jaundice) labetalol should be stopped and not restarted. Avoid in history of asthma or bronchospasm
(if no alternative, then use with extreme caution and under specialist
supervision), uncontrolled heart failure, prinzemetal angina, bradycardia
(heart rate <50 bpm), hypotension, sick sinus syndrome, second and third
degree atrioventricular block, cardiogenic shock, metabolic acidosis, severe
peripheral arterial disease, pheochromocytoma (unless used with an alpha
blocker). Use caution in patients with first –degree atrioventricular block,
portal hypertension, renal impairment (reduce dose), diabetes mellitus (small
decrease in glucose tolerance, which can mask symptoms of hypoglycemia),
history of hypersensitivity and myasthenia gravis, obstructive airway
disease, portal hypertension, psoriasis. Pregnancy- avoid (IUGR, neonatal
hypoglycemia and bradycardia). Breast feeding: avoid. Monitor lung function
in inadequate cardiac function and bronchospasm disease. Symptoms of
hypoglycemia and thyrotoxicosis may get masked. Assess weight daily, watch
for CHF (rales/crackles, jugular vein distension, weight gain, and edema).
Abrupt withdrawal of drug may exacerbate angina symptoms or precipitate
myocardial infarction in patients with coronary artery disease.","• Hypertension: Oral, adult: Initially 100 mg (50 mg for elderly) twice daily,
dose to be increased at intervals of 14 days; usual dose 200 mg twice daily,
increased if necessary up to 800 mg daily in 2 divided doses, higher doses
to be given in 3–4 divided doses; maximum 2.4 g per day. To be taken with
food
• Hypertension/ hypertensive emergencies: Intravenous injection: adult: 50
mg, administer over at least 1 minute, then 50 mg after 5 minutes if required;
maximum 200 mg per course.
• Hypertension/ hypertensive emergencies: Intravenous infusion: adult:
Initially 2 mg/minute until a satisfactory response is achieved, then
discontinue; usual dose 50–200 mg
• Hypertension following myocardial infarction: Intravenous Infusion, adult:
15 mg/hour, maximum dose 120 mg/hour, dose to be increased gradually.
• Hypertension of pregnancy: Intravenous infusion, adult: Initially 20 mg/
hour, then increased if necessary to 40 mg/hour after 30 minutes, then
increased if necessary to 80 mg/hour after 30 minutes, then increased
if necessary to 160 mg/hour after 30 minutes, adjusted according to
response. Maximum 160 mg/hour.
• Hypertension: Oral, child: 4 mg/kg/day in 2 divided doses. Maximum dose
up to 40 mg/kg/day.
• Hypertensive emergencies: Child, intravenous: 0.2-1.0 mg/kg/dose every 10
min as required. Maximum dose: 20 mg/dose
• Hypertensive emergencies: Child, infusion: 0.4-1.0 mg/kg/hr. Maximum
dose 3mg/kg/hr.","Difficulty in micturition, epigastric pain, liver damage,
nausea, postural hypotension, vomiting, weakness, severe hepatocellular
injury (with short or long term use)","Interferes with laboratory tests for
catecholamine. Concurrent use of digitalis increases the risk of bradycardia
Patient’s information: For oral formulation, take medicine after food. Patient
should remain supine up to 3 hrs. after intravenous administration."
NEBIVOLOL,"Tablets: 2.5 mg, 5 mg","Essential hypertension, hypertension in patient with renal
impairment, adjunct in stable mild to moderate heart failure","Avoid in acute or decompensated heart failure requiring intravenous
inotropes, decompensated heart failure, severe hepatic impairment (Child-
Pugh class C). Pregnancy (C). Breast feeding: avoid. Renal impairment: avoid
in heart failure if serum creatinine greater than 250 micromole/liter. Avoid in history of asthma or bronchospasm
(if no alternative, then use with extreme caution and under specialist
supervision), uncontrolled heart failure, prinzemetal angina, bradycardia
(heart rate <50 bpm), hypotension, sick sinus syndrome, second and third
degree atrioventricular block, cardiogenic shock, metabolic acidosis, severe
peripheral arterial disease, pheochromocytoma (unless used with an alpha
blocker). Use caution in patients with first –degree atrioventricular block,
portal hypertension, renal impairment (reduce dose), diabetes mellitus (small
decrease in glucose tolerance, which can mask symptoms of hypoglycemia),
history of hypersensitivity and myasthenia gravis, obstructive airway
disease, portal hypertension, psoriasis. Pregnancy- avoid (IUGR, neonatal
hypoglycemia and bradycardia). Breast feeding: avoid. Monitor lung function
in inadequate cardiac function and bronchospasm disease. Symptoms of
hypoglycemia and thyrotoxicosis may get masked. Assess weight daily, watch
for CHF (rales/crackles, jugular vein distension, weight gain, and edema).
Abrupt withdrawal of drug may exacerbate angina symptoms or precipitate
myocardial infarction in patients with coronary artery disease.","• Essential hypertension: Oral, adult: 5 mg daily; elderly: Initially 2.5 mg daily,
then increased if necessary to 5 mg daily
• Hypertension in patient with renal impairment: Oral, adult: Initially 2.5 mg
once daily, then increased if necessary to 5 mg once daily.
• Adjunct in stable mild to moderate heart failure: Oral, elderly (≥ 70 years):
Initially 1.25 mg once daily for 1–2 weeks, then increased if tolerated to 2.5
mg once daily for 1–2 weeks, then increased if tolerated to 5 mg once daily
for 1–2 weeks, then increased if tolerated to 10 mg once daily.","Bradycardia, gastrointestinal disturbances including
nausea, vomiting, diarrhea, constipation, abdominal cramp, fatigue, cold
hands and feet, hypertriglyceridemia.",
AMLODIPINE,"Tablet: 2.5 mg, 5 mg, 10 mg","Hypertension, angina pectoris","Cardiogenic shock, unstable angina,
significant aortic stenosis. In hepatic impairment: dose reduction. Try to
avoid large amount of alcohol. Pregnancy and breastfeeding: avoid.","• Hypertension or angina: Oral, adult: initially 5 mg once daily; maximum
dose 10 mg once daily.
• Oral, child: 0.1-0.6 mg/kg/day in 1-2 divided doses. Maximum dose: 20 mg/
day","Abdominal pain, nausea, flushing, edema (ankle edema),
headache, dizziness, sleep disturbances, fatigue, alopecia, arthralgia,
asthenia, back pain, dry mouth, dyspnea, impotence, gynecomastia, myalgia,
muscle cramp, skin discoloration.",
FELODIPINE,"Tablet: 2.5 mg, 10 mg","Angina, hypertension","Avoid in Cardiac outflow obstruction, aortic
stenosis uncontrolled heart failure, unstable angina, within 1 month of
myocardial infarction. Predisposition to tachycardia, severe left ventricular
dysfunction, withdraw if cardiogenic shock develops, if ischemic pain occurs
shortly after initiating treatment. Pregnancy- avoid. Breast feeding- safe. In
hepatic impairment, reduce dose.","• Angina: Oral, adult: 5 mg/day, maximum dose 10 mg/day. Oral, elderly: 2.5
mg/day, maximum dose 10 mg/day.
• Hypertension: initially 5 mg (elderly 2.5 mg) daily in the morning; usual
maintenance dose 5-10 mg once daily.","flushing, headache, peripheral edema.",
NIFEDIPINE,"Capsule: 5 mg, 10 mg; Tablet: 30 mg","prophylaxis of angina, hypertension, Raynaud’s phenomenon,
pulmonary hypertension.","Avoid in congestive heart failure or aortic
stenosis, especially in those receiving concomitant beta blocking agents. In
patients with angina, the drug may cause increased angina. Pregnancy (D)","• Hypertension and angina prophylaxis: Oral, adult: 20 mg twice daily. Usual
maintenance 10-40 mg twice daily.
• Raynaud’s phenomenon: Oral, adult: initially 5 mg 3 times daily with or after
food; usual maintenance 5-20 mg 3 times daily.
• Pulmonary hypertension: Oral, adult: 120 to 240 mg once daily dose.
• Hypertension: Child, sublingual: 0.25-0.5 mg/kg/dose may be repeated 6
hourly. Maximum dose 10 mg/dose.
• Hypertension: Child, sustained release tablet: 0.25-3 mg/kg/day in 1-2
divided dose. Maximum dose 120 mg/day
To be taken with or after food.","dizziness, giddiness, flushing, light headedness, peripheral
edema and palpitation.",
CLONIDINE,"Tablet: 25 mcg, 100 mcg.","Hypertension, prevention of recurrent migraine, prevention
of vascular headache, treatment for acute withdrawal in opioid dependent
patients.","Avoid in severe bradyarrhythmia secondary
to second- or third-degree AV block or sick sinus syndrome. Use caution in
cerebrovascular disease, constipation, heart failure, history of depression,
mild to moderate bradyarrhythmia, polyneuropathy, Raynaud’s syndrome
or other occlusive peripheral vascular disease. In hypertension, must be
withdrawn gradually to avoid severe rebound hypertension. Pregnancy: use
caution, may lower fetal heart rate. Breast feeding: avoid. Renal impairment:
Use with caution in severe impairment, reduce initial dose and increase
gradually.","• Hypertension: Oral, adult: Initially 50–100 mcg 3 times a day, increase
initial dose every second or third day, usual maximum dose 1.2 mg daily
• Prevention of recurrent migraine/Prevention of vascular headache: Oral,
adult: Initially 50 micrograms twice daily for 2 weeks, then increased if
necessary to 75 micrograms twice daily
• Treatment for acute withdrawal in opioid dependent patients: Oral, adult:
0.1-0.3 mg every 4-6 hours; increase by 0.1 mg/day; 0.15-0.75 mg/day if
required; do not exceed 2.4 mg/day","Constipation, depression, dizziness, drowsiness, dry mouth,
headache, malaise, nausea, postural hypotension, salivary gland pain,
sexual dysfunction, sleep disturbances, vomiting. Uncommon: bradycardia,
delusion, hallucination, paresthesia, pruritus, rash, Raynaud’s syndrome,
urticarial","concomitant use of alcohol may enhance effects
of alcohol
Patient’s information: Drowsiness may affect performance of skilled tasks
(e.g. driving)"
HYDRALAZINE HYDROCHLORIDE,"Powder for injection: 20 mg in ampoule; Tablet:
25 mg, 50 mg","Moderate and severe hypertension (adjunct), hypertensive
emergencies in pregnant (not a first line agent), hypertension with renal
complication and children","Avoid in severe tachycardia, high output
heart failure, myocardial insufficiency due to mechanical obstruction,
corpulmonale, dissecting aortic aneurysm, porphyria, idiopathic systemic
lupus erythematosus. Use caution in hepatic impairment, renal impairment,
coronary artery disease (may provoke angina, avoid after myocardial
infraction), pregnancy, elderly, cerebrovascular disease. Complete blood
count, LE cell preparation, antinuclear antibody should be performed
before and periodically during prolonged hydralazine therapy. Intravenous
hydralazine is not advisable in older patients, hypertensive patient with
coronary artery disease or cardiovascular risk factors. Monitor blood
glucose regularly in diabetics.","• Mild or moderate hypertension (as adjunct): Oral, adult: 25 mg twice daily,
increased to a maximum of 50 mg twice daily.
• Hypertensive emergencies (including pregnancy/ hypertension with renal
complications): intravenous infusion, adult: initially 200-300 mcg/minute,
maintenance usually 50-150 mcg/minute. Slow intravenous injection, adult:
5-10 mg, to be diluted with 10 ml of 0.9% saline, dose may be repeated
after 20-30 min.
• Hypertension: Oral, child: 0.75-1.0 mg/kg/day in 2-4 divided doses.
Maximum dose: 25 mg/dose. May increase to infants: 5mg/kg/day-,
Children: 7.5 mg/kg/day or 200mg/day
• Hypertension: Child, intravenous or intramuscular: Hypertensive crisis: 0.1-
0.2 mg/kg/dose every 4-6 hours. Maximum dose: 20 mg/dose. Usual IV/IM
dose: 1.7-3.5 mg/kg/day","Tachycardia, palpitation, hypotension, nausea, vomiting,
systemic lupus erythematosus like syndrome, weight gain and headache,
muscle weakness, cramps, dizziness. Patients who are slow acetylator of
hydralazine may have high risk of developing SLE.","With diuretic or other antihypertensives, the
hypotensive effect increases.
Patient’s information: Take drug early in day to avoid nocturia. Rise slowly
from sitting or lying position."
METHYLDOPA,Tablet: 250 mg,"Hypertension, hypertension in pregnancy","Avoid in acute porphyria, depression,
pheochromocytoma. Use cautiously in patients with history of liver disease and
renal impairment, Sino atrial dysfunction; May precipitate severe bradycardia
and sinus arrest. Screening for hepatotoxicity (e.g. with determination of
gamma-glutamyl transpeptidase or alanine aminotransferase) at 3 weeks
then at 3 months following initiation of treatment. Coomb’s test may be
positive in up to 30% of patients, but discontinue only if hemolysis develops.
Pregnancy and breast feeding: safe.","Hypertension, Hypertension in pregnancy: Oral, adult:
250 mg, 2-3 times a day. Single dose administration at bedtime minimizes
sedative effect but it is not sufficient for some patients, dose can be gradually
increased up to 3 g daily (maximum).
Protect the medication from light. Oral, elderly: initially 125 mg twice daily,
increase gradually up to maximum dose of 2 gm daily.","Sedation, dryness of mouth, decreased libido, parkinsonian
signs, hyperprolactinemia, gynecomastia, hepatitis and hepatotoxicity,
hemolytic anemia, leucopenia, lupus like syndrome, myocarditis,
retroperitoneal fibrosis, pancreatitis, malabsorbtion, diarrhea, amenorrhea,
Bell’s palsy, bone marrow depression, depression, eosinophilia, drug fever,
nasal congestion, nightmares, sialadenitis, toxic epidermal necrolysis.",
PRAZOSIN,"Tablet: 1 mg, 2.5 mg, 5 mg","Hypertension, benign prostatic hyperplasia.","Avoid in history of micturition syncope and
postural hypotension, congestive heart failure due to mechanical obstruction
(e.g. aortic stenosis). Use caution cataract surgery (risk of intra-operative
floppy iris syndrome), elderly, renal or hepatic impairment. Pregnancy (C),
Breast feeding: use caution.","• Hypertension: Oral, adult: 500 mcg 2-3 times daily for 3-7 days, the initial
dose on retiring to bed at night; increased to 1 mg 2-3 times daily for further
3-7 days then increased if necessary. Maximum dose 20 mg daily in divided
doses
• Benign prostatic hyperplasia: Oral, adult: Initially 500 mcg twice daily for
3–7 days, subsequent doses should be adjusted according to response,
maintenance 2 mg twice daily, initiate with lowest possible dose in elderly
patients.","Postural hypotension, dizziness, headache, palpitation,
nervousness, drowsiness, priapism, blurred vision, depression, dry
mouth, dyspnea, gastrointestinal disturbances, nasal congestion, edema,
palpitations, syncope, urinary frequency, vertigo, weakness.","Concomitant use with diuretics or other
antihypertensive drug may cause an additive hypertensive effect.
Patient’s information: First dose may cause collapse due to hypotension, take
first dose at bedtime; do not to drive/operate machine for 4 hr. after first
dose."
SODIUM NITROPRUSSIDE,Intravenous solution: 10 mg/ml,"Hypertensive crisis, controlled hypotension in anesthesia, acute
or chronic heart failure.","Severe hepatic impairment, compensatory
hypertension, severe vitamin B12 deficiency, Leber optic atrophy. Elderly,
hyponatremia, hypothermia, hypothyroidism, impaired cerebral circulation,
ischemic heart disease. Impaired pulmonary function; hypothyroidism;
renal impairment, ischemic heart disease, impaired cerebral circulation;
hyponatremia; raised intracranial pressure; Monitor blood pressure and
blood cyanide concentration; monitor blood. Thiocyanate concentration
if given for more than 3 days; avoid sudden withdrawal (reduce infusion
over 15–30 minutes to avoid rebound effects); Pregnancy: Avoid prolonged
use, potential for accumulation of cyanide in fetus. Breast feeding: safety
information not available. Caution advised due to thiocyanate metabolite.","• Hypertensive crisis: Intravenous infusion, adult: initially 0.5–1.5 mcg/
kg/minute, increased gradually to 0.5–6 mcg/kg/minute; (lower doses in
patients already being treated with antihypertensives); maximum, 8 mcg/
kg/minute. Stop infusion, if response is unsatisfactory after 10 minutes at
the maximum dose.
• Heart failure: 10- 15 mcg /minute, increased every 5-10 minutes as
necessary, usual range10-200 mcg/minute.","severe hypotension; associated with over-rapid. Reduction
in blood pressure include headache, dizziness; retrosternal discomfort,
nausea, retching, abdominal pain; perspiration; palpitations, anxiety,
perspiration; rarely reduced platelet count, and acute transient phlebitis.",
TAMSULOSIN,Capsule: 400 mg.,Benign prostatic hyperplasia,"Avoid in micturition syncope, postural
hypotension, severe liver impairment. Use caution if eGFR <10 ml/min/1.73m2.
Dosage schedule: Oral, adult: 400 mcg daily as once daily.","Oral, adult: 400 mcg daily as once daily.","Postural hypotension, dizziness, headache, palpitation,
drowsiness, priapism, pruritus, angioedema, asthenia, blurred vision,
rash, rhinitis, tachycardia, depression, intraoperative floppy iris syndrome,
gastrointestinal disturbances.
Patient’s information: Do not drive, use machinery, or do any activity that
requires alertness until you are sure you can perform such activities safely.
Not to crush, break, chew on oral intake.",
TERAZOSIN,"Tablet: 1 mg, 2 mg, 5 mg.","Benign prostatic hyperplasia (BPH), mild to moderate
hypertension","Avoid in history of micturition syncope and
postural hypotension, congestive heart failure due to mechanical obstruction
(e.g. aortic stenosis). Use caution cataract surgery (risk of intra-operative
floppy iris syndrome), elderly, renal or hepatic impairment. Pregnancy (C),
Breast feeding: use caution.","• Hypertension (mild to moderate): Oral, adult: Initially 1 mg once daily at
bedtime, dose doubled after 7 days if necessary, usual maintenance dose
2-10 mg according to response.
• BPH: Oral, adult: Initially 1 mg orally once daily at a bedtime. If necessary
dose may be doubled at intervals of 1-2 weeks according to response,
maintenance 5–10 mg daily; maximum 10 mg per day.","Postural hypotension and syncope (especially on the start
of therapy), dizziness, drowsiness, dry mouth, chest pain, pedal edema,
palpitation, headache, priapism, thrombocytopenia, decreased libido,
erectile disorders, weight gain, dyspnea, Angioedema, pain in extremities,
blurred vision","With Metoprolol causes additive hypotensive
effect"
PHENYLEPHRINE,Solution: 10 mg/ml,"Acute hypotension, Priapism","Avoid in hypertension, severe hyperthyroidism.
Hypertensive response of Phenylephrine has a longer duration of action than
noradrenaline (norepinephrine) and an excessive vasopressor response may
cause a prolonged rise in blood pressure. Pregnancy: avoid","• Acute hypotension: subcutaneous injection/ intramuscular injection, adult:
Initially 2–5 mg, followed by 1–10 mg, after at least 15 minutes, if required.
Slow intravenous injection, adult: 100–500 mcg, repeated as necessary
after at least 15 minutes; 1 mg/ ml solution to be used. Intravenous infusion,
adult: Initially up to 180 mcg /minute, reduced to 30–60 mcg/min, adjusted
according to response. Intravenous infusion give intermittently in Glucose
5% or Sodium chloride 0.9%. Dilute 10 mg in 500 mL infusion fluid.
• Priapism: Intracavernosal injection, adult: 100–200 mcg every 5–10 minutes;
maximum 1 mg per course. For intracavernosal injection, if suitable strength
of phenylephrine injection is not available, it may be specially prepared by
diluting 0.1 mL of the phenylephrine 1% (10 mg/mL) injection to 5 mL with
sodium chloride 0.9%.","Arrhythmias, hypertension, palpitation, tachycardia, angle-
closure glaucoma, anorexia, anxiety, bradycardia (also reflex bradycardia),
confusion, dyspnea, headache, hypoxia, insomnia, nausea, peripheral
ischemia, psychosis, tremor, urinary retention, vomiting, weakness",
DOBUTAMINE,Injection solution: 12.5 mg/ml in 20 ml vial.,"Inotropic support in infarction, cardiac surgery, septic shock,
cardiogenic shock and during positive end expiratory pressure ventilation.","Avoid
in
hypersensitivity,
pheochromocytoma. Use caution in severe hypotension, complicating
cardiogenic shock, heart failure.","Intravenous infusion, adult: 2.5-10 mcg/kg/minute,
adjusted according to response, alternatively 0.5-40 mcg/kg/min","Tachycardia, increase in systolic blood pressure, phlebitis.
Extravasation of the drug causes tissue necrosis","Additive (synergistic) effective with
Nitroprusside. Atenolol may negate the effect of dopamine. Do not mix with
sodium bicarbonate, furosemide and other alkaline solutions."
DOPAMINE,"Injection: 40 mg/ml in 5ml, 10ml vial.","Cardiogenic shock including in myocardial infarction and
cardiac surgery.","Avoid in tachyarrhythmia, ventricular
fibrillation, ischemic heart disease; pheochromocytoma, hyperthyroidism.
Correct hypovolemia before, and maintain blood volume during the
treatment; correct hypoxia, hypercapnia, and metabolic acidosis before or
at same time as starting treatment; use low dose in cardiogenic shock due to
myocardial infarction; history of peripheral vascular disease (increased risk
of ischemia of extremities. Pregnancy: use only if potential benefit outweighs
risk. Breast Feeding: May suppress lactation.","Cardiogenic shock: intravenous infusion, adult: initially
2–5 mcg/kg/minute into a large vein (preferably via central venous catheter),
gradually increased by 5-10 mcg/kg/minute according to blood pressure,
cardiac output, and urine output (seriously ill patients, up to 20–50 mcg/
kg/minute)
Prepared immediately before use in accordance with the manufacture’s
instruction. Protect medication from light.","Nausea, vomiting, peripheral vasoconstriction; hypotension
with dizziness, fainting, flushing; tachycardia, ectopic beats, palpitations,
anginal pain; headache, dyspnea; hypertension particularly in over dosage.
Extravasation of the drug causes tissue necrosis.","Propranolol and Metoprolol antagonize the
cardiac effects of dopamine. Ventricular arrhythmias and hypertension may
occur with halothane or cyclopropane anesthesia."
EPINEPHRINE /ADRENALINE,Injection: 1 mg in 1000 ml,"Cardiac arrest, adjunct with local anesthetics, acute anaphylaxis","Shock (other than anaphylactic shock),
second stage labor. Do not use the drug if the color of the injection is cloudy
or brownish. While using this drug monitor blood pressure, heart rate.","Acute anaphylaxis: intramuscular injection, adult: 0.5-1
ml, to be repeated every 10 minutes according to blood pressure and pulse,
until improvement occurs. Intramuscular injection, child (2-5 years): 0.2-0.4
ml; (6-12 years): 0.5 ml. Dosage to be repeated as in adult.
Acute hypotension: continuous intravenous infusion, neonate and child: 100
nanogram/kg/min (up to 1.5 mcg/kg/min) adjusted according to response.
Cardiopulmonary resuscitation: Intravenous injection, adult: 1 mg every 3-5
min as required, 1 in 10000(100 mcg/ml) solution is recommended.","Tachycardia, hypertension, tremor, chest pain, irregular
heartbeats, headache, nausea, vomiting, nervousness, restlessness, and
weakness.","It should be avoided in patients who are on
tricyclic antidepressants as it may be cause arrhythmias, hypertension or
tachycardia.
Patient’s information: Notify doctor if side effects (anaphylaxis) are seen."
MILRINONE,"Injection: 1 mg/ml, 10mg/10ml solution in
ampoules.","Short-term treatment of severe congestive heart failure
unresponsive to conventional maintenance therapy (not immediately after
myocardial infarction), acute heart failure, including low output states
following heart surgery","Avoid in severe hypovolemia. Use caution
in hypokalemia, renal impairment, heart failure associated with hypertrophic
cardiomyopathy, stenotic or obstructive valvular disease or other outlet
obstruction. Pregnancy: use with caution- use only if potential benefit
outweighs risk. Breast feeding: avoid.","Short-term treatment of severe congestive heart failure
unresponsive to conventional maintenance therapy (not immediately after
myocardial infarction)/ acute heart failure, including low output states
following heart surgery: intravenous injection, adult: Initially 50 mcg/kg,
given over 10 minutes, followed by intravenous infusion 375–750 nanogram/
kg/minute usually given following surgery for up to 12 hours or in congestive
heart failure for 48-72 hours; maximum dose: 1.13 mg/kg per day. Renal
impairment: Reduce dose and monitor response if eGFR < 50 mL/min/1.73 m2","Ectopic beats, headache, hypotension, supraventricular
arrhythmias (more likely in patients with pre-existing arrhythmias),
ventricular tachycardia. Less commonly seen: Chest pain, hypokalemia,
thrombocytopenia, tremor, ventricular fibrillation.",
NOREPINEPHRINE/NORADRENALINE,"Injection: 1 mg/ml. Noradrenaline (base) 4 mg/4
ml concentrate for solution for infusion ampoules.",Acute hypotension,"Hypertension. Use caution in coronary
vascular thrombosis, diabetes mellitus, elderly, following myocardial
infarction, hypercapnia, hyperthyroidism, hypoxia, mesenteric vascular
thrombosis, peripheral vascular thrombosis, variant angina, uncorrected
hypovolemia. Pregnancy: Avoid, may reduce placental perfusion.","Acute hypotension: intravenous, adult: Initially 0.16–0.33
mL/minute, solution containing noradrenaline 40 mcg (base)/ml, adjusted
according to response into large vein (preferably via central venous catheter).
1 mg of noradrenaline base is equivalent to 2 mg of noradrenaline acid
tartrate. Doses expressed as the base. For treatment of acute hypotension
in adults, use a solution containing noradrenaline 40 mcg (base)/ml. For
intravenous infusion, give continuously in Glucose 5% or 0.9% saline and
glucose via a controlled infusion device. For administration via syringe
pump, dilute 2 mg (2 mL of solution) noradrenaline base with 48 mL infusion
fluid. For administration via drip counter dilute 20 mg (20 mL of solution)
noradrenaline base with 480 mL infusion fluid; preferably through a central
venous catheter; incompatible with alkalis.","Angle-closure glaucoma, anorexia, anxiety, arrhythmias,
bradycardia, confusion, dyspnea, headache, hypertension, hypoxia,
insomnia, nausea, palpitation, peripheral ischemia, psychosis, tachycardia,
tremor, urinary retention, vomiting, weakness. Avoid extravasation, may
cause pain and subcutaneous tissue ischemia at the site.",incompatible with alkalis.
BOSENTAN,"Tablet: 62.5 mg, 125 mg","Pulmonary arterial hypertension, systemic sclerosis with
ongoing digital ulcer disease (to reduce number of new digital ulcers)","Avoid in acute porphyria, systemic systolic
blood pressure is <85 mmHg. Pregnancy (X) Breast feeding: avoid. Hepatic
impairment: avoid in moderate to severe impairment. Effective contraception
required during administration (hormonal contraception not considered
effective). Monthly pregnancy tests advised. Monitor: Hemoglobin before
and during treatment (monthly for first 4 months then 3-monthly); Liver
function before treatment, at monthly intervals during treatment and 2
weeks after dose increase (reduce dose or suspend treatment if liver enzymes
raised significantly)—discontinue if symptoms of liver impairment.","• Pulmonary arterial hypertension: Oral, adult: Initially 62.5 mg twice daily
for 4 weeks, then increased to 125 mg twice daily; maximum 500 mg per day
in 2 divided doses.
• Systemic sclerosis with ongoing digital ulcer disease (to reduce number of
new digital ulcers): Oral, adult: Initially 62.5 mg twice daily for 4 weeks, then
increased to 125 mg twice daily
Avoid abrupt withdrawal.","Anemia, diarrhea, flushing, gastro-esophageal reflux,
headache, hypotension, edema, palpitation, syncope, liver cirrhosis, liver
failure, leucopenia, neutropenia, thrombocytopenia.",
SILDENAFIL,"Tablet: 25 mg, 50 mg, 100 mg","Pulmonary arterial hypertension (PAH), erectile dysfunction","Avoid in hypotension, myocardial
infarction, unstable angina, not for use in children with PAH. Use caution in
patients with anatomic deformation of penis, retinitis pigmentosa, ischemic
heart disease.","Erectile dysfunction: Oral, adult: 50 mg 1 hr. before sexual activity, maximum
dose 100 mg or minimum dose 25 mg and maximum of 1 dose per day.
PAH: Oral, adult: 25 mg three times daily.","headache, flushing, epistaxis, dyspepsia, insomnia,
erythema, diarrhea, migraine, myalgia, nasal congestion, visual disturbance,
back pain.",
ATORVASTATIN,Tablet: 10 mg,"Primary hypercholesterolemia, homozygous or heterozygous
familial hypercholesterolemia or mixed hyperlipidemia in patients who have
not responded adequately to diet and other appropriate measures.","Avoid in pregnancy, breastfeeding, active
liver disease (or in patients with persistently abnormal lover function tests).
Use caution in patients with liver disease, elderly or with a high alcohol
intake. Non serious and reversible cognitive side effects may occur. Liver
function tests should be carried out before and within 1-3 months of starting
treatment and thereafter at intervals of 6 months for 1 year, unless indicated
sooner by signs or symptoms suggestive of hepatotoxicity.","• Primary hyperlipidemia and combined hyperlipidemia: Oral, adult: 10 mg
once daily; if necessary may be increased at intervals of at least 4 weeks
to maximum 80 mg once daily. Oral, child (10-13 years usually): 10 mg once
daily.
• Familial hypercholesterolemia: Oral, adult: initially 10 mg daily, increased
at intervals of at least 4 weeks to 40 mg once daily; if necessary, further
increased to maximum 80 mg once daily. Oral, child (10-13 years): up to 20
mg once daily.","reversible myositis, headache, angina, chest pain, arthralgia,
anorexia, weight gain, epistaxis, back pain, nasopharyngitis, hyperglycemia.","With clarithromycin increases plasma
concentration of atorvastatin. Reduced dose required (max. 10 mg daily) with
concomitant cyclosporine/ tipranavir combined with ritonavir. Maximum
dose of 40 mg once daily when combined with anion-exchange resin for
heterozygous familial hypercholesterolemia. Use with caution in patient with
high alcohol intake."
CHOLESTYRAMINE RESINS,Powder (sachet): 4 gm,"Adjunct to dietary therapy to decrease elevated serum
cholesterol and LDL concentrations, cholestasis induced pruritus.",Avoid in severe hypertriglyceridemia.,"• Lipid reduction (after initial introduction over 3-4 week): Oral, adult: 12-24 g
daily in water in single or up to 4 divided doses, up to 36 g daily if necessary
• Cholestasis induced pruritus: Oral, adult: 4-8 g daily in water.","Bloating, dyspepsia, constipation, abdominal pain and
distention, anorexia, biliary colic, and skin rash.","Long term high-dose cholestyramine therapy
may impair the absorption of fat-soluble vitamins. Concomitant use causes
reduced absorption of thyroid hormones, warfarin.
Patient’s information: Adverse effects can be substantially reduced if the
drug is completely suspended in liquid several hours before ingestion (e.g.
evening doses can be mixed in morning and refrigerated similarly morning in
previous evening)"
EZETIMIBE,Tablet: 10 mg.,"Adjunct to dietary measures and statin treatment in primary
hypercholesterolemia, adjunct to dietary measures and statin in homozygous
familial hypercholesterolemia, Primary hypercholesterolemia (if statin
inappropriate or not tolerated), Adjunct to dietary measures in homozygous
sitosterolemia","Avoid in moderate to severe hepatic
impairment, myopathy, elevated hepatic transaminases, renal impairment
(CrCl less than or equal to 30 ml/min/1.73 m2). Pregnancy (C) Breast feeding:
avoid.","Oral, adult: 10 mg daily","Fatigue, gastro-intestinal disturbances, headache, myalgia.
Rare: anaphylaxis, angioedema, arthralgia, hepatitis, hypersensitivity
reactions, rash. Very rare: cholecystitis, cholelithiasis, myopathy, pancreatitis,
raised creatine kinase, rhabdomyolysis, and thrombocytopenia","An increased risk of rhabdomyolysis if Ezetimibe
is used in combination with a statin. Avoid use with cyclosporine."
FENOFIBRATE,Capsule: 160 mg,Severe hypertriglyceridemia,"Avoid in gall bladder disease,
hypoalbuminemia, nephrotic syndrome, during pregnancy, breast feeding,
severe hepatic impairment. Use caution in mild to moderate renal and hepatic
impairment. Monitor serum liver transaminases enzymes every 3 month for a
year then periodically during therapy",Initially 160 mg once daily dose.,"Gastrointestinal disturbances, rash, urticaria, fatigue,
headache, impotence.","Avoid use with ketoprofen, other fibrates,
photosensitivity seen.
Patient’s information: Restrict fat diet during the therapy."
GEMFIBROZIL,Capsule: 300 mg,"Adjunct to dietary therapy in hyperlipidemias of types II a, II b,
III, IV and V.","Avoid in preexisting gallbladder disease,
hepatic dysfunction, history of hypersensitivity to the drug. Risk for
myopathy/ rhabdomyolysis increases with renal impairment. Assess the liver
function test, CBC and electrolytes every 3-6 months and then yearly during
therapy. Safety and efficacy in children younger than 18 years of age have
not been established. Pregnancy (C). Breast feeding: Avoid","Oral, adult: 1.2 g daily usually in 2 divided doses; range
0.9-1.2 g daily.","abdominal and epigastric pain, diarrhea, nausea, anorexia,
headache, sexual dysfunction, myopathy, myositis, urticaria and pruritus.","May potentiate the anticoagulant effects
of oral anticoagulants, may increase the effects of sulfonylurea and oral
hypoglycemia agents."
NICOTINIC ACID (NIACIN),"Tablet: 50 mg, 250 mg","Adjunct to statin in hypertriglyceridemia and or used alone if
statin not tolerated.","Avoid in arterial hemorrhage, active peptic
ulcer, and breast feeding. Use caution in liver disease, gout, diabetes mellitus,
gallbladder disease, renal impairment. Pregnancy (A, C- for doses exceeding
RDA). Breast feeding: use caution.","Oral, adult: Initially 100-200 mg 3 times daily, gradually
increased over 2-4 weeks to l-2 g 3 times daily.","diarrhea, nausea, vomiting, flushing, palpitations, dizziness,
pruritus and rash.","May potentiate the anticoagulant effects of
oral anticoagulants. Increased risk of rhabdomyolysis and other toxicitites
with HMC co-A reductase inhibitors."
SIMVASTATIN,"Tablet: 5 mg, 10 mg, 20 mg, 40 mg","Primary and secondary prevention of atherosclerotic
cardiovascular disease, in high risk individuals (e.g. with diabetes mellitus,
post Myocardial infarction)","Avoid in pregnancy(X), breast-feeding,
active liver disease (or in patients with persistently abnormal liver function
tests). Use caution in elderly (>65 years), hepatic or renal dysfunction, and
uncontrolled hypothyroidism and perioperative periods and other factors
inhibiting statin catabolism due to increased risk of myopathy. Dose should
be reduced if the aforementioned drugs should be used concomitantly. As
soon as myopathy is suspected, blood analysis should be done to document
significant elevation of creatinine phosphokinase (CPK) levels (>3 times the
upper limit of normal) then statin use should be discontinued.","For prevention of cardiovascular events: Oral, adult:
initially 20-40 mg once daily at night (maximum 80 mg once daily at
night- only for those with severe hypercholesterolemia and at high risk of
cardiovascular complications).","Upper respiratory tract infection, myalgia, myopathy
(dose dependent), myositis, rhabdomyolysis, eosinophilia, eczema,
vertigo, abdominal pain, dyspepsia, raised serum transaminases, hepatitis,
jaundice, peripheral neuropathy, paresthesia, anemia, alopecia, and rashes,
hypersensitivity reactions (angioedema and anaphylaxis), cognitive side
effects (non serious and reversible), hyperglycemia (HbA1c and fasting
glucose level increase), immune mediated necrotizing myopathy (rare)","With gemfibrozil, cyclosporine, digoxin,
warfarin, verapamil, diltiazem, macrolide antibiotics (erythromycin,
clarithromycin), azole antifungals, niacin, HIV protease inhibitors, and
amiodarone. These drug reduce the catabolism of statins and cause
myopathy and rhabdomyolysis"
ROSUVASTATIN,Tablet: 5 mg,"Primary hypercholesterolemia (type IIa including heterozygous
familial hypercholesterolemia), mixed dyslipidemia (type IIb), or homozygous
familial hypercholesterolemia in patients who have not responded adequately
to diet and other appropriate measures with or without high cardiovascular
risk, Prevention of cardiovascular events in patients at high risk of a first
cardiovascular event and with risk factors for myopathy or rhabdomyolysis","Avoid in pregnancy, breast feeding,
severe renal impairment (eGFR less than 30 ml/ minute/1.73 m2), hepatic100
NNF 2018
impairment. Use caution in mild to moderate renal impairment. In patients
with high cardiovascular risk. Breast feeding: avoid.","• Primary hypercholesterolemia (type IIa including heterozygous familial
hypercholesterolemia), mixed dyslipidemia (type IIb), or homozygous familial
hypercholesterolemia in patients who have not responded adequately to
diet and other appropriate measures / Prevention of cardiovascular events
in patients at high risk of a first cardiovascular event and with risk factors
for myopathy or rhabdomyolysis: Oral, adult: Initially 5 mg once daily, then
increased if necessary up to 20 mg once daily, dose to be increased at
intervals of at least 4 weeks.
• Severe primary hypercholesterolemia in patients with high cardiovascular
risk (under expert supervision): Oral, adult: Initially 5–10 mg once daily,
increased if necessary to 20 mg once daily, then increased if necessary to
40 mg once daily, dose to be increased at intervals of at least 4 weeks
• Dose adjustments with concomitant fibrate: Initially 5 mg once daily
increased if necessary to max. 20 mg daily.
• Renal impairment (eGFR 30–60 ml/minute/1.73 m2): Initially 5 mg once daily
(do not exceed 20 mg daily)","Flulike symptoms, constipation, urinary tract infection,
proteinuria. Gynecomastia, hematuria, peripheral neuropathy, arthralgia.",
FERROUS FUMARATE,"Tablet: 200 mg containing 65 mg of elemental
iron",Iron-deficiency anemia,"Hemochromatosis,
hemosiderosis,
hemolytic anemia (unless iron deficiency state is also present), any form of
anaemia not caused by iron deficiency; patients receiving repeated blood
transfusions; parenteral iron therapy. The hemoglobin concentration should
rise by about 100-200 mg/100 mL (1-2 g/L) per day or 2 g/100 mL (20 g/L)
over 3–4 weeks. Although iron preparations are best absorbed on an empty
stomach, they may be taken after food to reduce gastrointestinal adverse
effects; they may discolour stools","• Iron deficiency anemia (prophylactic): Oral, > 12 years: 210 mg elemental
iron 1–2 times a day.
• Iron deficiency anemia (therapeutic): Oral, 12 years: 210 mg 2–3 times a day","Diarrhea and constipation, nausea, epigastric pain and
heart burn. Liquid preparations containing iron salts should be well diluted
with water. If possible, swallowed through a drinking straw to prevent
discoloration of teeth.","Concurrent administration with antacids and
tetracyclines with oral iron preparation will inhibit absorption of tetracyclines
and iron. Citric acid and ascorbic acid increases the absorption of iron.
Patient information: Take missed dose as soon as remembered within 12 hr.
Do not double the dose. Advise patient that stool may become dark green or
black and this is harmless."
FERROUS FUMARATE with FOLIC ACID,"Tablet: Ferrous fumarate: 322 mg and Folic acid
350 mcg; Capsule: Ferrous fumarate 305 mg and Folic acid 350 mcg.",Iron deficiency anemia,,"Oral, adult: 1 tablet/capsule daily, to be taken before food",Tablets: 300 mg.,
FERROUS GLUCONATE,Tablets: 300 mg.,"Prophylaxis and treatment of iron deficiency anemia,","Hemochromatosis,
hemosiderosis,
hemolytic anemia (unless iron deficiency state is also present), any form of
anaemia not caused by iron deficiency; patients receiving repeated blood
transfusions; parenteral iron therapy. The hemoglobin concentration should
rise by about 100-200 mg/100 mL (1-2 g/L) per day or 2 g/100 mL (20 g/L)
over 3–4 weeks. Although iron preparations are best absorbed on an empty
stomach, they may be taken after food to reduce gastrointestinal adverse
effects; they may discolour stools.","• Prophylaxis of iron-deficiency anemia: oral, child (6–11 years): 300–900 mg
daily, child (12–17 years): 600 mg daily, dose to be taken before food, Adult:
600 mg daily, dose to be taken before food.
• Treatment of iron-deficiency anemia: oral, child (6–11 years): 300–900 mg
daily, child (12–17 years): 1.2–1.8 g daily in divided doses, adult: 1.2–1.8 g
daily in divided doses, dose to be taken before food","Diarrhea and constipation, nausea, epigastric pain and
heart burn. Liquid preparations containing iron salts should be well diluted
with water. If possible, swallowed through a drinking straw to prevent
discoloration of teeth.","Concurrent administration with antacids and
tetracyclines with oral iron preparation will inhibit absorption of tetracyclines
and iron. Citric acid and ascorbic acid increases the absorption of iron.
Patient information: Take missed dose as soon as remembered within 12 hr.
Do not double the dose. Advise patient that stool may become dark green or
black and this is harmless."
FERROUS SULPHATE,"Tablet: 300 mg contains 60 mg of elemental
iron, 200 mg contains 40 mg of elemental iron.",Iron deficiency anemia,"Hemochromatosis,
hemosiderosis,
hemolytic anemia (unless iron deficiency state is also present), any form of
anaemia not caused by iron deficiency; patients receiving repeated blood
transfusions; parenteral iron therapy. The hemoglobin concentration should
rise by about 100-200 mg/100 mL (1-2 g/L) per day or 2 g/100 mL (20 g/L)
over 3–4 weeks. Although iron preparations are best absorbed on an empty
stomach, they may be taken after food to reduce gastrointestinal adverse
effects; they may discolour stools.","• Prophylaxis: 200 mg dried ferrous sulfate daily after food.
• Treatment: 400-600 mg daily in divided doses after food.","Diarrhea, constipation, nausea, epigastric pain (dose
related)","Concurrent administration with antacids and
tetracyclines with oral iron preparation will inhibit absorption of tetracyclines
and iron. Citric acid and ascorbic acid increases the absorption of iron.
Patient information: Take missed dose as soon as remembered within 12 hr.
Do not double the dose. Advise patient that stool may become dark green or
black and this is harmless."
FERROUS SULFATE WITH ASCORBIC ACID,"Tablet: Ferrous sulphate 325 mg and Sodium
ascorbate 500 mg",Iron deficiency anemia,,"Oral, adult: 1 tablet daily, dose to be taken before food",,
FERROUS SULPHATE with FOLIC ACID,"Tablet: Elemental iron 60 mg and Folic acid 400
mcg",Prevention of iron and folic acid deficiencies in pregnancy,"Should never be given without vitamin B12
in undiagnosed megaloblastic anaemia or other vitamin B12 deficiency states
because of the risk of precipitating subacute combined degeneration of the
spinal cord; folate-dependent malignant disease. Also see under ferrous
fumarate.","• Severe anaemia: Oral, child <2 years, elemental iron, 25 mg + folic acid 100–
400 mcg daily for 3 months. Child 2–12 years, elemental iron 60 mg + folic
acid, 400 mcg daily for 3 months. Adult, elemental iron, 120 mg + folic acid
400 mcg daily for 3 months.
• Prevention of iron and folate deficiencies in pregnancy: Oral, adult: elemental
iron, 100 mg + folic acid, 350–400 mcg daily throughout pregnancy.","Diarrhea, constipation, nausea, epigastric pain (dose
related)","Concurrent administration with antacids and
tetracyclines with oral iron preparation will inhibit absorption of tetracyclines
and iron. Citric acid and ascorbic acid increases the absorption of iron.
Patient information: Take missed dose as soon as remembered within 12 hr.
Do not double the dose. Advise patient that stool may become dark green or
black and this is harmless."
FOLIC ACID,Tablet: 1 mg and 5 mg,"Folate deficiency megaloblastic anemia; prevention of neural
tube defect in pregnancy.","Should never be given without vitamin B12
in undiagnosed megaloblastic anaemia or other vitamin B12 deficiency states
because risk of precipitating subacute combined degeneration of spinal cord;
folate dependent malignant disease. Women receiving antiepileptic therapy
need counselling before starting folic acid. Monitor plasma folic acid levels,
hemoglobin, hematocrit and reticulocyte count before and after therapy.","• Treatment of folate deficiency megaloblastic anemia: Oral, adult: 5 mg
daily for 4 months (in pregnancy continued to term ); ≤15 mg daily may be
necessary in malabsorption states.
• Prevention of first occurrence of neural tube defect: Oral, adult: 400-500
mg daily before conception and during the first twelve weeks of pregnancy.
• Prevention of recurrence of neural tube defects: Oral, adult: 5 mg daily
(reduced to 4 mg daily) from at least 4 weeks before conception until
twelfth weeks of pregnancy.","Bronchospasm, erythema, malaise, pruritis, rash, slight
flushing","Pyrimethamine, methotrexate, trimethoprim
and triamterene prevent the activation of folic acid. Absorption of folic
acid is decreased by sulphonamide, antacids and cholestyramine. Folic
acid requirements are increased by estrogens, phenytoin, phenobarbital,
primidone, carbamazepine or corticosteroids. Folic acid may cause decrease
in serum concentrations of other vitamin B complex when given in high
continuous doses
Patient information: Urine may turn intensely yellow which is normal with
therapy. Encourage females to take folic acid in early pregnancy as it prevents
neural tube defects of children."
WARFARIN,"Tablet: 1 mg, 2 mg, 5 mg","Prevention of progression and recurrence of deep venous
thrombosis or pulmonary embolism following a initial course of heparin.
It is effective in prevention of thromboembolism in patients undergoing
gynecological and surgical procedure, acute MI, prosthetic heart valves or
chronic atrial fibrillation.","Patients with GI ulcers, severe
hypertension, bacterial endocarditis, pregnancy. Pregnancy category X.
Contraindicated in women who are or may become pregnant. Hepatic and
renal impairment, recent surgery, breast feeding","Initial dose 10 mg for 2 days, subsequent doses 3-9 mg
daily in accordance with the prothrombin activity of blood",,"Food in GI tract can decrease rate of
absorbtion. Barbiturates, rifampicin, phenytoin, chronic alcohol ingestion,
ingestion of large amount of Vit K rich food or supplements may cause
decreased effects of warfarin. Decreased metabolism and/or displacement
from protein binding site may be caused by phenylbutazone, metronidazole,
allopurinol, cimetidine, amiodarone, thus enhancing risk of hemorrhage
Patient information: Avoid OTC preparation that may cause serious product
interaction unless directed by prescriber. Patients should report any sign of
bleeding: gum, under skin, urine, and stool and avoid hazardous activities
(e.g. hockey, football)"
ACENOCOUMAROL,"Tablet: 1 mg, 2 mg, 3 mg and 4 mg.","Prevention of progression and recurrence of deep venous
thrombosis or pulmonary embolism following a initial course of heparin.
It is effective in prevention of thromboembolism in patients undergoing
gynecological and surgical procedure, acute MI, prosthetic heart valves or
chronic atrial fibrillation.","Patients with GI ulcers, severe
hypertension, bacterial endocarditis, pregnancy. Pregnancy category X.
Contraindicated in women who are or may become pregnant. Hepatic and
renal impairment, recent surgery, breast feeding","4-12 mg on first day, 4-8 mg on second day, maintenance
dose usually 1-8 mg daily.",,
APIXABAN,"Tablet: 2.5 mg, 5 mg","Stroke prophylaxis with atrial fibrillation, postoperative
prophylaxis of deep vein thrombosis/pulmonary embolism, deep vein
thrombosis or pulmonary embolism.","Active bleeding, malignant neoplasms,
oesophageal varices, recent brain surgery, recent gastro-intestinal ulcer,
recent intracranial, haemorrhage, recent ophthalmic surgery, recent spine
surgery, significant risk of major bleeding, vascular aneurysm. Anaesthesia
with postoperative indwelling epidural catheter (risk of paralysis), prosthetic
heart valve, risk of bleeding, pregnancy category B, lactation. Patients with
nonvascular atrial fibrillation and or spinal or epidural hematoma.","• Stroke prophylaxis with atrial fibrillation: adult, oral: 5 mg twice a day,
• Postoperative prophylaxis of deep vein thrombosis/pulmonary embolism:
2.5 mg per oral twice a day for 35 days,
• Deep vein thrombosis or pulmonary embolism: adult, oral: 10 mg twice a
day for 7 day, then 5 mg twice a day.","Anaemia, bruising, haemorrhage, nausea","Analgesics and anticoagulants (increases risk
of haemorrhage), antibacterial, antidepressants, antiepileptics (decreases
plasma concentration of rivaroxaban), antifungal and antiviral (increases
plasma concentration of rivaroxaban)."
DABIGATRAN,Capsule: 75 mg and 150 mg,"Stroke prophylaxis with atrial fibrillation, DVT/pulmonary
embolus treatment and or prophylaxis.","Severe renal impairment (CrCl <15 mL/min)
or haemodialysis, hypersensitivity, active pathologic bleeding, impairment of
haemostasis. Increased bleeding risk during labor and delivery, discontinue
1-2 days (CrCl ≥50 mL/min) or 3-5 days (CrCl <50 mL/min) before invasive
or surgical procedure to decrease bleeding risk, monitor Ecarin clotting time
(ECT), if unavailable than monitor aPPT, PT, or TT; aPPT. Also see under
apixaban and fondaparinux.","• Stroke prophylaxis with atrial fibrillation: adult, oral: CrCl >30 mL/min: 150
mg twice a day, CrCl 15-30 mL/min: 75 mg PO twice a day,
• DVT/pulmonary embolus treatment: adult, oral: CrCl >30 mL/min: 150 mg
twice a day,
• DVT/pulmonary embolus treatment prophylaxis: adult, oral: CrCl >30 mL/
min: 110 mg 1-4 hr after surgery and after haemostasis has been achieved
on first day, then 220 mg taken once a day for 28-35 days.","Dyspepsia, gastritis, intracranial hemorrhage,
hypersensitivity including urticaria, rash, pruritic.",
RIVAROXABAN,"Tablets: 10 mg, 15 mg and 20 mg","Prophylaxis of venous thromboembolism (orthopaedic surgery),
deep vein thrombosis, pulmonary embolism, nonvalvular atrial fibrillation.","Hypersensitivity, active bleeding, malignant
neoplasms, oesophageal varices, recent brain surgery, GI ulcer, vascular
aneurysm.Anaesthesia with postoperative indwelling epidural catheter (risk of
paralysis), bronchiectasis, prosthetic heart valve, risk of bleeding, pulmonary
embolism in patients with haemodynamic instability, severe hypertension,
vascular retinopathy. Also see under apixaban and fondaparinux.","• Prophylaxis of venous thromboembolism (orthopaedic surgery): oral, adult:
10 mg once a day for 12 days,
• Deep vein thrombosis or pulmonary embolism: oral, adult: 15 mg twice a
day for 21 days then 20 mg per oral once a day for 6 months.","Abdominal pain, constipation, diarrhoea, dizziness,
dyspepsia haemorrhage, headache, hypotension, nausea, pain in extremities,
pruritus, rash, renal impairment, vomiting","Analgesics and anticoagulants (increases risk
of haemorrhage), antibacterial, antidepressants, antiepileptics (decreases
plasma concentration of rivaroxaban), antifungal and antiviral (increases
plasma concentration of rivaroxaban)."
ASPIRIN,"Tablet: 50 mg, 75 mg and 300 mg.","Prophylaxis of cerebro vascular diseases, and myocardial
infarction, thromboembolic disorder, post-MI, ischemic stroke and angina","Antiplatelet drugs are not used in
the management of haemorrhagic stroke, hypersensitivity (including
asthma, angioedema, urticaria) to
acetylsalicyclic, active
peptic
ulceration,haemophilia and other bleeding disorder. Asthma, uncontrolled
hypertension, pregnancy. Tell the patient to take aspirin after food with full
glass of plenty of water to reduce stomach irritation. Aspirin should not be
given to children and adolescent due to Reye’s syndrome. Watch for signs of
bleeding. Watch for the sign of salicylate poisioning.","• Thromboembolic disorders: Adult: oral 325-650 mg/day.
• Transient ischemic attack: adult oral 50-325 mg/day.
• Evolving MI with ST segment elevation: adult oral 160-325 mg nonenteric,
chewed and swallowed immediately, maintenance 75-162 mg/day MI,
• Stroke prophylaxis: adult oral 50-325 mg/day","Bronchospasm, GI bleeding, thrombocytopenia, seizures,
Reye’ syndrome","Aspirin may increase the effects of oral
hypoglycemic effects.if it is given with anticoagulant; the chance of bleeding
will be increased."
CLOPIDOGREL,Tablet: 75 mg,"Prevention of atherothrombotic events, transient ischaemic
attack or acute ischaemic stroke for patients with aspirin hypersensitivity/
intolerant of aspirin, Prevention of artherothrombotic events in acute
coronary syndrome with or without ST-segment elevation (given with aspirin)","Hypersensitivity, Coagulation disorders,
active pathological bleeding. Risk of increased bleeding form trauma, surgery
or other pathological conditions. Pregnancy: Avoid, hepatic and renal
impairment: use with caution.","• Prevention of atherothrombotic events in percutaneous coronary
intervention (adjunct with aspirin) in patients not already on clopidogrel:
Adult, oral: Loading dose 300 mg, to be taken prior to the procedure, Or
loading dose 600 mg, higher dose may produce a greater and more rapid
inhibition of platelet aggregation
• Transient ischaemic attack for patients with aspirin hypersensitivity/
intolerant of aspirin, acute ischaemic stroke for patients with aspirin
hypersensitivity/ intolerant of aspirin: Adult, oral: 75 mg once daily
• Prevention of atherothrombotic events in peripheral arterial disease or
within 35 days of MI/ within 6 months of ischaemic stroke: Adult, oral: 75
mg once daily
• Prevention of artherothrombotic events in acute coronary syndrome
without ST-segment elevation (given with aspirin): Adult, oral: Initially 300
mg, then 75 mg daily for up to 12 months
• Prevention of artherothrombotic events in acute myocardial infarction with
ST-segment elevation (given with aspirin): Adult, oral: 18–75 years: Initially
300 mg, then 75 mg for at least 4 weeks. >75years and over: 75 mg daily
• Prevention of atherothrombotic and thromboembolic events in patients
with atrial fibrillation (with aspirin) and for whom warfarin is unsuitable:
Adult, oral: 75 mg once daily","Abdominal pain, bleeding disorders (including gastro-
intestinal and intracranial), diarrhea, dyspepsia.","Anticoagulants, aspirin, NSAIDS, increase
bleeding risks. It increases action of some NSAIDSs, Phenytoin, Tamoxifen.
Proton pump inhibitor decrease clopidogrel effects."
PRASUGREL,Tablet: 5 mg and 10 mg,"Prevention of atherothrombotic events in patients with acute
coronary syndrome undergoing percutaneous coronary intervention, Patients
undergoing coronary angiography within 48 hours of admission for unstable
angina or NSTEMI, alternative to clopidogrel in certain patients undergoing
percutaneous coronary intervention","Active bleeding, history of stroke or
transient ischemic attack. Pregnancy: D, Breastfeeding: avoid, Hepatic
impairment: Use with caution in moderate impairment, increased risk of
bleeding. Avoid in severe impairment, renal impairment Use with caution—
increased risk of bleeding. Body weight less than 60 kg, discontinue at least
7 days before elective surgery if antiplatelet effect not desirable, elderly,
patients at increased risk of bleeding(e.g. from recent trauma, surgery,
gastrointestinal bleeding, or active peptic ulcer disease)","• In combination with aspirin for the prevention of atherothrombotic events
in patients with acute coronary syndrome undergoing percutaneous
coronary intervention: Adult, oral: 18–74 years :body-weight up to 60 kg:
Initially 60 mg for 1 dose, then 5 mg once daily usually for up to 12 months.
body-weight ≥60 kg: Initially 60 mg for 1 dose, then 10 mg once daily usually
for up to 12 months. ≥75 years: : Initially 60 mg for 1 dose, then 5 mg once
daily usually for up to 12 months.
• Patients undergoing coronary angiography within 48 hours of admission for
unstable angina or NSTEMI: Adult, oral: Initially 60 mg, to be administered
at the time of percutaneous coronary intervention to minimize the risk of
bleeding, maintenance dose of 10 mg or 5 mg daily should then be selected
as appropriate.
• Alternative to clopidogrel in certain patients undergoing percutaneous
coronary intervention: Adult, oral: 60 mg as a single dose","Anemia, gastro-intestinal hemorrhage, hematoma,
hematuria, hemorrhage, intracranial hemorrhage, rash","More chance hypersensitivity reaction while
administered with thienopyridines (e.g. clopidogrel)"
TICLOPIDINE,Tablet: 250 mg,"Coronary artery stent thrombosis (prevention), stroke","Neutropenia,
thrombocytopenia,
hemostatic disorder or active bleeding, severe hepatic impairment, history
of either thrombotic thrombocytopenic purpura (TTP) or aplastic anemia.
Pregnancy: B. Breast feeding: avoid. Hepatic impairment: caution, avoid in
severe hepatic impairment. Monitor Complete blood count, Liver function
test prior to initiation of treatment and every 2 weeks for the first 3 months.
May cause lifethreatening hematologic events, inclusing neutropenia,
agranulocytosis, thrombocytopenia purpura and aplastic anemia.","• Coronary artery stent thrombosis (prevention): Adult, oral: 250 mg twice a
day with aspirin for 30 days.
• Stroke: adult, oral: 250 mg twice daily with food.","Diarrhea, elevated alkaline phosphatase and aspartate
aminotransferase, nausea, dyspepsia, rash, neutropenia, purpura","Concurrent use of other anticoagulant drugs
increases the incidence of bleeding"
ETHAMSYLATE,Tablet: 500 mg,"Blood loss in menorrhagia, post-partum bleeding, post abortion
bleeding.","Pregnancy or breastfeeding woman;
Category B. Avoid excess dosage.The drug should be used with caution if
patient develops fever with treatment, non-cancerous growths fibroids in
uterus and, porphyria","Oral, adult: 500 mg 4 times daily
during menstruation.","Headache, rashes, hypotension",
TRANEXAMIC ACID,Tablet: 500 mg,"Menorrhagia, epistaxis, thrombolytic overdose, hereditary
angioedema, prophylaxis of hereditary angioedema.","Severe renal impairment (CrCl<1.5 mg/dl)
and thromboembolic disease. Caution in renal impairment and pregnancy","• Menorrhagia (initiated when menstruation started): oral, adult: 1 g 3 times
daily for up to 4 days, maximum 4 g daily.
• Local fibrinolysis: adult, oral: 15-25 mg/kg 2-3 times daily. Epistaxis: oral,
adult: 1 g 3 times a day for 7 days.
• Hereditary angioedema: oral, adult: 1–1.5 g 2–3 times a day, for short-term.
Patient information: Drug shouldn’t be used in combination with hormonal
contraceptives (birth control pills, patches, rings, injection). Do not take for
more than 5 days in a row.","Nausea, vomiting, diarrhoea, disturbances in colour vision,
nose stuffiness",
DESMOPRESSIN,"Tablets: 100 mcg, 200 mcg. Injection: 4 mcg.","For bleeding control, diabetes insipidus, primary nocturnal
enuresis.","Hypersensitivity, pseudo Von Willebrand’s
disease, cardiac insufficiency, angina pectoris, hypertension, renal
impairment, hypertension and cardiovascular disease. Rhinitis or Upper
respiratory tract infection can decrease the effectiveness of intranasal
preparation","• Hemophilia A/ Von Willebrand’s disease: Intranasal (adults and children) 1
spray (150 mcg) in each nostril (if >50 kg), in one nostril (if <50 kg)
• Diabetes insipidus diagnosis: subcutaneous or intramuscular, adult and
child, 2 mcg; Treatment: subcutaneous, intramuscular or intravenous, adult:
1-4 mcg daily, child: 400 nanogram.
• Renal function testing: subcutaneous or intramuscular, adult and child: 2
mcg","Fluid retention, headache, nausea, vomiting, epistaxis,
allergic reaction. Less pressor activity, but still need for considerable caution
in renal impairment, cardiovascular disease and hypertension.","Chlorpropamide, clofibrate or carbamazipine
may enhance antidiuretic response to desmopressin. Demeclocycline,
lithium, norepinephrine, alcohol may diminish the antidiuretic response to
desmopressin."
CALCIUM,"Tablets: 1.25 g calcium carbonate (equivalent to
500 mg calcium); Injection: 500 mg/5 ml, 1 g/10 ml (as calcium gluconate)
and 100 mg/10 ml (as calcium chloride)","Hypocalcemia in tetany, osteoporosis","Hypercalcemic states, do not use if allergic
to any ingredients of calcium preparations","• Supplement: 1-2 g between meals; daily requirement varies with the age and
is greater in childhood, pregnancy, lactation and old age
• Acute hypocalcaemia: 1-2 g by slow intravenous injection","Constipation, bradycardia, cardiac arrhythmia, hypotension
and irritation after parenteral administration","Reduce absorption of ciprofloxacin,
tetracycline, iron, bisphosphonates"
PHOSPHATES,"Tablet: Potassium phosphate 126 mg with Sodium
phosphate 67 mg; Potassium phosphate 250 mg with Sodium phosphate 160
mg; Potassium phosphate 250 with Sodium phosphate 298 mg",Treatment of hypophosphatemia,"Hyperphosphotemia,
hyperkalemia,
hypocalcemia, hypomagnesemia",,"Diarrhoea, nausea, vomiting, fluid retention, and
hypocalcaemia",
SODIUM FLUORIDE,Tablet: 2.2 mg; Mouth wash: 0.05% and 0.2%,Prevention of dental caries,"Infants under 6 months of age, advisable
to institute artificial fluoridation in areas with drinking water containing less
than 700 μg/l (0.7 ppm)","• Water content less than 0.3 ppm: child up to 6 months none; 6 months-3
years 250 μg daily; 3-6 years 500 μg daily; over 6 years 1 mg daily;
• Water content 0.3-0.7 ppm: child up to 3 years none; 3-6 years 250 μg daily,
over 6 years 500 μg daily;
• Prevention of dental caries: as oral rinse, child over 6 years 10 ml 0.05%
solution daily or 10 ml 0.2% solution weekly","White flakes on teeth with recommended doses; Yellowish
brown discoloration of teeth with more than recommended doses",
ZINC,Tablets: 10 mg and 20 mg,"Zinc deficiency, diarrhoea in children (rota virus infection),
adjunct to vitamin A therapy","Must be taken for 2-3 months to be
effective. Used with caution in acute renal failure","Adjunct to oral rehydration solution in acute diarrhoea,
• Under 6 months: 10 mg (elemental zinc) daily for 10 days;
• 6 months – 5 years: 20 mg daily for 10 days","Dyspepsia, abdominal pain, headache, nausea, vomiting,
gastritis","Decreases absorption of floroquinolones;
absorption of zinc is reduced when taken with dietary products, caffeine"
VITAMIN A (RETINOL),"Capsules: 200,000 U; Soft gel capsules:
200,000 U (retinol) and 40 U (DL-alpha-tocopherol or tocopheryl acetate)","Deficiency states, prophylaxis in high risk subjects, steatorrhea,
severe biliary obstruction, cirrhosis of liver or following total gastrectomy,
severe ocular damage","Hypersensitivity to vitamin A,
malabsorption syndrome, hypervitaminosis A, pregnancy, breastfeeding,
impaired renal function, children, hepatic disease, alcoholism, hepatitis","• Treatment of xerophthalmia: infants (6-11 months) 100,000U (3 drops) on
diagnosis, repeated next day and then after one month; child over one year
and adult (except women of child-bearing age) 200,000 units on diagnosis,
repeated next day and then after one month
• Prevention of vitamin A deficiency: child age 6 months to 5 years, 200,000
U every 6 months
• Measles: 200,000 U on diagnosis, repeated next day
• Prolonged diarrhoea of more than 14 days: 200,000 U on diagnosis
• Newly delivered mothers: 200,000 U at delivery or in the first 6 weeks
• Severe malnutrition: 200,000 U on diagnosis","Hypervitaminosis, fatigue, irritability, mental change,
anorexia, nausea, vomiting, GI upset","Mineral oil, cholestyramine, colestipol decrease
absorption of Vitamin A
Patient information: Refer to prescriber upon development of adverse effects"
VITAMIN D3 (CALCITRIOL),Capsule: 0.25 μg and 0.5 μg; Injection: 1 μg/ml,"Hypocalcaemia with chronic renal disease, psoriasis,
renal dystrophy, prevention and treatment of rickets, post menopausal
osteoporosis","Hypersensitivity, hyperphosphataemia,
hypercalcaemia, Pregnancy, breastfeeding, renal calculi","• Hypocalcaemia (Stage 5 chronic kidney disease): Children > 5 yrs and
adults, oral, 0.25 μg/day, Children 1-5 year, oral, 1-5 μg/day; Rickets, oral,
1 μg/day,
• Osteoporosis prophylaxis in corticosteroid therapy: oral, 0.5-1 mcg/day","Drowsiness, headache, palpitations, Hypertension,
photophobia, hypercalcemia, myalgia, arthralgia, weakness, pain in injection
site","Hypercalcaemia may occur if thiazide
diuretics, calcium supplements are concomitantly used; cardaic dysarrythmia
may occur with concomitant use of cardiac glycosides, verapamil
Patient information: Avoid over the counter products containing calcium,
potassium, sodium; maintain adequate fluid and water intake"
VITAMIN E (TOCOPHEROL),"Capsule: 100 IU, 200 IU, 400 IU, 500 IU, 600
IU and 1000 IU","Vitamin E deficiency states, impaired fat absorption, hemolytic
anemia in premature neonates, prevention of retrolental fibroplasias, sickle
cell anemia, supplementation of malabsorption syndrome","Pregnancy, anemia, breastfeeding,
hypoprothrombinaemia.","Deficiency states: adult, oral, 60-75 IU/day, child, oral, 1
IU/day","Headache, fatigue, increased risk of thrombophlebitis,
cramps, diarrhea, gonadal dysfunction, weakness","Increases actions of oral anticoagulants,
concomitant use of cholestyramine, sucralfate decrease absorption of
vitamin E"
VITAMIN B1 (THIAMINE),"Tablets: 50 mg, 100 mg, 250 mg and 500 mg, 20
mg (enteric coated); Injection: 100 mg/ml","Vitamin B1 deficiency, polyneuritis, cheilosis, beri-beri, Wernicke-
Korsakoff syndrome, pellagra, metabolic disorders","Hypersensitivity, pregnancy
Dosage schedule: Adult, oral (males) 1.2-1.5 mg, (females) 1.1 mg, (pregnancy)
1.4 mg, (breast feeding): 1.4 mg; child, oral-0.5-0.9 mg; infant, oral 0.2 mg","Adult, oral (males) 1.2-1.5 mg, (females) 1.1 mg, (pregnancy)
1.4 mg, (breast feeding): 1.4 mg; child, oral-0.5-0.9 mg; infant, oral 0.2 mg","Weakness, restlessness, pulmonary edema, hypotension,
collapse, angioneurotic edema, cyanosis, hemorrhage
Patient information: About the necessary foods to be included in diet: yeast,
beef, liver legumes, whole grains.",
VITAMIN B2 (RIBOFLAVIN),"Tablets: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg and
250 mg","Vitamin B2 deficiency, polyneuritis, cheilosis, migraine and
prophylaxis","Hypersensitivity to vitamin B2, pregnancy.","Adult- 5-30 mg/day, child>12 yr: PO 3-10 mg/day then 0.6
mg/1000 calories ingested; Migraine porphylaxis: adult- 400 mg/day for
three months",Yellow discoloration of urine,"Decrease action of tetracyclines, may cause
false elevations of urinary catecholamines
Patient information: Urine may turn bright yellow; Avoid alcohol"
VITAMIN B3 (NIACIN),"Tablets: 50 mg, 100 mg, 250 mg and 500 mg
(niacin); Tablets: 100 mg and 500 mg (niacinamide)","Pellagra, hyperlipidemias (types 4, 5), peripheral vascular
disease","Pregnancy, breastfeeding, hypersensitivity,
peptic ulcer, hepatic disease, hemorrhage, severe hypotension, glaucoma,
coronary artery disease, diabetes mellitus, gout, schizophrenia. Assess
cardiac status, nutritional status, CNS symptoms, Niacin deficiency,
Hyperlipidemia","Pellagra: adult, up to 500 mg daily in divided doses.","Paraesthesia, headache, dizziness, anxiety, Postural
hypotension, vasovagal attacks, dysrhythmias, vasodilation, blurred vision,
ptosis, jaundice, hepatotoxicity, hepatitis, glycosuria,","When combined with statins, either increases
the toxicity of the other: increase risk of rhabdomyolysis. Cholestyramine,
erythromycin, insulin decrease the blood level of niacin.
Patient information: Flushing and increase in feelings of warmth will occur
several hours after taking medicine; remain recumbent if postural hypotension
occurs; abstain from alcohol if product is prescribed for hyperlipidemia;
avoid sunlight if lesions are present"
VITAMIN B6 (PYRIDOXINE),"Tablets: 10 mg, 25 mg, 50 mg and 100 mg; 100
mg (extended release); Injection: 100 mg/ml; Capsules: 150 mg (extended
release)","Vitamin B6 deficiency, seizures, isoniazid therapy, oral
contraceptives, alcoholic polyneuritis","Pregnancy, breastfeeding, children,
Parkinson’s disease, patients taking levodopa should avoid supplemental
vitamins with >5 mg pyridoxine.","• Deficiency states: oral, 25–50 mg up to 3 times daily;
• Isoniazid neuropathy, prophylaxis: oral, 10 mg daily;
• Isoniazid neuropathy treatment: oral, 50 mg 3 times daily;
• Sideroblastic anemia: oral, 100–400 mg daily in divided doses","Paresthesia, flushing, warmth, lethargy, pain at injected
site.","Decrease the effects of levodopa
Patient information: Avoid vitamin supplements unless directed by prescriber;
increase meat, bananas, potatoes, lima beans, whole grains, and cereals in
diet"
VITAMIN B9 (FOLIC ACID),"Tablets: 0.1 mg, 0.4 mg, 0.8 mg, 1 mg and 5 mg;
Injection: 5 mg/ml and 10 mg/ml","Megaloblastic or macrocytic anemia caused by folic acid
deficiency; hepatic disease, alcoholism, hemolysis, intestinal obstruction,
pregnancy to reduce risk for neural tube defects","Pregnancy, anemia other than
megaloblastic/macrocytic anemia, vit B12 deficiency anemia, uncorrected
pernicious anemia.","• Treatment of folate-deficiency, megaloblastic anemia: oral, adult, 5 mg
daily for 4 months (in pregnancy continued to term); up to 15 mg daily may
be necessary in malabsorption states;
• Prevention of first occurrence of neural tube defects: oral, adult, 400–
500 micrograms daily before conception and during the first 12 weeks of
pregnancy;
• Prevention of recurrence of neural tube defects: oral, adult, 5 mg daily from
at least 4 weeks before conception until 12th week of pregnancy.","Confusion, depression, excitability, irritability, anorexia,
nausea, pruritus, rash, erythema, bronchospasm, anaphylaxis","Folic acid by estrogen, hydantoins,
carbamazepine, glucocorticoids, decreased levels of methotrexate,
sulfonamides, sulfasalazine, trimethoprim
Patient information: Urine will turn bright yellow; alter nutrition to include
high folic acids"
VITAMIN B12 (COBALAMIN),"Injection: 1 mg/ml (cyanocobalamine), 1 mg/ml
(hydroxycobalamine); Tablets: 50 μg","Vitamin B12 deficiency states, malabsorbtion, pernicious anemia,
stomach or lower ileal resection; macrocytic anemia","Hypersensitivity to Vitamin B12, uremia,
folate deficiency, concurrent infections, iron deficiency, renal dysfunction.
Parenteral products should be used when deficiency is due to malabsorption.","• Vitamin B12 deficiency of dietary origin: oral- adult, 50-150 μg /day
(cyanocobalamin), child, 25-50 μg, twice daily; intramuscular injection-
initially 1 mg repeated 10 times at intervals of 2-3 days, maintenance 1 mg
every month;
• Pernicious anaemia and other macrocytic anaemias without neurological
involvement: intramuscular injection, initially 1 mg (hydroxocobalamin)
repeated 5 times at intervals of 2 days, then 1 mg every 3 months
Parenteral preparation should be used until hematologic remission develops
and then should be switched to oral preparations","Dizziness, memory impairment, restlessness, hypertension,
chest pain, tachycardia, dry throat, eye redness, diarrhea, dyspepsia,
thrombocytosis, hypokalemia, pain at injection site","Chloramphenicol and antineoplastics
may decrease hematologic response to B12; Colchicine, aminoglycosides,
aminosalicylic acid, cimetidine, excess intake of alcohol or vitamin C may
decrease oral absorbtion or effectiveness of B12
Patient information: Patient should be encouraged to comply with diet
recommendations of heath care professional."
VITAMIN C (ASCORBIC ACID),Tablet: 50 mg,"Vitamin C deficiency, scurvy, delayed wound, bone healing,
chronic disease; urine acidification; before gastrectomy; dietary supplement","Tartrazine, sulfite sensitivity; glucose-6-
phosphate deficiency. Pregnancy, gout, diabetes, renal calculi.","• Prophylaxis of scurvy: oral, 25–75 mg daily;
• Treatment of scurvy: oral, not less than 250 mg daily in divided doses
Patient information: Addition of citrus fruits; avoid smoking","Headache, insomnia, dizziness, fatigue, flushing, nausea,
vomiting, diarrhea, anorexia, heartburn, cramps, polyuria, hemolysis",
ACETAZOLAMIDE,"Tablet: 125 mg and 250 mg; Powder for injection:
500 mg; Extended release capsule: 500 mg; Eye drops: 2%","Open-angle glaucoma, angle-closure glaucoma (preoperatively
if surgery delayed), secondary glaucoma, acute altitude sickness, CHF, drug
induced edema","Hypersensitivity to sulfonamide, severe renal
disease, hepatic disease, electrolyte imbalance (hyponatremia/hypokalemia),
hyperchloremic acidosis, addison’s disease, adrenocortical deficiency,
cirrhosis, long-term use in non-congestive angle-closure glaucoma. Not
recommended in pregnancy (C) and lactation: , hypercalciuria, diabetes,
respiratory acidosis, pulmonary obstruction, emphysema and COPD,
concomitant high dose aspirin.","• Angle closure glaucoma: per oral/intravenous- 250 mg 24hr and 250 mg BD
for short term therapy.
• Open-Angle glaucoma: per oral/intravenous – 250 mg/day in divided doses
for amounts of more than 250 mg or 500 mg BD (max 1 g/day)","Confusion, convulsions, cholestatic jaundice, drowsiness,
malaise, metallic taste, metabolic acidosis","Increases action of amphetamines, phenytoin,
procainamide, quinidine, anticholinergic; increases toxicity of salicylate and
cyclosporine; causes cardiac toxicity if hypokalemia develops with arsenic
trioxide, cardiac glycoside.
Patient’s information: May impair alertness and/or physical coordination."
AMILORIDE HYDROCHLORIDE,Tablet: 5 mg,"Oedema, CHF/HTN/Thiazide induced hypokalemia","Hyperkalaemia, Addison’s Disease, Renal
failure (if CrCL<10), Anuria, Diabetic nephropathy. Pregnancy, breast-feeding,
children, elderly, dehydration. Should be used with caution in patients with
diabetes mellitus, mild renal impairment.","• Oedema (used alone): per oral: initially 10 mg daily in 1 or 2 divided doses,
adjusted according to response (maximum 20 mg daily).
• Oedema (in combination with a thiazide or a loop diuretic): per oral: initially
5 mg daily, increasing to 10 mg daily if necessary (maximum 20 mg daily).
• CHF/HTN/Thiazide induced hypokalemia: 5-10 mg/day PO q day or divided
every 12 hour
• Renal impairment: If CrCl 10-50 ml/min: 50% normal dose; If CrCl<10 ml/
minute: not recommended","Hyponatremia, postural hypotension, diarrhoea, loss of
appetite, dizziness.","When combined with lithium: increases toxicity
Patient information: Take with food. To rise slowly from sitting to standing
to avoid orthostatic hypotension.To avoid driving and using machineries if
dizziness occurs. To avoid potassium-rich food."
CHLORTHALIDONE,"Tablet: 15 mg, 25 mg, 50 mg and 100 mg","Hypertension, ascites due to cirrhosis in stable patients (under
close supervision), oedema due to nephrotic syndrome, mild to moderate
chronic heart failure, nephrogenic diabetes insipidus, partial pituitary
diabetes insipidus.","Hypersensitivity to it or sulfonamides,
anuria. Pregnancy (B/D possible hazards include fetal or neonatal jaundice,
thrombocytopenia). Lactation not recommended.","• Hypertension: 12.5- 25 mg daily; per oral, dose to be taken in the morning,
increase if necessary to 50 mg daily.
• Edema: 50-100 mg/day PO or 100 mg PO every other day; not to exceed
200 mg/day.
• Mild to moderate heart failure: 25–50 mg daily; per oral, dose to be taken
in the morning, then increased if necessary to 100–200 mg daily, reduce to
lowest effective dose for maintenance.
• Nephrogenic diabetes insipidus |Partial pituitary diabetes insipidus:
Initially 100 mg per oral twice daily then reduced to 50 mg daily.","Hypotension, vasculitis, photosensitivity, phototoxicity,
electrolyte abnormalities, hyperglycemia, hyperuricemia, constipation,
diarrhea, loss of appetite, nausea, vomiting, spasticity, restlessness, dizziness,
headache, paresthesia, cardiac dysrhythmia (rare), pancreatitis (rare)","Aminolevulinic acid oral/topical +
Chlorthalidone-increases toxicity by pharmacodynamic synergism.
Amisulpride+Chlorthalidone:- Pharmacodynamic synergism, risk of
hypokalemia. Cisapride+Chlorthalidone: Contraindicated .Risk of prolonged
QTc interval. Tretinoin topical+ Chlorthalidone: Increased phototoxicity.
Avoid concurrent use with lithium (lithium dose reduction by 50% may be
necessary).
Patient information: Administered in the morning with food. Report to
treating doctor if dizziness and other mentioned side effects occurs."
EPLERENONE,Tablet: 25 mg and 50 mg,"HTN, heart failure post MI, renal impairment, hepatic impairment","Hypersensitivity. Serum potassium >5.5
mEq/L at initiation. Renal impairment if CrCl <50ml/min or Serum creatinine
>2 mg/dl in males or >1.8 mg/dl in females. Concomitant use with strong
CYP3A inhibitors. Pregnancy(B). Lactation –unknown. Hyperkalemia,
liver dysfunction, metabolic or respiratory acidosis, renal impairment,
hypersensitivity to spironolactone. Risk of hyperkalemia is higher in patients
with impaired renal function, proteinuria, diabetes and those concomitantly
treated with ACEIs and ARBs, NSAIDS and moderate CYP3A inhibitors.","• HTN: Initial 50 mg PO qDay; may increase to 50 mg PO every 12 hour; may
take up to four weeks for full therapeutic response; hyperkalemia may134
NNF 2018
occur with doses >100mg/day
• Heart failure post MI: Initial 25 mg PO qDay; may titrate to maximum of 50
mg once daily within 4 weeks as tolerated (Dose adjusted may be required
based on potassium levels).","Hyperkalemia, increased risk of hyperkalemia in presence
of renal dysfunction, dizziness, fatigue, albuminuria, abdominal pain","Itraconazole and Nefazodone and Saquinavir:
will increase the level or effect of eplerenone by affecting hepatic/intestinal
enzyme CYP3A4 metabolism. May increase the risk of hyperkalemia and
hypotension.
Patient’s information: Report to your treating doctor if awareness of heart
beat (palpitation) occurs and all other mentioned side effects occurs. Do not
use other medications without consulting registered doctor."
FUROSEMIDE,"Injection: 10 mg/ml in 2 ml ampoule; Tablet: 20
mg and 40 mg","Edema, heart failure, hypertension resistant to thiazide, fluid
overload in AKI/CKD, Acute Pulmonary edema/hypertensive crisis/increased
intracranial pressure","Renal failure with anuria, comatose
or precomatose states associated with liver cirrhosis, dehydration,
hyperkalemia, hypovolemia, severe hyponatremia. Pregnancy(C).Lactation:
drug excreted into breast milk; use with caution; may inhibit lactation. In
patients with liver cirrhosis, hypotension, elderly (reduce dose), oliguria,
renal and hepatic impairment and prostatic enlargement.","• Edema: initially 40 mg in the morning, maintenance 20-40 mg daily,
increased in resistant edema to 80 mg daily; child 1-3 mg/kg daily. Refractory
CHF may necessitate larger doses.
• Hypertension resistant: 20-80 mg PO divided every 12 hour
• Acute Pulmonary edema/Hypertensive crisis/Increased intracranial
pressure: 0.5 mg/kg (or 40 mg) IV over 1-2 minutes; may be increased to 80
mg if there is no adequate response within 1 hour; not to exceed 160-200
mg/dose.
• Hyperkalemia in Advanced Cardiac Life Support (ACLS): 40-80 mg IV.
• Hypermagnesemia in ACLS: 20-40 mg IV q3-4hr PRN.","Hypokalemia, hyponatremia, tinnitus, reversible or
permanent hearing impairment, rashes, loss of appetite, vomiting, diarrhea,
constipation, hyperuricemia gout.","Patients receiving cardiac glycoside,
furosemide predisposes the patient to digitalis toxicity principally due to
hypokalemia. The hypotensive effects enhanced when given concomitantly
with ACE inhibitors, alcohol, alpha blockers, general anesthetic agents,
angiotensin-II receptor antagonists, beta blockers and calcium channel
blockers. Concomitant administration of furosemide and aminoglycosides
may result in increased incidence of ototoxicity and nephrotoxicity. Cisapride
+ Furosemide:-C/I; Risk of prolonged QTc interval.
Patient information: To take high potassium diet or potassium replacement
with drug as hypokalemia is seen. Rise slowly from lying or sitting position
because orthostatic hypotension may occur, to take with food or milk for GI
symptoms, to use sunscreen or protective clothing to prevent photosensitivity."
HYDROCHLORTHIAZIDE,"Tablet: 12.5 mg, 25 mg and 50 mg","Edema associated with mild congestive heart failure, hepatic
cirrhosis, nephritic syndrome, chronic renal failure, acute glomerulonephritis,
hypertension, nephrogenic diabetes mellitus, calcium nephrolithiasis.","Hypersensitivity, anuria, hyponatremia,
hypercalcemic states (hyperparathyroidism, malignancies), hypokalemia,
hyperuricemia, contraindicated in patients hypersensitive to sulfonamide,
polymorphic ventricular tachycardia. Pregnancy(B), Lactation: drug excreted
in breast milk. Use with caution in gout, elderly, may unmask latent diabetes
mellitus, glucose intolerance, history of MI, DM, fluid or electrolyte imbalance,
hypercholesterolemia, SLE.","• Hypertension: 12.5 mg daily per oral (can be increased up to 25-50mg)
administered in morning or in twice daily dose (second dose should be
before 6pm)
• Edema: 25-50 mg per oral initially, maintenance dose 25-50 mg on alternate
days.","Anaphylaxis, anorexia, confusion, dizziness, extracellular
fluid volume depletion, hypotension, hypokalemia, hyponatremia,
hyperglycemia, hypercalcemia, hyperuricemia, hyperlipidemia, erectile
dysfunction, CNS and GI disorders are less common or rare, hepatotoxicity,
cholesterol.","Amphotericin B and Corticosteroids increase
the risk of hypokalemia, Torsade’s de pointes and fatal ventricular fibrillation
when used along with Quinidine. Decreased effects of anticoagulants,
uricosuria drugs, sulfonyl ureas and increased effects of loop diuretics,
anesthetics, digitalis, lithium when concomitantly used.
Patient’s information: To rise slowly from lying or sitting position. To report if
any signs of electrolyte imbalance, confusion occurs."
INDAPAMIDE,"Tablet: 2.5 mg (immediate release), 1.5 mg
(sustained release)","Hypertension, congestive heart failure","Avoid in severe hepatic impairment, renal
impairment. Use caution in acute porphyria, hypotension, diabetes mellitus,
hyperuricemia, gout, SLE, hepatic and/or renal impairment. Pregnancy
(B). Breast feeding: avoid. Efficacy and safety of the drug has not been
established in children","• Essential hypertension: oral (using immediate-release), adult: 2.5 mg daily,
dose to be taken in the morning
• oral (using sustained release), adult: 1.5 mg daily, may increase at 4 week
interval up to 5 mg, dose to be taken in the morning.
• Congestive heart failure: oral (using immediate-release), adult: 2.5 mg daily,
dose to be taken in the morning","Skin rash, hypokalemia, anorexia, diarrhea, orthostatic
hypotension, palpitation.","Avoid if hypersensitivity to sulfonamides. Avoid
concurrent use with arrhythmogenic drugs such as amisulpride, amitriptyline,
artemether/ lumefantrine, astemizole, Chlorpromazine, cisapride,
clarithromycin, disopyramide, desimipramine, fluconazole, ketoconazole,
itraconazole, nilotinib, octreotide, haloperidol. Avoid use with other diuretics
due to risk of hypokalemia."
METOLAZONE,"Tablet: 2.5 mg, 5 mg and 10 mg","Hypertension, Edema","Hypersensitivity to it or sulfonamides.
Anuria, Hepatic coma or precoma. Acute porphyrias. Pregnancy (drug crosses
placenta; hypokalemia, hypoglycemia, jaundice, thrombocytopenia and
hyponatremia reported in fetus following maternal use of thaizide diuretics)
Lactation: The amount present in milk is too small to be harmful. Large doses
may suppress lactation. Use with caution in DM, hypercholesterolemia,
hyperuricemia or gout, hypotension, SLE, previously sympathectomy, liver
disease.","• Oedema: 5–10 mg daily, dose to be taken in the morning, dose may be
increase in resistant oedema; increased if necessary to 20 mg daily;
maximum 80 mg per day.
• Hypertension: initially 5 mg daily, dose to be taken in the morning;
maintenance 5 mg once daily on alternate days","Chest pain, chills, dizziness, drowsiness, electrolyte
abnormalities, glucosuria, hyperuricemia, hepatotoxicity","Aminolevulinic acid oral/topical + Metolazone-
increases toxicity. Amisulpride+Metolazone, risk of hypokalemia.
Cisapride+Metolazone: Contraindicated .Risk of prolonged QTc interval.
Tretinoin topical+ Metolazone: Increased phototoxicity.
Patient’s information: Tablets may be crushed and mixed with water
immediately before use."
SPIRONOLACTONE,"Tablet: 25 mg, 50 mg and 100 mg","Edema and ascites in cirrhosis of liver, nephrotic syndrome,
congestive heart failure, primary hyperaldosteronism.","Hyperkalemia, hyponatremia, addison
disease,moderate renal impairment. Elderly (reduce dose), diabetes mellitus,
renal and hepatic impairment, pregnancy, breastfeeding. Spironolactone
should be cautiously used when aforementioned drugs are to be used
concomitantly. Serum level of Blood Urea Nitrogen (BUN) and K+ should be
monitored regularly.","• Edema: In adult:100-200 mg per oral daily, increased up to 400 mg daily in
resistant edema; maintenance dose 25-200 mg daily. (child) 1-3 mg/kg daily
in 1- 2 divided doses.
• Primary hyperaldosteronism: per oral (adult) 400 mg daily for 3-4 weeks,
preoperative management: 100-400 mg daily; if not suitable for surgery,
lowest effective dose is used as maintenance therapy.
• Adjunct in severe heart failure: per oral (adult) usually 25 mg daily.","Hyperkalemia, metabolic acidosis (in cirrhotic patients),
gynecomastia, impotence, decreased libido, hirsutism, menstrual irregularity,
diarrhea, gastritis, gastric bleeding, breast cancer risk is increased in chronic
use.","Hepatic CYP3A4 isoform inhibitors like
macrolide antibiotics, (clarithromycin), azole antifungals (ketoconazole,
itraconazole), protease inhibitors(indinavir,ritonavir) may induce dangerous
hyperkalemia by inhibiting spironolactone catabolism.
Patient information: Avoid foods with high potassium content, oranges,
bananas, salty food."
TORSEMIDE,"Tablet: 10 mg, 20 mg and 100 mg","Congestive heart failure, Chronic renal failure, Hepatic cirrhosis,Hypertension.","Known hypersensitivity to torsemide or
to povidone, Anuria, Hepatic Coma. Pregnancy & Lactation- No available
data. Use with caution in DM, fluid or electrolyte imbalance (hypokalemia,
hyponatremia), hyperglycemia, hyperlipidemia, hyperuricemia or gout, severe
liver disease with cirrhosis and ascites.","• CHF: 10-20 mg PO/IV mg once daily initially, doubled until desired diuretic
effect is achieved, individual dose not to exceed 200 mg.
• CRF: 20 mg PO/IV OD initially; doubles until desired diuretic effect is
achieved; individual dose not to exceed 200 mg.
• Hepatic cirrhosis: 5-10 mg PO/IV once daily initially with aldosterone
antagonist or potassium sparing diuretic; individual dose not to exceed 40
mg.
• Hypertension: 2.5-5 mg/day PO initially; increased to 10 mg/day PO in 4-6
weeks PRN","Headache, Electrolyte imbalance, Dizziness, Rhinitis,
Constipation, Cough, Diarrhoea, Dyspepsia
Patient’s information: Rise slowly from lying or sitting position. Limit alcohol
use. Take the medication with milk or food to limit GI symptoms. Use
sunscreen, protective clothing to prevent sunburn.",
TRIAMTERENE,Tablet: 50 mg,"Edema, potassium conservation with thiazides and loop
diuretics.","Addison’s disease, anuria, hyperkalemia.
Diabetic mellitus, elderly, gout, may causes blue fluorescence of urine.
Regular monitoring of blood K+ to check for hyperkalemia","Initially 15-250 mg daily, reducing to alternate days after 1
week, taken in divided dose after breakfast and lunch, lower initial dose when
given with other diuretics.","Hyperkalemia, nausea, vomiting, diarrhea, muscle cramps,
dizziness","When other K+ sparing diuretics are
concomitantly used dangerous hyperkalemia may develop.
Patient’s information: Avoid using high K+ diet like avocado, banana, dried
apricots etc."
DESMOPRESSIN,Tablet: 100 μg and 200 μg; Injection: 4 μg,"Diabetes insipidus, primary nocturnal enuresis, post-operative
polyuria or polydipsia, nocturia associated with multiple sclerosis.","Hyponatremia. In cardiac insufficiency,
renal impairment, conditions treated with diuretics, polydipsia in alcohol
dependence, psychogenic polydipsia. Asthma, cardiovascular disease,
cystic fibrosis, heart failure. If hyponatremia occurs therapy may be hold or
discontinued.","• Diabetes insipidus: adult and child, initially 300 μg per oral daily (in three
divided doses); maintenance: 300-600 μg daily in three divided doses;
range 0.2-1.2 mg daily. By injection in diabetes insipidus, for diagnosis
(subcutaneous or intramuscular adult and child, 2 μg; for treatment
(subcutaneous, intramuscular or intravenous) adult 1-4 μg daily, child 400
ng
• Primary nocturnal enuresis: Adult and child over 5 years: 200 μg at bedtime,
increased to 400 μg if lower dose not effective.
• Postoperative polyuria/polydipsia: adjust dose according to urine
osmolality.
• Renal function testing (subcutaneous or intramuscular): adult and child:
2 μg.","fluid retention, headache, nausea, vomiting, epistaxis,
allergic reaction.","Chlorpropamide/dobutamine increases effects
of desmopressin by pharmacodynamic synergism.
Patient’s information: Patients being treated for primary nocturnal enuresis
should avoid fluid overload and stop taking desmopressin during an episode
of vomiting or diarrhoea. Do not take excessive fluid while on therapy."
NITROFURANTOIN,Tablet: 50 mg and 100 mg,"UTI, cystitis, pyelonephritis, and postoperative infection of
urinary tract.","Hypersensitivity, infant under 1-month,
impaired renal function with estimated GFR <30 ml/min, pregnancy at term
(38-42 weeks), hepatic dysfunction. Gastritis patients, gastrointestinal
disease, diabetes. Pregnancy (B). Crosses placenta. Lactation: enters breast
milk; discontinue drug or do not nurse. Avoid long term use in elderly.","Adult 50-100 mg per oral tid/qid. Child: 3-6 mg/kg body
weight per oral in four divided doses.","Headache, dizziness, peripheral neuritis and neurological
effects, chest pain, leukopenia, blood dyscrasias, hemolytic anemia, GI
intolerance, nausea, diarrheas, anorexia","Probenecid increases levels of nitrofurantoin
Increases antagonistic effect of norfloxacin.
Patient’s information: Suggested to take medicine after meal to avoid gastric
irritation. Color of the urine can be brownish, not to worry. Tablets should
not be crushed. Protect from light."
BETHANECHOL,"Tablet: 5 mg, 10 mg, 25 mg and 50 mg",Urinary retention,"Hypersensitivity,
hyperthyroidism,
peptic ulcer, asthma, bradycardia, hypotension, AV Conduction defects,
CAD vasomotor instability, vagotonia, epilepsy, parkinsonism, obstructive
pulmonary disease, HTN. GI disturbances or anastomosis. Pregnancy (C),
Lactation: decision should be made whether to discontinue nursing or to
discontinue drug.","Urinary retention: 10-50 mg PO 3-4 times daily. Some
patients may require doses of 50-100 mg PO twice daily. Take 1 hour before
or 2 hours after meal.","Abdominal cramps, belching, bronchial constriction,
diarrhoea, flushing, headache, urinary urgency","Ambenonium: It increases effects of bethanechol
by pharmacodynamic synergism. Amitriptyline: Bethanechol increases
and amitriptyline decreases cholinergic cholinergic effects/transmission.
Flavoxate/ Solifenacin/Ipratropium: Bethanechol increases and flavoxate/
solifenacin/ Ipratropium decreases cholinergic effects/transmission.
Patient’s information: Take 1 hour before meal or 2 hour after meals"
FLAVOXATE,Tablet: 100 mg,Overactive bladder (OAB),"Obstructive uropathy, pyloric/duodenal
obstruction, ileus, GI bleeding, achalasia. Pregnancy (B). Lactation: not
known. Use caution in patients with glaucoma. May impair ability to perform
hazardous tasks. May cause ocular disturbances; advice patients of potential
effects.","OAB (indicated for dysuria, increased urinary frequency/
incontinence, nocturia, suprapubic pain, urinary incontinence, urinary tract
irritation, urinary urgency): 100-200 mg PO q6-8hr","Abdominal pain, Blurred vision, Confusion, Constipation,
Distubance in ocular accommodation, Drowsiness, Dry mouth, Dysuria,
Increased ocular tension, Vertigo.","Pramlintide+Flavoxate: either increases effects
of the other by pharmacodynamic synergism. Contraindicated. Synergistic
inhibition of GI motility. Secretin: Flavoxate decreases effects of secretin
by pharmacodynamic antagonism. (avoid or use alternative drug). Monitor
closely while using amilsulpride/amitriptyline/Clozapine/Chlorpromazine.
Patient’s information: Vertigo can occur."
MIRABEGRON,Tablet: 25 mg and 50 mg,Overactive Bladder (OAB),"Hypersensitivity, Pregnancy (C), Lactation:
unknown, discontinue nursing or the drug. May increase BP, Urinary
retention may occur with bladder outlet obstruction or with concomitant
antimuscarinic therapy. Angioedema of the face, lips, tongue and/or larynx
reported.","Indicated for OAB with symptoms of urge urinary
incontinence, urgency and urinary frequency: 25 mg PO qDay. 25 mg dose is
typically effective within 8 weeks. May increase to 50 mg PO qDay based on
individual efficacy and tolerability. Dosage modification in renal impairment:
Severe (Crcl-15-29ml/min) not to exceed 25 mg/day. ESRD-not recommended.","Elevated BP occurring predominantly in patients with
preexisting hypertension, dry mouth, nasopharyngitis, UTI, headache,
constipation, cystitis, back pain, arthralgia, Steven Johnson syndrome.","Monitor closely: while using amitriptyline/
codeine/metoprolol/tramadol- Mirabegron will increase the level or effect
of amitriptyline/codeine/metoprolol/tramadol, by inhibiting hepatic enzyme
CYP2D6 metabolism. Patient’s information: May take with or without food. Swallow whole with
water, do not chew, divide or crush tablet."
OXYBUTYNIN,"Tablet: 5 mg; Tablet extended-release: 5 mg, 10
mg and 15 mg; Syrup: 5 mg/ml",Overactive bladder (OAB),"Hypersensitivity, gastric or urinary
obstruction or retention, paralytic ileus, severe ulcerative colitis, uncontrolled
narrow –angle glaucoma. Use with caution in : Myasthenia gravis, tachycardia
secondary to cardiac insufficiency or thyroxicosis. Pregnancy/Lactation: NA.
In controlled angle closure glaucoma; mild to moderate ulcerative colitis,
hyperthyroidism; partial obstructive uropathy; benign prostatic hyperplasia.
hepatic and renal impairment. May aggravate symptoms of decreased
gastrointestinal motility in patients with autonomic neuropathy.","• OAB: Relief of symptoms (e.g. urge incontinence,frequency, urgency)
in patients with uninhibited neurogenic or reflex neurogenic bladder.
Immediate release: 5 mg PO twice/three times daily; not to exceed 5 mg PO
four times daily. Extended release: 5-10 mg/day PO; may be increased by 5
mg/day at weekly intervals; not to exceed 30 mg/day. Pediatric: Tab 5 mg,
Syrup: 5 mg/ml
• Detrusor overactivity: Bladder overactivity associated with a neurologic
condition (e.g. Spina bifida) ≥5 yrs (immediate release):5 mg PO every 12
hour;may be increased to 5 mg POq8hr. ≥ 6 yrs (Extended release):5 mg/
day PO initially;may be increased by 5 mg/day at weekly intervals; not to
exceed 20 mg/day.","Dry mouth, constipation, somnolence, nausea","Potassium chloride + oxybutynin. Avoid or
use alternate drug. Patients using drugs with extensive anti cholinergic
effects should avoid concomitant use with solid oral dosage forms of
potassium chloride. May use effervescent potassium preparations as
alternatives. Pramlintide + oxybutynin: Either increases effects of the other
by pharmacodynamic synergism. Contraindicated. Synergistic inhibition
of GI motility. Secretin: Oxybutynin decreases effects of secretin by
pharmacodynamic antagonism.
Patient’s information: May cause memory loss. Contact doctor if symptoms
do not improve with 2 weeks of initial use."
SOLIFENACIN,Tablet: 5 mg and 10 mg,"Overactive bladder (OAB), Urge incontinence","Urinary or gastric retention, uncontrolled
narrow angle glaucoma, severe hepatic impairment, hypersensitivity.
Pregnancy (C), Lactation: Avoid using drug or stop nurse. Bladder outflow
obstruction, controlled narrow angle glaucoma, decreased GI motility, renal
or hepatic impairment. Peripheral edema, exfoliative dermatitis, erythema
multiforme, elevated liver enzymes, hyperkalemia, muscular weakness, renal
impairment, GERD were noted after post marketing.",OAB: 5 mg PO OD; may be increased to 10 mg PO OD,"Dry mouth, Constipation, Abdominal Pain, Blurred Vision","Itraconazole: it will increase the level or effect of
solifencain by inhibiting hepatic/intestinal enzyme CYP3A4 metabolism(C/I)
Coadministration with solifenacin in hepatic/renal impairment may result
in potentially fatal adverse events. Use caution while using Ondansetron/
Ketoconazole/carbamazepine together with Solifencacin.
Patient’s information: Reports if there is headache, confusion, hallucinations
and somnolence."
TOLTERODIN,Tablet: 1 mg and 2 mg,"Overactive bladder, Urge incontinence","Urinary
or
gastric
retention,
Uncontrolled narrow angle glaucoma, hypersensitivity. Pregnancy(C),
Lactation: Unknown. Controlled narrow angle glaucoma, bladder outflow
obstruction, gastrointestinal obstruction, hepatic or renal impairment.
Caution with patients of myasthenia gravis. Reduce dosage of tolterodine
when coadministered with strong CYP3A4. Anaphylaxis and angioedema
necessitating hospitalization and emergency treatment reported with first or
subsequent doses.","OAB, urge incontinence: immediate release 2 mg PO every
12 hour, Extended release: 2-4 mg PO once daily","Dry mouth, blurred vision, constipation, dizziness,
drowsiness, dyspepsia","Carbamazepine will decrease the level or effect
of tolterodine. Clarithromycin will increase the level or effect of tolterodine
by affecting CYP3A4 metabolism.
Patient’s information: Report if dizziness/somnolence occurs. Do not drive or
operate heavy machinery until adjusted to therapy."
BAMBUTEROL,Tablet: 10 mg and 20 mg,"Bronchial asthma, COPD","Renal disorders, liver diseases, heart
diseases, diabetes, epilepsy, hyperthyroidism and hypertension, myocardial
insufficiency, history of seizures, heart disease. Pregnancy category B,
caution in lactation","Initially, 10 mg once daily at bed time, increased if
necessary after 1-2 weeks to 20 mg once daily; not recommended in children.","Muscle cramps, dizziness, headache, muscle tremor,
palpitation, ankle edema, hypokalemia.","Concomitant use of high dose of salbutamol
and corticosteroids or diuretics increases the risk of hypokalemia."
SALBUTAMOL,"Aerosol pressurized inhalation: 100 µg per
inhalation; Dry powder: 200 µg per dose; Injection: 50 µg and 500 µg/ml;
Oral Solution: Each 2 mg/5 ml; Tablets: 2 mg, 4 mg and 8 mg.","Bronchial asthma, COPD","Salbutamol must not be used to prevent
premature labour in the case of pre-eclampsia, placenta previa and bleeding.
Hyperthyroidism, myocardial insufficiency, arrhythmias, susceptibility to
QT-interval prolongation, hypertension, pregnancy (high doses should be
given by inhalation because parenteral use can affect the myometrium and
possibly cause cardiac problems), breastfeeding. Monitor blood Glucose
(Ketoacidosis has been reported in Diabetes Mellitus following Intravenous
administration)","• By mouth: 4 mg (elderly and sensitive patient initially 2 mg) 3-4 times daily;
maximum single dose 8 mg (but unlikely to provide much extra benefit or to
be tolerated), child under 2 years 100 µg /kg 4 times daily; 2-6 years 1-2 mg
3-4 times daily; 6-12 years 2 mg
• By subcutaneous or intramuscular injection: 500 µg , repeated every 4
hours if necessary
• By slow intravenous injection: 250 µg repeated if necessary
• By intravenous infusion: initially 5 µg /minute, adjusted according to
response and heart-rate usually in range 3-20 µg /minute or more if
necessary
• By aerosol inhalation: 100-200 µg (1-2 puffs); for persistent symptoms up
to 3-4 times daily; child 100 µg (1 puff) increased to 200 µg (2 puffs) if
necessary. Prophylaxis in exercise induced bronchospasm, 200 µg (2 puffs);
child 100 µg (1 puff)
• By inhalation of a powder: 200-400 µg ; for persistent symptoms up to 3-4
times daily; child 200 µg. Prophylaxis in exercise-induced bronchospasm
(powder), 400 µg ; child 200 µg
• By inhalation of nebulized solution: adult and child over 18 months, chronic
bronchospasm unresponsive to conventional therapy and severe acute
asthma, 2.5 mg, repeated up to 4 times daily, increased to 5 mg if necessary,
child 2.5 mg increased to 5 mg if required.","Muscle cramps, dizziness, headache, muscle tremor,
palpitation, ankle edema, hypokalemia.","Concomitant use of high dose of salbutamol
and corticosteroids or diuretics increases the risk of hypokalemia."
TERBUTALINE SULFATE,"Aerosol pressurized inhalation: 250 µg dose;
Injection: 500 µg per ml; Tablets: 2.5 mg and 5 mg","Bronchial asthma, COPD","It must not be used to prevent
premature labour in the case of pre-eclampsia, placenta previa and bleeding.
Hyperthyroidism, myocardial insufficiency, arrhythmias, susceptibility to
QT-interval prolongation, hypertension, pregnancy (high doses should be
given by inhalation because parenteral use can affect the myometrium and
possibly cause cardiac problems), breastfeeding. Monitor blood Glucose
(Ketoacidosis has been reported in Diabetes Mellitus following Intravenous
administration). Tolerance develops
in patients receiving long term therapy; dose may have to be changed;
monitor rebound bronchospasm","• Oral: 2.5-5 mg 2-3 times daily; child 0.1 µg /kg 3 times daily.
• By subcutaneous, intramuscular or slow intravenous injection: 250-500 µg
up to 4 times daily; child <12 years 0.01µg /kg every 20 minutes 3 doses;
• By continuous intravenous infusion (as a solution containing): 3-5 µg /ml,
1.5-5 µg /minute for 8-10 hours, reduce dose for children.
• By aerosol inhalation: adults and children 250-500 µg (1-2 puffs), for
persistent symptoms up to 3-4 times daily.","Muscle cramps, dizziness, headache, muscle tremor,
palpitation, ankle edema, hypokalemia.","Increases hypertensive crisis with MAOIs.
Decreases the action of beta-blockers. The effect of terbutaline is increased
with green tea (large amounts)."
MONTELUKAST,"Tablet: 4 mg, 5 mg and 10 mg.","Chronic asthma in adults and children, seasonal allergic rhinitis,
bronchospasm prophylaxis.","Hypersensitivity. Pregnancy, breastfeeding,
children <6 yrs, acute attack of asthma, alcohol consumption, severe hepatic
disease, corticosteroid withdrawal, phenylketonuria, suicidal ideation,
depression.","Adult and child>15 yr: 10 mg/day in PM; child 6 -14 yrs: 5
mg chew tab/day in PM; child 2 – 5 yrs: 1 packet (4 mg) granules taken in PM","Dizziness, fatigue, headache, behavior change,
hallucinations, seizures, agitation, anxiety, Churg-Strauss syndrome.
Patient information: Avoid hazardous activities; dizziness may occur,
continue the use inhaled beta agonists if exercise-induced asthma.",
ZAFIRLUKAST,Tablet: 10 mg and 20 mg.,"Prophylaxis and chronic treatment of asthma in adults/children
>5yr, allergic rhinitis","Hypersensitivity, hepatic encephalopathy.
Pregnancy, breastfeeding, children, geriatric patients, hepatic disease,
Churg-strauss syndrome, acute bronchospasm. Adult patients carefully for
symptoms of Churg- Strauss syndrome; Liver function test.","Adult and children>yr: 20 mg twice daily; Child 5-11yr: 10
mg twice daily; Child >12 yr: 20 mg twice daily","Headache, dizziness, nausea, diarrhea, abdominal pain,
vomiting, hepatic failure, hepatitis, angioedema",Food decrease bioavailability.
SODIUM CROMOGLYCATE,Hard gelatin capsule: 20 mg,"Prophylaxis of asthma, allergic rhinitis, allergic conjunctivitis.","Known hypersensitivity. Pregnancy,
lactation, old age children
and used with caution in patients with cardiac,
hepatic and renal diseases","Inhalation of powder, adults and children, 20 mg 4 times
daily, increased in severe cases to 8 times daily.","Throat irritation and cough, nasal congestion, headache,
dizziness, arthralgia, rashes, bronchospasm
Patient’s information: The capsules are intended for use in an inhaler and
not to be swallowed. Sodium cromoglycate insufflation should be protected
from moisture. Nasal sol. blow nose, hold pump between fingers; if its use,
spray in air until fine mist occurs, Aerosol: take off cover mouthpiece, sake
gently, breathe out slowly, place mouthpiece in mouth, close mouth around
it, till head back, breathe in as inhaler, inhalation: Do not swallow sol, empty
ampule into power driven nebulizer as directed.",
EPHEDRINE HYDROCHLORIDE,Tablets: 30 mg,Reversible airways obstruction,"The drug should be used with caution
in patients with
hypertension, severe renal impairment and prostate
hypertrophy.","15-60 mg 3 times daily; child 3 times daily, up to 1 year: 7.5
mg, 1-5 years: 15 mg, 6-12 years: 30 mg.","Arrhythmias, insomnia, tremor, tachycardia.",
AMINOPHYLLINE,Tablet: 100 mg; Injection: 250 mg/10ml,"Bronchial asthma, COPD, Neonatal apnea.","Hyperthyroidism,
uncontrolled
arrhythmias. Patient of Age> 60 years, patient with liver disease. Should not
be given to the children under one year of age except in apnea of prematurity,
therapeutic dose is near the toxic dose so that give carefully, don’t give IM
or SC.","Adult: 100-300 mg three times a day; Injection: IV dose
6 mg /kg over 20 to 30 minutes as loading dose, then maintenance dose 0.4
to 0.7 mg/kg/hour depending on comorbidities; Child dose, loading dose: IV
5-6mg/kg, maintenance dose: IV 1-2 mg/kg/dose every 8 hours","Headache, dizziness, extra systoles, sinus tachycardia,
anorexia, nervousness, tremor","Additive CVS and CNS side effects can be seen
with sympathomimetic, elevated serum levels in patients receiving cimetidine,
beta blockers, erythromycin, allopurinol or oral contraceptive pills.
Patient information: Suggest patients to take a lot of water with this medicine."
DOXOFYLLINE,Tablet: 400 mg,"Asthma, COPD","Hypersensitivity, acute myocardial
infarction, hypotension. Use with caution in patients with hypoxemia,
hyperthyroidism, liver disease, renal disease, in those with a history of peptic
ulcer and in elderly.","Adult: 400 mg once daily or twice daily; Children: 12 mg/
kg/day","Headache, nausea, vomiting, sleeplessness, dizziness","Should not be administered together with
other xanthine derivatives, including beverages and foods containing caffeine"
THEOPHYLLINE,Tablet: 100 mg and 200 mg,"COPD, Bronchial asthma, Nocturnal asthma","Hyperthyroidism,
uncontrolled
arrhythmias. Patient of Age> 60 years, patient with liver disease. Should not
be given to the children under one year of age except in apnea of prematurity,
therapeutic dose is near the toxic dose so that give carefully, don’t give IM
or SC.Close monitoring
of the patient taking medicine should be done because the effective dose is
very close to the toxic dose.","• Adult: 200 mg bid .Dose can be increased after 1 week up to 300 mg bid,
Over 70 kg: 200-300 mg twice daily;
• Neonatal apnea: Loading dose: PO 5 mg/kg/dose, maintenance dose: PO
3-6 mg/kg/day in 3-4 divided doses; Child: >1 year
• Bronchospasm: PO 12-14 mg/kg/day in 3-4 divided doses (Max. dose 300
mg/day)","Nausea, vomiting, GI upset, headache, dizziness, convulsion","Never combine with ciprofloxacin, corticosteroids,
theophylline, erythromycin and cimetidine they may cause increase the level
of theophylline in the blood. Never combine with carbamazepine; phenytoin
and barbiturates they may cause decrease the level of theophylline in the
blood. Patient information: Suggest patients to take a lot of water with this medicine."
CODEINE PHOSPHATE,"Tablet: 15 mg, 30 mg and 60 mg","Non-productive cough, pain","In asthmatics, patients with decreased
respiratory reserve, patients who are allergic to codeine or oxycodone,
patients with history of drug abuse and drug seeking behavior (due to
abuse liability). It should be cautiously used in patients with severe prostatic
hypertrophy and hepatic disease; pregnancy, breastfeeding, COPD.","• Mild to moderate pain: 30-60 mg every 4 hours when necessary, to a
maximum of 240 mg daily; child 1-12 years, 0.5-1 mg/kg/dose every 6 hours
(Max. dose 60 mg/kg);
• Dry or painful cough: 15-30 mg 3-4 times daily. Child 5-12 years, 1-1.5 mg/
kg 4 times daily.","Nausea, constipation, drowsiness, confusion,
blurred vision, hypotension, bradycardia, respiratory depression on large
doses, physical dependence on prolonged use.","Codeine is used with extreme caution in patient
receiving MAO inhibitors, additive CNS depression occurs with alcohol,
antidepressants, antihistamines, sedative and hypnotics.
Patient information: Avoid driving or other activities requiring high alertnes"
BROMHEXINE,Tablets: 5 mg; Syrup: 4 mg/5 ml,Reduction of sputum viscosity in COPD patients.,"Not recommended for infants < 1 year,
peptic ulcer, severe hepatic /renal impairment. Should be used with caution in
pregnant and breastfeeding women. Since mucolytics may disrupt the gastric
mucosal barrier, bromhexine should be used with caution in patients with a
history of gastric ulceration. Clearance of bromhexine or its metabolites may
be reduced in patients with severe hepatic or renal impairment.","Oral: 8 to 16 mg three times daily; child 2-6 years 8 mg 2-3
divided dose daily; 6-12 years: 4-8 mg per dose three times daily.","Gastrointestinal side effects may occur occasionally with
bromhexine and a transient rise in serum aminotransferase values has
been reported. Other reported adverse effects include headache, vertigo
(dizziness), sweating and allergic reactions.","Should not be given with especially paracetamol
(if so chances of hepatitis is increased).
Patient information: Should be taken after meal."
CARBOCYSTEINE,Capsules: 375 mg; Syrup: 250 mg/5 ml,Reduction of sputum viscosity in COPD.,"Avoid use in pregnancy. It should be used
with caution by patients with a history of peptic ulceration. Should be
cautiously used in children under 2 years old.","750 mg 3 times daily initially; then 1.5 g daily in divided
doses; child 2-5 years 200-500 mg per day 2- 4 times divided dose daily, 6-12
years 300-750 mg 3 times divided dose daily.","Skin rashes, occasional gastro- intestinal irritation.",
PHENYLEPHRINE,"Tablet: 5 mg; Nasal spray: 0.125%, 0.25%,
0.5% and 1%","Nasal congestion associated with acute or chronic rhinitis,
common cold, and sinusitis","Patients with diabetes, hypertension,
ischemic heart disease, hepatic impairment, renal impairment. Stinging may
occur: to rinse dropper with hot water to prevent contamination.","Oral: 5 mg 3-4 times a day; Child 1-6 years: 1-2 drops
0.01%, 6-12 years: 1-2 drops 0.25 %,> 12 years: 0.25 or 0.5%.","Increased heart rate, palpitation, tremors, ventricular
premature contractions and hypertension.",
PSEUDOEPHEDRINE,Syrup: 30 mg/5 ml; Tablets: 60 mg,"Nasal congestion associated with acute or chronic rhinitis,
common cold, sinusitis. In patients with otic inflammation or infection,
the drug may be useful in opening obstructed Eustachian tube. The drug
may be used as an adjunct to analgesics, antihistamines, antitussives when
indicated.","Use cautiously in patients with prostatic
hypertrophy, ischemic heart disease, glaucoma and diabetes mellitus.","60 mg 3-4 times daily; child 4 mg/kg/day per oral in 3-4
divided doses.","Nervousness, restlessness, dizziness, insomnia, headache
and drowsiness. Larger doses may cause lightheadedness, nausea and /or
vomiting.","Do not use with MAOIs or tricyclics;
hypertensive crisis may occur.
Patient information: Do not crush, divide, chew or dissolve, avoid taking drug
near bed time because stimulation can occur."
BENZOIC ACID AND SALICYLIC ACID, Ointment/Cream: 6% w/w of benzoic acid and 3% w/w of salicylic acid in a suitable base,"Superficial dermatophyte infections - Tinea corporis, Tinea cruris","Hypersensitivity (to any of the
components). alicylate toxicity may occur particularly if applied on large
areas of skin. Avoid broken or inflamed skin, avoid contact with eyes, and
avoid contact with mucous membranes",Apply twice daily until the infected skin is shed (usually at least 4 weeks).,"Erythema, hypersensitivity reactions, itching, mild burning
sensation, occasional local irritation",
FUSIDIC ACID,Cream/Ointment: 2%,"Staphylococcal skin infection (impetigo, folliculitis), erythrasma, pitted keratolysis","Allergy to fusidic acid and its salt or any of its ingredient. Avoid contact of cream or ointment with eyes. To avoid the development of resistance, fusidic acid should not be used for longer than 10 days","Staphylococcal skin infection: apply 3–4 times a day in
the skin",Hypersensitivity reactions Patient information: Avoid contact of cream or ointment with eyes.,
METRONIDAZOLE,Cream: 0.75%; Gel: 0.75%,"Rosacea, malodorous gravitational and decubitus ulcers","Hypersensitivity to this product or
nitroimidazoles, parabens. Hepatic disease, blood dyscrasias, children.
Watery eyes, metallic taste in mouth, numbness and paraesthesias or any
other side effects may occur and need to be reported."," Acute inflammatory exacerbation of rosacea: Apply twice daily for 8 weeks,
to be applied thinly
• Inflammatory papules and pustules of rosacea: Apply twice daily for 6
weeks (longer if necessary)
• For malodorous fungating tumours and malodorous gravitational and
decubitus ulcers: Apply 1-2 times a day, to be applied to clean wound and
covered with non-adherent dressing"," Dryness, itching, burning, stinging","May cross-react in patients with allergy to oral
forms.
Patient information: Topical skin products are not for intravaginal therapy
Drugs used in Skin Disorders
382
and are for external use only; do not use skin products near the eyes, nose,
or mouth. Avoid exposure to strong sunlight or UV light."
MUPIROCIN,Ointment: 2%,"Bacterial skin infections, particularly those caused by Gram positive organisms (except pseudomonal infection)",": Known hypersensitivity. Renal impairment,
burns, large open wounds, pregnancy, lactation. If reactions suggesting
chemical irritation or sensitivity occur, treatment should be discontinued and
alternative therapy for the infection should be instituted.","Impetigo, skin infections (Staphylococcus aureus, Streptococcus pyogenes): Apply up to 3 times a day for up to 10 days","Burning sensation, local reactions, pruritus, rash, urticaria
Patient information: Avoid contact with the eyes. The medication should
be discontinued in case of irritation, severe itching or rash and health care
provider should be contacted. If impetigo has not improved by 3-5 days,
contact with health care provider.",
SILVER SULFADIAZINE,Cream: 1% w/w,Minor burns,"Hypersensitive to sulphonamides,
pregnancy [C, X (near term)], breastfeeding and neonates. Hepatic, renal
impairment, G-6PD deficiency. Owing to the association of sulfonamides with
severe blood and skin disorders, treatment should be stopped immediately if
blood disorders or rashes develop.",Apply once daily or twice daily if exudative,"Allergic reactions, argyria (following treatment of large areas of skin or prolonged use), burning, itching, leucopenia, rashes"," Decreases effects of collagenase, pepain,
trypsin"
AMOROLFINE,Nail lacquer: 5%; Cream: 0.25%," Fungal nail infections, dermatophyte infections, yeasts infection","Hypersensitivity. Avoid contact with ears,
avoid contact with eyes and mucous membranes, use with caution in child
likely to suck affected digits. Do not use in children under 12 years.","Fungal nail infections: By transungual application, Apply 1–2 times a week for 6 months to treat finger nail and for toe nails 9–12 months (review at intervals of 3 months), apply to infected nails after filing and cleansing, allow drying for approximately 3 minutes. • Dermatophytes/yeast infections: Apply once daily on affected areas for 4 weeks.","Burning sensation, erythema, hypersensitivity reactions,
NNF 2018
383
itching, occasional local irritation
Patient information: Treatment should be discontinued if side-effects are
severe. Avoid nail varnish or artificial nails during treatment",
CLOTRIMAZOLE,Cream: 1% w/w; Gel: 1% w/w; Solution: 1% w/w,"Tinea pedis, T. cruris, T. corporis, T. versicolor, Cutaneous candidasis","Hypersensitivity to any of the
formulation components. Contact with eyes and mucous membranes
should be avoided. Treatment should be discontinued if side effects are
severe.",Apply 2-3 times daily for 4-6 weeks,"Local irritation, erythema, hypersensitivity reactions, itching,mild burning sensation Patient information: Contact with eyes and mucous membranes should be avoided",
GENTIAN VIOLET,Solution: 1% w/v,Cutaneous/mucocutaneous infections caused by Candida albicans,"Avoid use in ulcerated lesions, broken skin,mucous membranes.","Local application: apply locally, 2-3 times daily","Irritation/ sensitivity reactions, mucous membranes ulcerations",
MICONAZOLE NITRATE,Ointment: 2% w/w; Ovule: 200 mg,"Fungal skin infections, fungal nail infections, oral fungal infection, vaginal candidiasis","Hypersensitivity to this product or imidazoles. Avoid in acute porphyrias, contact with eyes and mucous membranes should be avoided. Treatment should be discontinued if side effects are severe",Fungal skin infections: Apply twice daily continuing for 10 days after lesions have healed ;Fungal nail infections: Apply 1–2 times a day," Local irritation and burning.
Patient information: Contact with eyes and mucous membranes should be
avoided.",
NEOMYCIN,"Combination ointment: Neomycin 1000 units, Polymyxin 5000 units and Bacitracin 1500 units","Steroid responsive dermatoses with infection, prophylaxis of
skin infection in minor injury.","Hypersensitivity. Pregnancy(C), Lactation use with caution.",Apply cream/ointment BID-QID for 7 days,"Sensitization, burning, itching, irritation, dryness","Not recommended in allogenic cultured
keratinocytes/fiboblasts in bovine collagen."
NYSTATIN,"Cream/Ointment: 100,000 units/g; Powder:
100,000 units/g","Mucocutaneous infection, vaginal infections","Hypersensitivity. Pregnancy (B), Lactation–not known. Cream preferred to ointment in candidiasis involving intertriginous areas. Moist lesions best treated with powder.","Mucocutaneous infection: Apply to affected area q8-12hr for 2 weeks.
 Vaginal infections: Insert 1 tab/day qHS for 2 weeks.","Non-toxic well tolerated by all age groups, contact
dermatitis, Steven-Johnson syndrome, acneiform eruption (rare)
Patient information: Report if hypersensitivity occurs.",
SERTACONAZOLE,Cream: 2% ,Tinea pedis,"Hypersensitivity, not indicated for
ophthalmic, oral or intravaginal use. Pregnancy (C). Sensitivity to imidazole
antifungals (cross reactivity may occur). If no improvement 2 weeks after
treatment period, review diagnosis.","Apply BID for 4 weeks; apply enough to cover affected
area, and immediately surrounding healthy skin","Contact dermatitis, dry skin, burning, erythema,
vesiculation, desquamation, hyperpigmentation",
TERBINAFINE,Cream: 1%,Tinea infections,"Breastfeeding, hypersensitivity to this
drug. Pregnancy (B). Not for oral, intravaginal, ophthalmic use; no more than
4 weeks","Tinea pedis: To the affected area using cream. Apply 1–2 times a day for up
to 1 week, to be applied thinly.;Tinea corporis and Tinea cruris: To the affected area using cream. Apply
NNF 2018
385
1–2 times a day for up to 1–2 weeks, to be applied thinly, review treatment
after 2 weeks ","Erythema, hypersensitivity reactions, itching, mild burning sensation,occasional local irritation. Patient information: Avoid contact with eyes and mucous membranes.",
BENZYL BENZOATE,Lotion: 25% ,Scabies,"Children; broken or secondarily infected
skin. Contact with eyes and mucous membranes. For use in children, dilute
the product to reduce irritant effect",Apply over the whole body; repeat without bathing on the following day and wash off 24 hours later; a third application may be required in some cases.,"Burning sensation (especially on genitalia and
excoriations),rashes, skin irritation.
Patient information: Avoid contact with eyes and mucous membranes,
suspend breastfeeding until the product has been washed off.",
IVERMECTIN,Lotion: 0.5%; Cream: 1%,"Lice, rosacea","Hypersensitivity. Pregnancy (C). To prevent
ingestion, administer to children only with direct adult supervision. Not for
oral, opthalmic or intravaginal use.",,,
PERMETHRIN,Cream: 5%; Lotion: 1%,"Scabies, body lice, head lice","Hypersensitivity. Avoid contact with eyes, children aged 2 months–2 years, medical supervision required for dermal cream (scabies), do not use on broken or secondarily infected skin. Pregnancy (B), Lactation: not known, distributed in breast milk,may temporarily withhold the drug while mother is nursing.","Scabies and body lice: Apply cream over whole body and wash off after
Drugs used in Skin Disorders
386
8-12 hours (if hands washed with soap within 8 hours of application for
treating scabies, treat again) repeat after 7 days for scabies and 10 days
for body lice.;Head lice: Apply lotion to clean damp hair and rinse after 10 minutes, repeat
after 10 days.","Local irritations, rashes, itching, erythema Patient information: Avoid contact with eyes. For external use only",
ACICLOVIR,Cream/Ointment: 5%,"Herpes labialis, genital herpes, herpetic keratitis","Hypersensitivity. Pregnancy (B). Excretion
in milk unknown. Not recommended for recurrent infections. Use cautions in
immunocompromised patients. Not for use on eye or inside mouth.","Herpes labialis: Apply topically to lips and around mouth 5 times per day
for 4 days.; Initial genital herpes: Apply sufficient quantity to adequately cover all
lesions Q3hr, 6 times/day for 7 days. "," Burning/stinging, pruritus, dry lips, rash, angioedema,vulvitis
Patient information: Avoid physical contact when lesions are present.
For external use only. Use rubber gloves when applying to prevent
autoinnoculation of other body sites and transmission of infection to others.",
CLOBETASONE BUTYRATE,Cream: 0.05%,Eczemas and dermatitis of all types," Hypersensitivity, use of some preparations
on face, axilla, groin; monotherapy for primary bacterial infections. Pregnancy
(C), breastfeeding, children. Do not use with occlusive dressings. Treatment
should be limited to 2 wks.","Eczemas and dermatitis of all types: Maintenance
between courses of more potent corticosteroids. Child: Apply 1–2 times a
day, to be applied thinly","Hyperglycemia, burning, folliculitis, pruritus, dermatitis,
irritation, erythema, hypertrichosis, acne",
CLOBETASOL PROPIONATE,Cream: 0.05%; Lotions: 0.05%,"Corticosteroids responsive dermatoses, scalp psoriasis, plaque
psoriasis","Hypersensitivity, use of some preparations
on face, axilla, groin; monotherapy for primary bacterial infections.
Pregnancy(C), breastfeeding, children. Do not use with occlusive dressings.
Treatment should be limited to 2 week.","Recalcitrant eczemas unresponsive to less potent
corticosteroids and Psoriasis: Apply 1–2 times a day for up to 2 weeks, to be
applied thinly, maximum 50 g of 0.05% preparation per week","Hyperglycemia, Burning, folliculitis, pruritus, dermatitis,
irritation, erythema, hypertrichosis, acne",
DITHRANOL (ANTHRALIN),"Cream: 0.1%, 0.25%, 0.5%, 1% and 2%", Psoriasis,"Acute and pustular psoriasis,
hypersensitivity. Avoid sensitive areas of skin, avoid use near eyes. ","Subacute and chronic psoriasis: For application to skin
or scalp, 0.1–0.5% cream suitable for overnight treatment, 1–2% cream for
maximum 1 hour (consult product literature)",": Local burning sensation, local irritation, stains hair, stains
skin
Patient information: When applying Dithranol, hands should be protected
by gloves or they should be washed thoroughly afterwards. Dithranol should
be applied to chronic extensor plaques only, carefully avoiding normal skin.
Dithranol can stain the skin, hair and fabrics.",
FLUOCINOLONE ACETONIDE,Cream: 0.025%,"Severe inflammatory skin disorders such as Eczemas, Psoriasis."," Hypersensitivity, use of some preparations
on face, axillae, groin; monotherapy for primary bacterial infections.
Pregnancy(C), breastfeeding, children. Do not use with occlusive dressings."," Severe inflammatory skin disorders such as eczemas,
psoriasis Apply 1–2 times a day, to be applied thinly, reduce strength as
condition responds"," Hyperglycemia, Burning, folliculitis, pruritus, dermatitis,
irritation, erythema, hypertrichosis, acne.
Patient information: Do not apply medicine for long period of time.",
FLUTICASONE,Cream: 0.05%; Ointment: 0.005% ,"Dermatitis and eczemas unresponsive to less potent
corticosteroids, Psoriasis","Hypersensitivity. Pregnancy (C), children,
breast-feeding, skin infections, skin atrophy, children. Not to use with
occlusive dressings, below 2 months child","Apply 1–2 times a day, to be applied thinly.","Burning, pruritus, dermatitis, hypertrichosis, hives,
hyperglycemia, glycosuria, HPA axis suppression, Cushing syndrome
Patient information: To apply sparingly in a thin film and rub gently into the
cleansed, affected area.",
HYDROCORTISONE,"Cream: 0.1%, 0.5%, 1%, 2.5%; Ointment/Lotion
Drugs used in Skin Disorders
388
1%, 2.5%","Mild inflammatory skin disorders such as eczemas, nappy rash","n disorders such as eczemas, nappy rash
Contraindications/Precautions: Underlying infection, hypersensitivity,
opthalmic use. Pregnancy (C), breastfeeding, children, HPA suppression (with
higher potency used >2 weeks). Avoid use in face, ano-genital region, broken
or infected skin (including cold sores, acne, and athlete’s foot)","Eczema: Apply 1–2 times a day, to be applied thinly for 2 weeks.; Nappy rash: Apply as required for no more than 1 week, discontinued as
soon as the inflammation subsides","Burning, folliculitis, pruritus, dermatitis, maceration,
hyperglycemia, glycosuria, striae
Patient information: Apply only for short period of time if not responsive
consult dermatologist.",
HYDROCORTISONE BUTYRATE,Scalp lotion: 0.1%; Topical emulsion: 0.1%; Lipocream: 0.1%; Ointment: 0.1%,"Severe inflammatory skin disorders such as eczema unresponsive to less potent corticosteroids, Psoriasis","Children under 10 years or for pregnant women; face, anogenital region, broken or infected skin (including cold sores, acne, and athlete’s foot)","Apply 1–2 times a day, to be applied thinly",Similar to other topical steroids,
ACITRETIN,Capsules: 10 mg and 25 mg," Psoriasis, severe congenital ichthyosis, Darier’s disease","Hyperlipidaemia, hypersensitivity to retinoids, pregnancy (X), breastfeeding, severe hepatic impairment, severe renal impairment. Avoid excessive exposure to sunlight and unsupervised use of sunlamps; diabetes (can alter glucose tolerance—initial frequent blood glucose checks); in children use only in exceptional circumstances and monitor growth parameters and bone development (premature epiphyseal closure reported); investigate atypical musculoskeletal symptoms. Check liver function at start, then every 2–4 weeks for first 2 months and then every 3 months. Monitor serum-triglyceride and serum-cholesterol concentrations before treatment, 1 month after starting, then every 3 months.","Severe extensive psoriasis resistant to other forms of therapy, Palmoplantar
pustular psoriasis; Severe congenital ichthyosis (under expert supervision): Initially 25–30 mg
daily for 2–4 weeks, then adjusted according to response to 25–50 mg daily,
increased to up to 75 mg daily, dose only increased to 75 mg daily for short
periods in psoriasis; Severe Darier’s disease (keratosis follicularis) (under expert supervision):
Initially 10 mg daily for 2–4 weeks, then adjusted according to response to
25–50 mg daily",">10%: cheilitis, alopecia, hypertriglyceridemia, skin peeling, dry skin, dysglycemia, increased LFT, nail disorder, pruritus, rhinitis, arthralgia, changes in phosphorus, potassium, sodium, & magnesium levels, dry mouth, epistaxis, erythematous rash, hepatotoxicity, hyperesthesia, paresthesia, paronychia, rigors, skin atrophy, spinal hyperostosis, sticky skin, xerophthalmia; edema, flushing, depression, fatigue, headache, insomnia, somnolence, abdominal pain, anorexia, diarrhea, gingivitis, increased appetite, nausea, stomatitis, vomiting, hot flashes, vision changes, corneal epithelial abnormality, sinusitis","Avoid concomitant use of keratolytics
• Tetracyclines: Both acitretin and tetracyclines can cause increased
intracranial pressure.
• Methotrexate: Either increases toxicity of the other by pharmacodynamic
synergism. Risk of additive hepatotoxicity
• Ethanol: Ethanol converts acitretin to etretinate, a teratogenic substance
that can remain in the body for years. Women on acitretin should totally
abstain from ethanol during and 2 months after stopping acitretin.
• Contraceptives: Acitretin decreases effects of medroxyprogesterone;
NNF 2018
391
norethindrone acetate and norethindrone. Contraceptive failure may result.
• Nitazoxanide: Either increases levels of the other by mechanism:
pharmacodynamic synergism. Use Caution/Monitor.
• Ospemifene: Either increases levels of the other by plasma protein binding
competition. Modify therapy/monitor closely.
Patient information: Females of child-bearing potential must be advised
on pregnancy prevention for at least 3 years after last use of drug. Do not
donate blood during and for 2 years after stopping therapy (teratogenic risk)"
ISOTRETINOIN,"Capsule: 5 mg, 10 mg, 20 mg, and 40 mg","Acne vulgaris, ichythyosiform disorders","Pregnancy (X), breastfeeding, hepatic impairment; diabetes, dry eye syndrome (associated with risk of keratitis), history of depression- monitor for depression. With topical use- allow peeling (resulting from other irritant treatments) to subside before using a topical retinoid, alternating a preparation that causes peeling with a topical retinoid may give rise to contact dermatitis (reduce frequency of retinoid application, avoid accumulation in angle of the nose, avoid contact with eyes, nostrils, mouth and mucous membranes; eczematous, broken or sun burned skin, avoid exposure to UV light (including sunlight, solariums), avoid in severe acne involving large areas, avoid use of topical retinoids with abrasive cleaners, comedogenic or astringent cosmetics; caution in sensitive areas Drugs used in Skin Disorders 392 such as the neck ; personal or familial history of non-melanoma skin cancer.","Topical treatment of mild to moderate acne: Apply 1–2 times a day, to be applied thinly. • Severe acne (acne which is associated with psychological problems, acne which has not responded to an adequate course of a systemic antibacterial)/Systemic treatment of nodulo-cystic and conglobate acne: per oral:-Initially 500 micrograms/kg daily in 1–2 divided doses, increased if necessary to 1 mg/kg daily for16–24 weeks, repeat treatment course after a period of at least 8 weeks if relapse after first course; maximum150 mg/kg cumulative dose per course","With oral use: anaemia, arthralgia, dryness of eyes (with blepharitis and conjunctivitis), dryness of lips (sometimes cheilitis), dryness of nasal mucosa (with epistaxis), dryness of pharyngeal mucosa (with hoarseness), dryness of skin (with dermatitis, scaling, thinning, erythema, pruritus), epidermal fragility (trauma may cause blistering); haematuria; headache; myalgia; neutropenia; proteinuria; raised bloodglucose concentration; raised plasma-triglyceride concentration; raised serum cholesterol concentration (with reduced high-density lipoprotein concentration); raised serum-transaminase concentration; thrombocytopenia; thrombocytosis","Alcohol increased risk of teratogenicity in women
of child-bearing potential; Antibacterials: possible increased risk of benign
intracranial hypertension when retinoids given with tetracyclines (avoid
concomitant use); Anticoagulants: acitretin possibly reduces anticoagulant
effect of coumarins; Antiepileptics: isotretinoin possibly reduces plasma
concentration of carbamazepine; Antifungals: plasma concentration of
alitretinoin increased by ketoconazole; possible increased risk of tretinoin
toxicity when given with fluconazole, ketoconazole and voriconazole;
Cytotoxics: acitretin increases plasma concentration of methotrexate (also
increased risk of hepatotoxicity) avoid concomitant use; Lipid-regulating
drugs: alitretinoin reduces plasma concentration of simvastatin"
DOXEPIN,Cream: 5%; Tablets: 25 mg,Pruritus (eczema),"Hypersensitivity, urinary retention, Drugs used in Skin Disorders 396 closed-angle glaucoma, prostatic hypertrophy, acute recovery from MI. Avoid application to large areas, breastfeeding, geriatric patients, seizures, pregnancy (B), mania, hepatic impairment, to use in below 12 years of age. Before using this medication, tell your doctor or pharmacist your medical history, especially of bleeding problems, breathing problems, liver problems, recent heart attack, problems of urination (such as due to enlarged prostate), overactive thyroid (hyperthyroidism), personal or family history of glaucoma (angle-closure type), personal or family history of mental/mood conditions (such as bipolar disorder, psychosis), family history of suicide, seizures, conditions that may increase your risk of seizures (such as other brain disease, alcohol/sedative withdrawal). Doxepin may cause a condition that affects the heart rhythm (QT prolongation). QT prolongation can rarely cause serious (rarely fatal) fast/irregular heartbeat and other symptoms (such as severe dizziness, fainting) that need medical attention right away.","Apply up to 3 g 3–4 times a day, apply thinly; coverage should be less than 10% of body surface area; maximum 12 g per day","Dizziness, drowsiness","Arbutamine, thyroid supplements, anticholinergic drugs (such as benztropine, belladonna alkaloids), centralacting drugs to treat high blood pressure (such as clonidine, guanabenz, reserpine). Taking Monoamine oxidase inhibitors with this medication may cause a serious (possibly fatal) drug interaction. Avoid taking MAO inhibitors (isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, safinamide, selegiline, tranylcypromine) Patient information: Drowsiness may affect performance of skilled tasks (e.g. driving). Effects of alcohol enhanced."
MINOXIDIL,Scalp foam: 5%; Solution: 2% and 5%,Androgenetic alopecia,"Pheochromocytoma, pregnancy. Avoid contact with broken, infected, shaved, or inflamed skin, avoid contact with eyes; avoid inhalation of spray mist; avoid occlusive dressings. Avoid in case of headache, irritation and rashes.","Apply 1 ml twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year","Headache, local irritation, when used topically systemic effects unlikely, only about 1–2% absorbed (greater absorption may occur with use on inflamed skin).","Caution avoid topical drugs which enhance absorption. Patient information: Ensure hair and scalp dry before application, patients and their care taker should be advised to wash hands after application of liquid or foam. Treatment must continue for the long term, or new hair will be lost."
POTASSIUM PERMANGANATE,Powder: 20 g; Tablets for cutaneous solution: 400 mg,Cleansing and deodorizing suppurating eczematous reactions and wounds,Hypersensitivity. Irritant to mucous membranes.,"Wet compress twice daily till lesions dry up. For wet dressings, use approximately (1 in 40,0000 to 1:25000) solution for weeping or oozing, 1:25000 for medicated bath. Potassium permanganate 0.1% solution to be diluted 1 in 10 to provide a 0.01% (1 in 10 000) solution. With potassium permanganate tablets for solution, 1 tablet dissolved in 4 liters of water provides a 0.01% (1 in 10 000) solution. Concentrated solution may cause irritation, dryness or erosion","Corrosion, irritation, redness, pain and burns Patient information: Can stain clothing, skin and nails (especially with prolonged use). Should be diluted in a tub of water until light pink. If it is too red, throw away the solution and dilute adding water to make it light pink only",
TETRACYCLINE,Eye ointment: 1%; Tablet/capsule: 250 mg or 500 mg,"Superficial bacterial infection of eye, chlamydial infection of eye, trachoma, chemical injury, blepharitis","Hypersensitivity. Pregnancy cat (D), lactation, less than 12 years children. Elderly, Topical use may result in overgrowth of non-susceptible organism like fungi, hepatic and renal impairment, SLE",Given once or twice a day,,"With topical corticosteroid, may mask clinical signs of bacterial, fungal or viral infection or may suppress hypersensitivity reactions to antibiotics or any ingredients in formulation"
ACYCLOVIR,"Eye ointment: 3%, Tablet: 400 mg and 800 mg",Herpes simplex epithelial keratitis and herpes zoster opthalmicus associated keratitis,,Ointment to apply 5 times a day for 2 weeks to 3 weeks," Local burning and stinging, blepharitis, superficial punctate keratitis",
INDOMETHACIN,Tablets: 25 mg; Sustained release tablets: 75 mg,"Cystoid macular degeneration, anterior uveitis, vernal conjunctivitis, prevention of intra-op miosis, episcleritis, scleritis, gastritis, gastric ulcer",,25 mg TDS or SR 75 mg OD for 7-10 days,"Corneal changes and deposits, ocular irritation, conjunctival hyperemia, superficial punctate keratitis",
KETOROLAC,Eye drops: 0.5%; Tablet: 10 mg; Injectable solution: 15-30 mg/ml,"Superficial ocular surface inflammation, moderate to severe pain, ocular itching associated with seasonal allergic conjunctivitis, prophylaxis and decrease of postoperative ocular inflammation, cystic macular edema","Children, lactation, hypersensitivity to aspirin or other NSAIDS, asthma, hypovolemia or dehydration, history of peptic ulcer or coagulation disorders, nasal polyps, angioedema, bronchospasm, labor, moderate to severe renal impairment, cerebrovascular bleeding. Elderly, weight","Ophthalmic (eye drops): • Ocular surface inflammation: Adult: Instill 1 drop of 0.5% solution 4 times daily into affected eye for 7-10 days • Prophylaxis and reduction of postoperative ocular inflammation: Adult: Instill 1 drop of 0.5% solution into appropriate eye(s) 4 times daily. Continue for 2 weeks • Cystoid macular edema: Adult: Instill 1-2 drops of 0.5% solution into appropriate eye(s) every 6-8 hours and continue for 3-4 weeks • Pain and photophobia after incisional refractive surgery: Adult: Instill 1 drop of 0.5% solution 4 times daily into operative eye for up to 3 days after surgery; •Oral: • Moderate to severe pain: Adult: 10 mg every 4-6 hourly maximum 40 mg/ day, maximum duration: 7 days; Elderly: 10 mg every 6-8 hourly; maximum duration: 7 days; • Parenteral: • Moderate to severe pain: Adult: 60 mg single dose intramuscular injection or 30 mg SD intravenous injection. Alternately, 30 mg every 6 hourly IM or IV up to maximum 120 mg daily; half the doses if weight","Gastrointestinal ulcer, bleeding and perforation, drowsiness, rash, bronchospasm, psychosis, dry mouth, fever, bradycardia, chest pain, dizziness, headache, sweating, edema, pallor, liver function changes, transient stinging and local irritation (eye)",
ACETAZOLAMIDE,Tablets: 250 mg; Injection: 500 mg,"Open-angle glaucoma, angle-closure glaucoma (preoperatively if surgery delayed)","Hypersensitivity to sulfonamide ,Stevens Johnson syndrome, severe renal, hepatic disease, electrolyte imbalance, hyperchloremic acidosis, Addison’s disease, adrenocortical deficiency, long-term use in non-congestive angle-closure glaucoma. Pregnancy cat C, breast-feeding, hypercalciuria, respiratory acidosis, pulmonary obstruction, emphysema and COPD",Acute attack of angle closure glaucoma: Adult: PO/IV500 mg stat followed by 250mg TID or QID,"Seizures, confusion, cholestatic jaundice, metabolic acidosis"," Increases action of Amphetamines, Phenytoin, procainamide, quinidine, anticholinergic; Increases toxicity of salicylate and cyclosporine; causes cardiac toxicity if hypokalemia develops with arsenic trioxide, cardiac glycoside, levo methadyl"
CIPROFLOXACIN with HYDROCORTISONE,"Suspension: ciprofloxacin 0.2%, Hydrocortisone 1%",Chronic suppurative otitis media,,Intraaural: 2-3 drops in the affected ear 2-3 times a day for 7-10 days.,,
AMOXICILLIN,,"Otitis media, sinusitis",,"Oral, Child (1–11 months): 125 mg 3 times a day; increased if necessary up to 30 mg/kg 3 times a day. Child (1–4 years): 250 mg 3 times a day; increased if necessary up to 30 mg/kg 3 times a day. Child (5–11 years): 500 mg 3 times a day; increased if necessary up to 30 mg/kg 3 times a day (max. Per dose 1 g). 12 years and above: 500 mg 3 times a day; increased if necessary up to 1 g 3 times a day, use increased dose in severe infections",,
AZITHROMYCIN,,"Otitis media, sinusitis (beta lactamase producing strains of H. influenza and M catarrhalis.",,"Oral, adult: 2000 mg (2 extended release tablet) 2 times a day for 10 days",,
CEFTAZIDIME,"Powder: 250 mg, 500 mg, 1 gm to be reconstituted Indications: Perichondritis",,,"Oral, adult: 2000 mg (2 extended release tablet) 2 times a day for 10 days",,
CEFTAZIDIME,"Powder: 250 mg, 500 mg, 1 gm to be reconstituted",Perichondritis,,"Intravenous, adult: 1-2 gm in 2 divided doses in a day (along with aminoglycosides), for 6- 8 weeks.",,
PROCHLORPERAZINE,Tablet: 5 mg,Acute vertigo,,"Oral: 5 mg during acute phase, can be given 3 times a day, usually not recommended for more than a week.",,
BETAHISTINE,Tablet: 8 mg,Ménière’s disease.,"Pheochromocytoma. Use with caution asthma, history peptic ulcer. Not recommended in children. Pregnancy: avoid, unless clearly necessary. In lactation and elderly, use with caution.","Oral, adult: Initially 16 mg 3 times daily, preferably with food; maintenance 24- 48 mg daily.","Gastrointestinal disturbances, headache, pruritus, rashes",
CINNARIZINE,"Tablet: 25 mg, 75 mg.","Tablet: 25 mg, 75 mg. Indications: Relief of symptoms of vestibular disorders, such as vertigo, tinnitus, nausea, and vomiting in Ménière’s disease, motion sickness","Avoid in acute porphyria, neonate, pregnancy, severe liver disease (increased risk of coma). Use with caution renal impairment, epilepsy, glaucoma (in children), Parkinson’s disease (in adults), prostatic hypertrophy (in adults), pyloroduodenal obstruction, susceptibility to angle closure glaucoma (in adults), urinary retention.","Relief of symptoms of vestibular disorders in Ménière’s disease: oral, 12 years and above: 25 mg 3 times a day, up to 5-7 days or unless indicated. Motion sickness: oral, child (5–11 years): Initially 15 mg, dose to be taken 2 hours before travel, then 7.5 mg every 8 hours if required, dose to be taken during journey. 12 years and above: Initially 30 mg, dose to be taken 2 hours before travel, then 15 mg every 8 hours if required, dose to be taken during journey","Drowsiness, although paradoxical stimulation (especially with high doses in children), anaphylaxis, angioedema, angle-closure glaucoma, arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, lichen planus, liver dysfunction, lupus-like skin reactions, palpitation, photosensitivity reactions, rashes, sleep disturbances, sweating, tremor, weight gain, antimuscarinic effects, blurred vision, dry mouth, gastro-intestinal disturbances, headache, psychomotor impairment, urinary retention. Children and elderly are more susceptible to side effects.",
PREDNISOLONE,"Tablets: 5 mg, 10 mg, 20 mg","Bell’s palsy, sudden sensorineural hearing loss, Ramsay-Hunt syndrome, vestibular neuronitis",,"Bell’s palsy: oral, adult: 1 mg/kg/day for 5 days to 3 weeks depending on the patients progression then taper in every 5 days;Sudden sensorineural hearing loss: oral, adult: 1 mg/kg/day for 10-15 days;Ramsay-Hunt syndrome: oral, adult: 1 mg/kg for 14 days, followed by a declining dose of 5 mg/ day in every 5 days. For endrocine Disorder:Oral, adult- 5-60 mg/day; children: 0.14-2 mg/kg/day in 3-4 divided doses; IV: 10-40 mg, 1-2 times weekly; IM 100 mg, 1-2 times weekly","Patient’s information: Preferably taken in the morning after breakfast or
food; can often be reduced within a few days but may need to be continued
for several weeks or months. ",
MUPIROCIN,Ointment: 20 mg/gram,"For eradication of nasal carriage of staphylococci, including methicillin-resistant Staphylococcus aureus (MRSA)",,"intranasal: 2–3 times a day for 5 days; a sample should be taken 2 days after treatment to confirm eradication. Course may be repeated
if sample remains to be positive",,
CETIRIZINE,Tablet: 10 mg; Syrup: 5 mg/5ml,"Symptomatic treatment of any allergic condition elated to ENT, urticaria, chronic idiopathic urticaria","Avoid in acute porphyrias and pregnancy.
Use with caution in epilepsy. Renal impairment: In adults, use half normal
dose if eGFR 30- 50 mL/minute/1.73 m2. Use half normal dose and reduce
dose frequency to alternate days if eGFR 10- 30 mL/minute/1.73 m2. ","Oral, child (2-5 years): 2.5 mg twice daily. Child (6–11 years): 5 mg twice daily. 12 years and above: 10 mg once daily","Antimuscarinic effects, blurred vision, dry mouth, gastrointestinal. disturbances, headache, psychomotor impairment, urinary retention, anaphylaxis, angioedema, angle-closure glaucoma (in adults), arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, liver dysfunction, palpitation, photosensitivity reactions, rashes, sleep disturbances, tremor, drowsiness. Children and the elderly are more susceptible to side effects.",
DESLORATADINE,Tablet: 5 mg,"Symptomatic treatment of any allergic condition elated to ENT, urticaria, chronic idiopathic urticaria","Contraindicated if history of hypersensitivity to loratadine. Use with caution in acute porphyrias, epilepsy, severe renal impairment. Pregnancy: avoid","Oral, child (1–5 years): 1.25 mg once daily; child (6–11 years): 2.5 mg once daily, 12 years and above: 5 mg once daily","Antimuscarinic effects, blurred vision, dry mouth, gastrointestinal. disturbances, headache, psychomotor impairment, urinary retention, anaphylaxis, angioedema, angle-closure glaucoma (in adults), arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, liver dysfunction, palpitation, photosensitivity reactions, rashes, sleep disturbances, tremor, drowsiness. Children and the elderly are more susceptible to side effects.",
EBASTINE,"Tablet: 10 mg, 20 mg","Symptomatic treatment of any allergic condition elated to ENT, urticaria, chronic idiopathic urticaria",,"Oral, adult: 10-20 mg once daily","Antimuscarinic effects, blurred vision, dry mouth, gastrointestinal. disturbances, headache, psychomotor impairment, urinary retention, anaphylaxis, angioedema, angle-closure glaucoma (in adults), arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, liver dysfunction, palpitation, photosensitivity reactions, rashes, sleep disturbances, tremor, drowsiness. Children and the elderly are more susceptible to side effects.",
FEXOFENADINE,"Tablet: 30 mg, 120 mg, 180 mg","Symptomatic relief of seasonal allergic rhinitis, symptomatic relief of chronic idiopathic urticarial",Use with caution in epilepsy,"Symptomatic relief of seasonal allergic rhinitis: oral, Child (6- 11 years): 30 mg twice daily, 12 years and above: 120 mg once daily; Symptomatic relief of chronic idiopathic urticarial: oral, 12 years and above: 180 mg once daily","Antimuscarinic effects, blurred vision, dry mouth, gastrointestinal. disturbances, headache, psychomotor impairment, urinary retention, anaphylaxis, angioedema, angle-closure glaucoma (in adults), arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, liver dysfunction, palpitation, photosensitivity reactions, rashes, sleep disturbances, tremor, drowsiness. Children and the elderly are more susceptible to side effects.",
LEVOCETIRIZINE,Tablet: 5 mg,"Symptomatic treatment of any allergic condition elated to ENT, urticaria, chronic idiopathic urticaria","Avoid in acute porphyria, pregnancy. Use with cautions: epilepsy. Renal impairment: in adults 5 mg on alternate days","Oral, 6 years and above: 5 mg once daily","Antimuscarinic effects, blurred vision, dry mouth, gastrointestinal. disturbances, headache, psychomotor impairment, urinary retention, anaphylaxis, angioedema, angle-closure glaucoma (in adults), arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, liver dysfunction, palpitation, photosensitivity reactions, rashes, sleep disturbances, tremor, drowsiness. Children and the elderly are more susceptible to side effects.",
LORATADINE,"Tablet: 5 mg, 10 mg","Symptomatic treatment of any allergic condition elated to ENT, urticaria, chronic idiopathic urticaria","Avoid in acute porphyria, epilepsy. Reduce dose frequency to alternate days in severe hepatic impairment","Oral, child (2-11 years and body weight ≤ 30 kg): 5 mg once daily. Oral, child (2-11 years and body weight >30 kg): 10 mg once daily. Oral, ≥ 12 years: 10 mg once daily","Antimuscarinic effects, blurred vision, dry mouth, gastrointestinal. disturbances, headache, psychomotor impairment, urinary retention, anaphylaxis, angioedema, angle-closure glaucoma (in adults), arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, liver dysfunction, palpitation, photosensitivity reactions, rashes, sleep disturbances, tremor, drowsiness. Children and the elderly are more susceptible to side effects.",
TRANEXAMIC ACID,Tablet: 500 mg,"Menorrhagia, epistaxis, thrombolytic overdose, hereditary angioedema, prophylaxis of hereditary angioedema.",Severe renal impairment (CrCl<1.5mg/dl) and thromboembolic disease. Caution in renal impairment and pregnancy,"Epistaxis: 1000-1500 mg every 8-12 hours for 10 days ;Menorrhagia (initiated when menstruation started): oral, adult: 1 g 3 times
daily for up to 4 days, maximum 4 g daily; Local fibrinolysis: adult, oral: 15-25 mg/kg 2-3 times daily. Epistaxis: oral,
adult: 1 g 3 times a day for 7 days; Hereditary angioedema: oral, adult: 1–1.5 g 2–3 times a day, for short-term.
Patient information: Drug shouldn’t be used in combination with hormonal
contraceptives (birth control pills, patches, rings, injection). Do not take for
more than 5 days in a row. ","Nausea, vomiting, diarrhoea, disturbances in colour vision, nose stuffiness",
CHLORHEXIDINE + LIDOCAINE + METRONIDAZOLE,"Ointment: Chlorhexidine 1% (w/w), Lidocaine 2% (w/w), Metronidazole 1% (w/w)","Oral cavity laceration, apthous ulcer, oral ulcers with high risk of infection (sutured wound)",Hypersensitivity reaction,"Oral cavity lesion, local application, three times a day for 5-7 days",,
CEFDINIR,"Capsule: 300 mg, Oral suspension: 125 mg/5mL, 250 mg/5mL","Acute tonsillitis, acute oropharyngitis"," Hypersensitivity, skin rashes","Tonsillitis and pharyngitis: adult, 600 mg oral, once a day for 10 days or 300 mg oral, twice a day for 10 days; child, 14 mg/kg PO once daily for 10 days","Urtricaria, skin rash",
PENICILLIN V," Tablet: 250 mg, 500 mg; Oral suspension: 125 mg/5mL, 250 mg/5mL","Tonsillitis and pharyngitis, quinsy (with metronidazole)","Hypersensitivity reaction, renal impairment","Tonsillitis and pharyngitis (penicillin susceptible): adult, 500 mg oral, two times a day for 10 days or 250 mg oral, four times a day for 10 days; child, 25-50 mg/kg/day divided every 6 hours for 10 days","Diarrhea, nausea, vomiting",
VALACYCLOVIR,"Tablet: 500 mg, 1 gm",Herpes labialis,"Hypersensitivity reaction, acute renal failure","Herpes labialis: oral, 2 grams, two times a day for one day",,
ACETAMINOPHEN (PARACETAMOL),Tablet: 500-1000 for Adult,"Acute laryngitis, acute tonisilitis, acute oropharyngitis, quinsy",,"Adult: 4times a day in gap of 6hrs(Max:4000mg) Children:10-15mg/kg, 4times a day in  6hrs(Max: 65mg/kg)",,
PANTOPRAZOLE,Tablet: 40 mg,Laryngopharyngeal reflux,,"Laryngopharyngeal reflux: oral, 40 mg, two times a day for 6 weeks with/without domperidone",,
ASPIRIN,Tablet: 75 mg non-enteric coated chewed and swallowed. Chewable tablet: one to four 81 mg chewed and swallowe),Tablet: 75 mg non-enteric coated chewed and swallowed. Chewable tablet: one to four 81 mg chewed and swallowe),,Administer as soon as the MI attack occurs.,,
GLYCERYL TRINITRATE (GTN),Sublingual tablet 0.5 mg; Spray 0.4 mg; Injection 1 mg/ml, Relief of chest pain associated with angina pectoris encountered during dental treatment,GTN must be placed under the tongue (administered sublingually) & retained in the mouth until dissolved or discarded (a local burning or tingling sensation may occur); Inability to relieve chest pain after 3 doses indicates acute MI - should be rushed to emergency department if possible,"When angina starts, one sublingual tablet or 1-2 spray should be placed under the tongue & if symptoms do not resolve, may be repeated at 5 minutes interval for a total of 3 doses If symptoms have not resolved after a total of 3 doses, patient should seek prompt medical attention",,
DIPHENHYDRAMINE,"Injectable solution 50mg/ml; Tablets: 25mg, 50mg",Allergic reactions to any material or medication used during dental procedures.; As an alternative anesthetic agent in cases of local “caine” anesthetic allergies.,,25 – 50mg PO 6 to 8 hourly; not to exceed 300mg per day; 10-50mg (no more than 100mg) IV/IM 4 to 6 hourly; not to exceed 400mg per day,,
AMOXICILLIN,"Oral preparations- Dispersible tablets, syrup, and capsules 125 mg, 250 mg, 500 mg; Adults: 250-500mg, three times a day; Children: 20-40 mg/kg/day in three divided doses; Suspension- 125 mg per 5 mL, 250 mg per 5 mL"," Orodental infections, actinomycosis, acute maxillary sinusitis; Also used as a prophylactic drug.","Cannot be used in patients who are allergic to β-lactam antibiotics (e.g., penicillins and cephalosporins); Care to be taken in patients with chronic renal dysfunction.",,,
AMOXICILLIN + CLAVULANIC ACID,"Oral preparations - Tablets, 30 ml syrup and suspension; Tablets (for adults): Amoxicillin 250mg + Clavulanic acid 125mg; Amoxicillin 500mg + Clavulanic acid 125mg; Amoxicillin 500mg + Clavulanic acid 500mg; Tablets (for children): Amoxicillin 125mg + Clavulanic acid 31.25mg; Syrup (30ml): Amoxicillin 125mg + Clavulanic acid 31.25mg per 5ml; Amoxicillin 250mg + Clavulanic acid 125mg per 5ml",,,,,
TETRACYCLINE,Oral preparations- Capsules and tablets 250mg and 500mg Adults: 1gm daily in 2-4 divided doses (maximum of 2gm/day) Children: 20-40 mg/kg/day in 2-4 divided doses, Apthous Ulcers; Periodontal diseases,"Hypersensitivity to tetracycline; Renal failure, Systemic Lupus Erythematosus; Pregnant women and nursing mothers; Children less than 8 years of age",,"Taking the medicine during pregnancy may affect the tooth and bone development in the unborn baby due to the affinity of tetracycline for calcium and gets deposited as tetracycline calcium orthophosphated complex. Deposits of these antibiotics in teeth causes yellow discoloration. Taking the medicine during last half of pregnancy can cause permanent tooth discoloration later in the child’s life; Diarrhea, nausea, vomiting, light sensitive rashes, Benign Intracranial hypertension, Pancreatitis, Pseudomembranous colitis; The critical period for tetracycline-related discolouration in the primary dentition is 4 months in utero to 3 months postpartum for maxillary and mandibular incisors and 5 months utero to 9 months postpartum for maxillary and mandibular canines ;The sensitive period for tetracycline-induced discolouration in the permanent maxillary and mandibular incisors and canines is 3 to 5 months postpartum to about the seventh year of the child’s life. The maxillary lateral incisors are an exception because they begin to calcify at 10 to 12 months postpartum.",
DOXYCYCLINE,Oral preparations- Capsules and tablets 50mg and 100mg; Adults: First day- 100 mg 2 times/day followed by 100mg one per day; Children: 5 mg/kg/day in 2 divided doses,,,,,
METRONIDAZOLE,"Oral preparations: Tablets: 200mg, 400mg; Suspension: 100mg/5ml suspension, 200mg/5ml suspension.; Parenteral NNF 2018 441 preparations: 500mg/100ml IV infusions; Adults: 400mg three times a day; Children: 30-50mg per kg weight per day in divided doses",Anaerobic infections (first choice of drug); Ulcerative gingivitis,"Has mutagenic potential therefore not to be used in the
first trimester of pregnancy. Neurological diseases, chronic alcoholism and
blood dyscrasias.
Patient’s Information: Discontinue consumption of alcoholic beverages or
products containing propylene glycol while taking Metronidazole tablets
and for at least three days afterward because abdominal cramps, nausea,
vomiting, headaches, and flushing may occur",,,
NYSTATIN,"Oral - 5, 00,000 unit tablets TDS; Topical - 100,000 unit/gm cream and ointments. It is available currently for topical use in creams, ointment, suppositories, lotion, suspension, vaginal tablets, and oral pastille.",Oral candidiasis (Oral thrush); Denture stomatitis (chronic atrophic candidiasis): 0.2% chlorhexidine solution with Mycostatin tablet dissolves in it forming gel used mainly in such patients.; Candidial Angular cheilitis,Hypersensitivity to nystatin,"Thrush is treated by holding 5 ml of nystatin suspension (for infants- 2 ml) in oral cavity for several minutes 4 times daily before swallowing. Alternative treatment is to retain vaginal tablet in the mouth until it dissolves, at least 4 times a day. Nystatin oral pastille (200,000 units) dissolved slowly in the mouth 5 times a day—can be mixed with glycerin.",,
CLOTRIMAZOLE,"Topically: 1% Gel, cream, lotion, solution.; Oral: 100 mg, 200 mg, 500 mg tab.",Candidiasis, Hypersensitivity to imidazole; 1st trimester of pregnancy,"For oropharyngeal candidiasis, 10 mg lozenge of clotrimazole is allowed to dissolve in the mouth 3-4 times a day, or the lotion/ gel is applied/ swirled in the mouth for as long as possible.",,
KETOCONAZOLE (KTZ),"Topical Solution: 1%; Cream: 1%, 2%; Oropharyngeal lozenge: 10mg",Mucocutaneous candidiasis ; Oropharyngeal candidiasis (thrush),Pregnancy; Azole antifungals hypersensitivity,"For fungal infections: Adults—At first, 200 milligrams (mg) once a day.; Children 2 years of age and older—Dose is based on body weight and must be determined. The dose is usually 3.3 to 6.6 milligrams (mg) per kilogram (kg) of body weight per day.; Children younger than 2 years of age—Use and dose must be determined by your doctor.",,
ACYCLOVIR,"Topical – Cream 5%, ointment, mucoadhesive buccal tablet; Capsules (200mg, 400mg, 500mg, 800mg)","To treat cold sores around the mouth (caused by Herpes Simplex),oral lesions related to chicken pox & shingles ( caused by Varicella Zoster )","Take this medicine by mouth with or without
food, usually 2 to 5 times a day as directed by your doctor; Treatment with
acyclovir should be started as soon as possible after the first appearance of
symptoms. ( such as tingling, burning, blisters)
Patient’s information: Take acyclovir for the entire length of time prescribed
by your doctor; Seek medical advice as soon as lesion appears",Should be administerd within first 72 hours in a dosage of 200 mg 5times a day for 10 days.; As a prophylactic measure for recurrent herpes infection – 400 mg twice a day for 10 days; 800 mg 5times a day for a week or Valacyclovir 1000mg or Famciclovir 500mg 3 times a day for a week for oral lesions of Herpes Zoster,Stinging and burning sensation after each application; Mouth pain while using an acyclovir buccal tablet,
SUBANTIMICROBIAL DOSE OF DOXYCYCLINE (SDD / Periostat),Tablet - 20mg (doxycycline hyclate),"As an adjunct to scaling & root planning in the treatment of chronic periodontitis & aggressive periodontitis; May also be benefit in cases that are refractory to treatment, as well as in patients with risk factors such as smoking or diabetes, in whom treatment response might be limited; As an adjunct to periodontal surgery",Any patient with history of allergy or hypersensitivity to tetracyclines; Should not be given to pregnant or lactating women; Children < 12 yrs as due to high potential for discoloration of developing dentition. Should not be used as a stand-alone therapy,"20mg, taken twice a day for 3 months (maximum of 9 months)",20mg dose is usually well tolerated by the body,Efficacy of oral contraceptive pills may be reduced when used with tetracylines
MINOCYCLINE HYDROCHLORIDE,121 unit dose of 1mg cartridges of microsphere powder 2% w/w gel,As an adjunct during dental scaling & root planing to reduce NNF 2018 451 pocket depth in adults with periodontitis,"Contraindications: Allergy to any tetracycline antibiotic; Periodontal pockets associated with abscess formation; Renal failure; Patient under 12 years of age; Should not be used in children, pregnant or nursing women during the tooth development phase, as it can cause permanent discoloration of the teeth; Precautions: Liver or renal disease; Use with caution in pregnant women or nursing mothers","Powder form: Cartridges used in a single visit and up to 3 treatments, at 3-month intervals Gel form: Applied 3-4 times with an interval of 14 days. Procedure repeated, if necessary, after 6 months.","Swelling of the eyes, mouth and possibly hands, feet and throat, breathing difficulties, rash, hives (raised, often itchy, red patches on the skin), itching at the site of application.",
TRANEXAEMIC ACID,"5% mouthwash (500 mg tablet dissolved in 10mL of water); 10mg/kg body weight IV, with the dose being repeated 4-6 hourly.",Indicated in dental extractions in patients with hemophilia for short term use (2-8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extractions.,"Contraindications: In patients with active intravascular clotting Tranexaemic acid injections are contraindicated in patients with acquired defective colour vision.; In patients with hypersensitivity to it or any of its ingredientsPrecautions: The dose of tranexaemic acid injection should be reduced in
patients with renal insufficiency because of the risk of accumulation
Caution should be taken in patients with upper urinary tract bleeding
Patients with previous history of thromboembolic disease may be at increased
risk for venous or arterial thrombosis.
It may cause dizziness therefore may influence the ability to drive or use
machines. ",,Nausea and Diarrhoea; Headache and giddiness; Thrombophlebitis of injected veins,
EPSILON AMINO-CAPROIC ACID (EACA),"Injectable solution - 250mg/ml; Syrup - 1.25g/5Ml; Tablet-500 mg, 1000 mg","It is a specific antidote of fibrinolyic agents and has been used in many hyperplasminemic states associated with excessive intravascular fibrinolysis resulting in bleeding, such as: Overdose of streptokinase/ urokinase/alteplase; Certain traumatic and surgical bleedings; To prevent recurrence of subarachnoid and g.i. harmorrhage Abruptio placentae and certain cases of menorrhagia",It should not be used when there is evidence of an active intravascular clotting process. It must not be used in the presence of DIC without concomitant heparin. It should be cautiously used when renal function is impaired,,"Edema, headache, malaise.; Allergic and anaphylactoid reactions, anaphylaxis.; Bradycardia, hypotension, peripheral ischemia, thrombosis.; Abdominal pain, diarrhea, nausea, vomiting.; Agranulocytosis, coagulation disorder, leukopenia, thrombocytopenia. Confusion, convulsions, delirium, dizziness, hallucinations, intracranial hypertension, stroke, syncope. Dyspnea, nasal congestion, pulmonary embolism. Pruritis, rash. Tinnitus, vision decreased, watery eyes","Aminocaproic acid should not be administered with Factor IX Complex concentrates or Anti-Inhibitor Coagulant concentrates, as the risk of thrombosis may be increased."

